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According to recent statistics, one of every five deaths in the 
u.s. is from cancer (American Cancer Society, 1982). Claiming over 
1200 deaths per day, it ranks second to cardiovascular disease as the 
leading killer in our country. Because it can strike at any age, it is 
no surprise that cancer has been called "the most feared disease of 
the 20th century" (Holland, 1981). Indeed, many still equate the word 
cancer with death. This equation was reflected in the pre-1970 psycho-
social oncology literature, which almost exclusively emphasized the 
dying process and coping in the terminally ill cancer patient (e.g., 
Kubler-Ross, 1969). One exception to this rule was the pioneering work 
of Arthur Sutherland on the psychological impact of cancer and its 
treatment on, for example, colon (Sutherland, Orbach, & Dyk, 1952) and 
breast cancer patients (Bard & Sutherland, 1955). 
Attention to the problems of the surviving cancer patient has 
followed the progress of medical science in the treatment of cancer. 
In the early 1900's, surgery was the only treatment for cancer, so 
cure was possible only when the lesion was detected early and complete-
ly excised. The introduction of radiation therapies in the 1930's, 
and the addition of chemotherapy in the 1950's have dramatically im-
proved the prognosis for many types of cancer. At present, a projected 
38% (46% if one excludes death from other causes) of cancer patients 
diagnosed this year will still be alive in five years (American Cancer 
Society, 1982). Many of these will be off treatment, and may go on 
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to live out their full life span. However, all of them hold a respon-
sibility to their health which requires vigilance toward symptoms of 
relapse. Cancer is therefore better defined today as a chronic life-
threatening illness, than as a fatal disease. Thus, today's "cured" 
cancer patient faces the same tasks as those suffering from any serious 
chronic illness. The National Cancer Institute has identified two 
general tasks which the cancer patient must confront: 1) coping with 
illness and its complications, such as pain or paralysis; and 2) cop-
ing with life as it is altered by illness (Blumberg, Flaherty, & 
Lewis, 1980). The present study is concerned with the second of these 
tasks. This task, relating to quality of life, has been further sub-
divided into four general categories: a) preserving a reasonable 
emotional balance; b) preserving a satisfactory self-image; c) pre-
serving relationships with family and friends; and d) preparing for 
an uncertain future (Blumberg et al., 1980). 
The advent of multimodal cancer treatment (including surgery, 
radiation, and chemotherapy) has ushered in a new era of cancer sur-
vival which makes the study of the above tasks possible. The paradox 
of this medical advancement lies in the legacy which it leaves behind: 
that most successfully treated cancer patients must face a new spec-
trum of problems that are related to the late (physiological) effects 
of treatment. 'The normal physiology of virtually every organ or 
structure of the body can be impaired more or less by radiation ther-
apy, chemotherapy, and their combinations" (D'Angio & Ross, 1981, p. 
45). Consequently, whereas multimodal therapies have had dramatic 
positive effects on the survival rates of some cancers, they have also 
increased the risks of morbidity and mortality in the post-five-year 
period. These include risk of relapse, heightened risk of second 
malignancies (Li, 1977; Li, Cassady, & Jaffe, 1975), increased risk of 
carditis, pericarditis, and pneumonia (Desforges, Rutherford, & Piro, 
1979; Jaffe, 1975), and permanent sterility (Sherins & DeVita, 1973; 
Sutcliffe, 1979). Because of this, the study of late, or delayed 
psychological effects of cancer and its treatment is a necessary one. 
Globally, there are two conceptual models for understanding 
adaptation to survival from serious illness. The first views the 
direction of adaptive response as anticipatory vis-a-vis the prospect 
of death. This approach postulates a mechanism of anticipatory grief 
in the face of threatened loss, analogous to the experience of actual 
loss sustained in mourning proper. This approach borrows heavily from 
the phase-theory description of terminality by Kubler-Ross (1969). 
Thus, the patient, confronted with the diagnosis of cancer, is said 
to undergo a fixed sequence of bereavement responses, including 
denial, anger, bargaining, depression, and acceptance. Following 
from this scheme, the surviving cancer patient is said to be in a 
protracted state of anticipatory grief which gives rise to anxiety, 
depression, vulnerability, and death-related concerns. 
The second conceptual model for survivor adaptation, and that 
embraced by this study, views the direction of adaptive response as 
residual vis-a-vis the past stressor of diagnosis and resulting treat-
ment. In the medical psychology literature, the conceptualization of 
diagnosis (Katz, Weiner, Gallagher, & Hellman, 1970), the experience 
of illness itself (Lipowski, 1970), and the initiation of treatment 
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(Cohen & Lazarus, 1973; Janis, 1958) with life-threatening illnesses, 
are seen as stressors which are disruptive to homeostatic functioning. 
At present, the majority of studies of cancer survival lie in the area 
of adaptation to diagnosis and treatment itself. The next clinical 
event associated with psychological disruption is disease recurrence, 
frequently responded to with elevated depression and anxiety, because 
the patient is confronted with the failure of treatment (Silberfarb, 
1982; Silberfarb~ Maurer, & Crouthamel, 1980). Subsequent risk for 
increase in anxiety and depression are also expected at cessation of 
a successful course of treatment, when the patient confronts the twin 
demands of separation from the therapy milieu and re-entry into per-
sonal lifestyle (Holland, Rowland, Lebovits, & Rusalem, 1979; Sut-
cliffe, 1979). There is also widespread confirmation that trait 
classification of global adaptational capability (Koocher & O'Malley, 
1981), coping adequacy (Penman, 1979), ego strength (Worden & Sobel, 
1978), and level of distress (Sobel & Worden, 1979), as measured on 
various state variables, differentiate poor from good adjustment 
during these periods. 
The next logical step in psychosocial adaptation research is the 
investigation of long-term sequelae. In a recent comprehensive re-
view article, the understanding of the long-term impact of cancer is 
given as one of the key questions which remains unanswered in psycho-
social oncology (Freidenbergs, Gordon, Hibbard, Levine, Wolf, & 
Diller, 1981-82). Information in this area is cited as essential to 
"facilitate the development of a systematic psychosocial intervention 
program for the cancer patient" (p. 315). 
4 
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This study attempted to evaluate psychological functioning in a 
successfully treated sample which is not currently plagued by treatment 
side-effects or by reactions to recurrence. All patients have 
been disease and treatment free for a minimum of six months. This en-
abled an unprecedented retrospective study of psychological adjustment 
in young adult male Hodgkin's disease patients who have been success-
fully treated. Besides the general cancer variable, the independent 
variables of interest wereseverity of disease stage (early vs. late) 
and time off treatment (recent vs. distant). Dependent measures as-
sessed psychosexual dysfunction, psychiatric symptomatology, mood 
states, death anxiety, self-esteem, coping style (thinking), psycho-
social problems in interview, and readiness for intimacy (intimacy 
motivation). 
Adaptation is the central concept in this study. The term 
"adaptation" is preferred over "coping" (adaptation under difficult 
conditions), "mastery" (behavior in which frustration is surmounted), 
and "defense" (response to danger). As explained by White (1976) and 
Sutherland (1956), adaptation (to cancer) would focus on the chronic 
process of adjustment (to cancer) and its subtle intrustions upon 
homeostatic functioning. This is the outlook preferred also by Silber-
farb (1982). Thus, the young adult cancer patient is constantly con-
fronted with the realization that he is different from those around 
him. He must make adjustments to account for the unique stressors of 
untimely disease, debilitating treatment, and chronic uncertainty. 
This study attempts to measure these adjustments by comparing Hodgkin's 
disease patients to an age-matched healthy comparison group, and to 
themselves across the variables of disease stage severity and time off 
treatment. Dependent measures were chosen and hypotheses made accord-
ing to the available cancer survivor literature. 
The choice of young adult men as the target population for this 
study came in part from consideration of relevant developmental tasks 
in this age group. For example, Erikson (1950) considers the central 
task of this group to be the development of a capacity for intimacy, 
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or a sense of mutuality with a loved partner, with whom the individual 
regulates work, procreation, and recreation. Young adulthood is a time 
of beginnings in personal, social, and occupational spheres. The 
impact of a major disease at this time in life is usually both a sur-
prise and a source of resentment. In the case of all participants 
chosen for this study, it was the first time they experienced any real 
threat to their lives. 
To summarize, this study attempts to identify problems in adapta-
tion to cancer which young men face in the post-treatment period. 
Because of its view on adaptation as described by White (1976), the 
investigation concerns itself as much with day-to-day adaptational 
difficulties as it does with more overt problems which may surface. 
Each individual is seen as striving toward suitable compromise rather 
than mastery in the face of adversity, and so the study will at times 
seek to determine unique patterns of adjustment rather than necessar-
ily a picture of psychiatric morbidity or exaggerated stress-response 
syndromes. 
It was decided on methodological grounds to limit the investiga-
tion to one form of cancer (Hodgkin's disease) and one sex (male). 
Men were chosen over women on the supposition that they would repre-
sent a more homogeneous group with regard to occupational goals, and 
because literature to be reviewed later has identified the young male 
patient as at higher risk for post-treatment interpersonal difficulty 
(Leiber, Plumb, Gerstenzang, & Holland, 1976). Hodgkin's disease 
was chosen for three reasons: 1) its status as a "good prognosis" 
cancer, with five-year survival rates ranging from 70% (late stage) 
to 90% (early stage) (American Cancer Society, 1978); 2) peak inci-
dence in young adults; and 3) the debilitating quality of the com-
bined modality treatment for Hodgkin's disease. 
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REVIEW OF THE RELATED LITERATURE 
This chapter is divided into two main sections. The first sec-
tion describes Hodgkin's disease in terms of its pathology, staging, 
and treatment. Specific attention will be given to treatment proce-
dures at Memorial Hospital in New York City since the current sample 
comes from there. The second main section reviews the available liter-
ature on the late psychological and psychosexual effects of successful 
treatment of Hodgkin's disease in particular and cancer in general. At 
the end of the second section arepresented the hypotheses of the study. 
Hodgkin's Disease and Its Treatment 
Hodgkin's Disease: Description and Epidemiology 
Definition of the disease. Hodgkin's disease is a form of lym-
phatic cancer which accounts for approximately 40% of all malignant 
lymphomas. Lymphomas in turn account for around 5% of all cancers 
(American Cancer Society, 1982). It can strike at any age, but inci-
dence generally follows a bimodal curve, peaking between 15 and 34, 
and then again after age SO. In this 15-34 age group, 66% of all 
lymphomas are Hodgkin's lymphomas (Schottenfeld, 1976). 
Hodgkin's disease usually presents as a painless rubbery swell-
ing, usually in the supraclavicular or cervical node areas. Axillary 
and mediastinal node masses are also common. It may or may not be 
associated with symptoms such as fever, night sweats, or weight 
loss (Ultmann & Stein, 1979). Pruritis and alcohol sensitivity are 
other possible symptoms which are much less common. 
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Hodgkin's disease is diagnosed histologically, where the essen-
tial feature is the presence of the multinucleated "Reed-Sternberg" 
giant cell. Thus, a patient must receive a biopsy before diagnosis 
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can be made definitively. Once diagnosis is established, the disease 
must be subclassified and staged. Subclassification is according to 
the Rye (Rye, New York Conference, 1966) histologic classification 
system (Lukes, Craver, Hall, Rappaport, & Rubin, 1966), and includes 
four subtypes. The first three, lymphocyte predominant, mixed cellu-
larity, and lymphocyte depleted, are on a continuum of the same basic 
"diffuse" pattern. The lymphocyte predominant subtype has an abundance 
of normal lymphocytes, sparsely distributed granulocytes, and only 
occasional malignant Reed-Sternberg cells. The lymphocyte depleted 
subtype involves most of the normal lymphocytes replaced by fibrosis 
and usually an abundance of Reed-Sternberg cells. The mixed cellular-
ity subtype lies between these two extremes, with moderate numbers of 
lymphocytes and granulocytes as well as readily-identifiable-but-not-
abundant Reed-Sternberg cells. The fourth histologic subclassifica-
tion is the nodular sclerosing subtype, a qualitatively different 
subtype which shows a nodular patterning of cells and "lacunar" Reed-
Sternberg cells (i.e., retraction of cell cytoplasm, leaving the Reed-
Sternberg cells in an apparent space, or "lacuna"). This nodular 
sclerosing subtype is the most common (60%), especially in the young 
adult patient group (Schottenfeld, 1976). Compared to the lymphocyte 
depleted and mixed cellularity subtypes, it is also the most benign 
in terms of its progression in the absence of treatment (Desforges, 
Rutherford, & Piro, 1979). 
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Staging of Hodgkin's disease. While histologic subclassifica-
tion is important in helping to determine appropriate treatment and 
prognosis, staging is critical. The stage of Hodgkin's disease is the 
single most important prognostic indicator and is usually the best 
guide to appropriate treatment (Ultmann & Stein, 1979). The commonly 
accepted staging criteria are those which were established at a 1971 
oncology conference in Ann Arbor, Michigan (Carbone, Kaplan, & Musshoff, 
1971). These Ann Arbor criteria delineate four distinct stages: 
Stage I (involvement of a single lymph node region or of a single 
extralymphatic organ or site); Stage II (involvement limited to one 
side of the diaphragm, either of two or more lymph node regions or 
localized involvement of an extralymphatic site and at least one lymph 
node region); Stage III (involvement of lymph node regions on both 
sides of the diaphragm, which may include localized involvement of an 
extralymphatic site or spleen); and Stage IV (diffuse or disseminated 
involvement of one or more extralymphatic organ or any liver involve-
ment, with or without associated lymph node involvement) (from 
Desforges et al., 1979). Each patient is then further classified as 
either "A" (asymptomatic) or "B" (symptomatic). The three cardinal 
symptoms, at least one of which is necessary for "B" status, are: 
1) unexplained weight loss of at least 10% of total body weight in the 
past six months; 2) unexplained fever, with temperatures above 38° 
centigrade; and 3) night sweats. The most common stages diagnosed 
are IA, IIA, IliA, IIIB, and IVB. IB is especially rare, and liB and 
IVA somewhat rare (Schottenfeld, 1976). Some diagnosticians also 
like to add the subscript "s" to denote splenic involvement (connnon 
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in later stages), and the subscript "e'' to denote the involvement of an 
extralymphatic site primarily or by direct extension (e.g., mediastinal 
mass which has extended to involve a lung) (Ultmann & Stein, 1979). This 
study did not concern itself with the "s" or ''e" subscripts because they 
are not deemed critical in the staging process at Memorial Hospital. That 
is, decisions about appropriate treatment at Memorial are generally made 
by determination of stage number and the presence or absence of B symptoms. 
Treatment of Hodgkin's Disease 
Before discussing the four specific patient protocols relevant to 
this study, a general review of the development of Hodgkin's disease treat-
ment over the past 50 years will be furnished as background information. 
Background: Development of the treatment of Hodgkin's disease. 
The three general treatment modalities for Hodgkin's disease in par-
ticular and cancer in general have been mentioned. They are surgery, 
radiation, and chemotherapy. Prior to 1950, radical surgery followed 
by diffuse radiation was the principal treatment (Kaplan, 1980). The 
five-year survival rate during the 1940-1949 decade was 25% (Schotten-
feld, 1976). Over the past 30 years, the development of megavoltage 
radiotherapy apparati, with "mantle" and "inverted Y" fields con-
structed to protect the body outside of the lymph node areas has per-
mitted much more aggressive (high voltage) radiation treatment. This 
helped bring the five-year survival rate to around 42% by 1960. 
Combined with the disadvantages of cosmetic disfigurement of radical 
surgical techniques, this improvement in radiation technology has led 
to the wane of surgery as a common primary treatment for any but the 
most severe cases of Hodgkin's lymphomas (Kaplan, 1980). Surgery is 
still indicated for some cases of extralymphatic organ involvement, 
however (e.g., splenectomy). 
The third modality, chemotherapy, has recently introduced even 
more dramatic survival rates, to the point where some are willing to 
use the term "cure" for Hodgkin's disease (e.g., Des forges et al., 
1979). After World War II experimentation with mustard gases, it was 
discovered that nitrogen mustard and its derivatives were effective 
against leukemias and lymphomas (Kaplan, 1980). This drug was first 
shown to be effective against Hodgkin's disease by Rhoads (1948), in 
a clinical trial at Memorial Hospital. In the 20 year period follow-
ing World War II, numerous other tumoricidal agents have been intro-
duced and used in various combinations (see Krakoff, 1981). 
It is an accepted fact in cancer medicine that chemotherapy 
for Hodgkin's disease using more than one agent (called "combination 
chemotherapy") is more effective than chemotherapy with single agents, 
when considering response rates (how many people of those treated 
enter remission) and length of remission period (Carter & Goldsmith, 
1976; DeVita, Serpick, & Carbone, 1970; Krakoff, 1981; Wittes & 
Lacher, 1976). The first successful combination chemotherapy regimen 
for Hodgkin's disease, ·tried by Lacher and Durant (1965), included 
vinblastine and chlorambucil. They achieved a complete response rate 
(percent of patients who show no evidence of disease after treatment) 
of 62% in early stage patients. But the most dramatic advancements 
during this period took place within the National Cancer Institute of 
the National Institutes of Health (NCI). The first NCI combination 
12 
13 
for Hodgkin's disease included cyclophosphamide, vincristine, metho-
trexate, and prednisone given in conjunction with radiotherapy (~fuxley, 
DeVita, Bruce, & Frei, 1967). 
A second and more successful combination chemotherapy devised at 
NCI by DeVita and colleagues (Canellos, Schein, Chabner, Bagley, & 
Young, 1973; DeVita & Serpick, 1967; DeVita, Serpick, & Carbone, 1970) 
is referred to as the '~OPP" regimen. MOPP is the acronym for ~ustar­
genR(nitrogen mustard), QncovinR(vincristine), £rocarbazine, and £red-
nisone. Initial reports of this regimen on 43 patients in an uncon-
trolled study claimed 81% complete remission and 14% partial remission, 
for an overall response rate of 95%. Seven year disease-free survival 
was reported in 15 (43%) of the 35 complete remission patients (DeVita 
et al., 1973). 
Since 1973, research in the treatment of Hodgkin's disease has 
centered around this MOPP regimen, usually comparing it to radiation 
therapy alone or to other combinations of chemotherapeutic agents. So 
far, some combinations of drugs have been found to be as effective as 
MOPP, but none has been proven definitively better (Desforges et al., 
1979). 
In summary, research and advancements over the past 50 years in 
the science and technology of radiation therapy, and in the use of 
combinedtumoricidalchemical agents has transformed Hodgkin's disease 
from an almost invariably fatal illness to one that is quite frequently 
cured. Recently the American Cancer Society (1978) has reported 90% 
five-year survival in early stage disease. 
Research on the treatment of Hodgkin's disease at Memorial Sloan-
14 
Kettering Cancer Center is dedicated to further improvement of response 
and survival rates. This research consists of randomized clinical 
trials of various combinations of chemotherapy and radiation treatment 
for different stages of the disease. The next subsection will describe 
the four clinical trial treatment protocols which are relevant to this 
study. 
Hemorial Hospital treatment protocols. Memorial Hospital for 
Cancer and Allied Diseases is the treatment unit of the Memorial Sloan-
Kettering Cancer Center. Located on the East side of Manhattan, it is 
a major tertiary referral hospital for patients with cancer from all 
parts of the country. The hospital provides care for approximately 
16,000 inpatients per year and records nearly 140,000 outpatient visits 
per year (1980 hospital statistics). Except for initial biopsy and 
staging procedures, as well as disease or treatment complications, 
all of the treatment for Hodgkin's disease is done on an outpatient 
basis. 
After a patient with suspected lymphoma is given a biopsy and 
Hodgkin's disease is histologically diagnosed, staging is the next step. 
It is the severity of disease stage which determines the placement into 
treatment protocol. Two of the four relevant treatment protocols are 
for early stage patients and two for late stage patients. They will 
be discussed in that order. 
Table 1 presents a summary of the four Memorial Hospital Hodgkin's 
disease treatment protocols. The first early stage protocol was in 
effect from 1975 to 1981, while the second has been in operation since 
then (1981-present). The first protocol (M.H. #75-103) called for six 
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Table 1 
Basic Overview of Four Memorial Hospital 
Treatment Protocols 
Protocol Years Disease Stages Treatment Estimated Chemotherapy 
Number in Use Applicable Length Radiation Agents 
75-103 1975- Early: 7 months 3500 rads MOPP 
1981 IA, IB, IIA, (@ 5000 rads 
IIB, IliA for IIIA) 
81-103 1981- Early: 5 months 3500 rads MOPP or TBV 
present IA, IIA, IIIA 
75-104 1975- Late: 24 months @ 5000 rads MOPP/ABDV 
1979 IIB (unfav.) 
IIIA (unfav.) 
IIIB, IVA, IVB 
79-17 1979- Late: 11 months @ 3500 rads MOPP/ABDV 
present IIB, IIIB, (more as or 
IVA, IVB needed) MOPP/ ABV/ CAD 
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28-day cycles of the MOPP chemotherapy regimen with one month of in-
volved field radiation "sandwiched" in between the six cycles. Each 
cycle consisted of 14 days on treatment and 14 days off treatment. 
Dosages were as follows: Day 1 and 8, nitrogen mustard 6 mg/m2 i.v. 
(max. 10 mg), and vincristine 1.4 mg/m2 i.v. (max. 2 mg); Days 1-14, 
procarbazine 100 mg/m2 p.o. (max. 150 mg), and prednisone 40 mg/m2 p.o. 
(cycles 1 and 4 only). When patients could not tolerate the nausea 
and vomiting from the nitrogen mustard, cyclophosphamide 650 mg/m2 i.v. 
(i.e., "COPP"), or Thio-tepa 15-18 mg/m2 i.v. (i.e., "TOPP"), was sub-
stituted. Also, other deviations from this protocol were occasionally 
made for individual patients due to drug reactivity, drug toxicity, 
poor early response, or side-effect intolerance. The same is true of 
all four protocols. 
The seven month treatment protocol just discussed was proposed 
because of high relapse rates reported for early stage patients who 
were successfully treated with radiation alone (40-60%). It was con-
ceptualized as an attempt to heighten survival rates in "favorable" 
prognosis patients who would previously have received the more standard 
radiation-only treatment. Memorial Hospital investigators included 
stages IA, IB, IIA, liB, and IliA in this "favorable" group. Exper-
ience with patients on this protocol showed that liB patients had 
significantly more non-complete responders, and so this subgroup was 
switched to the late stage group for the more recent protocols. 
The second early stage protocol (//81-103) began in 1981 and has 
been used with stages IA, IIA, and IliA patients. Prior experience 
with early stage patients at Memorial Hospital revealed clear gains 
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in induction and duration of remission with the combined modality 
approach over the radiation-only approach (Koziner, Braun, Garrett, 
Nisce, Young, Lee, & Clarkson, 1978). However, concern over the addi-
tive risks to endocrine and gonadal function and the increase in 
future second malignancies from highly cytotoxic agents in combination 
with radiation has led to efforts at finding a chemotherapy regimen of 
equal (if not better) efficacy to MOPP, which might have lowered long 
term health risks. Thus, the second early stage protocol randomized 
patients into one of two groups: MOPP plus segmental radiotherapy, 
or "TBV" plus segmental radiotherapy. TBV (Thio-tepa, vinblastine, 
and bleomycin) is hoped to be connected with less post-treatment 
oncogenicity and fewer post-treatment gonadal disturbances than MOPP. 
Results are not yet available on this. 
The treatment schedule on protocol #81-103 was as follows: four 
28-day cycles of MOPP (or TBV) with a one-month period of radiation 
therapy "sandwiched" in between. MOPP dosages are the same as in 
protocol #75-103, but there are now two fewer chemotherapy cycles (six 
lowered to four). Total treatment time is therefore cut from seven to 
five months. The TBV dosages are: Days 1 and 15, Thio-tepa 35 mg/m2 
i.v., vinblastine 6 mg/m2 i.v. (max. 10 mg); and days 4-12, 18-26, 
bleomycin 2 mg/day subcutaneously. 
The two late stage protocols are M.H. #'s 75-104 (1975-1979) and 
79-17 (1979-present). These involve more aggressive treatments which 
attempt to produce complete remission rates superior to the MOPP plus 
radiotherapy regimen typically used. Protocol #75-104 used eight 
drugs (MOPP/ABDV) plus radiation over a course of 24 months. This 
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approach alternated (by monthly cycle) the use of MOPP with that of 
ABDV (adriamycin, bleomycin, DTIC, and vinblastine), a combination 
found to be as effective as MOPP by Bonadonna, Zucali, and Monfardini 
(1975). In the first four months the patient received alternate 
cycles of MOPP and ABDV. The fifth month was for radiation treatment. 
The sixth through ninth months proceeded identically to months one 
through four. Months 11, 13, 15, 17, 19, 21, and 23 were alternating 
MOPP, then ABDV cycles. The even numbered months were reserved for 
immunotherapy in half the group and no treatment in the other half. 
MOPP dosages were essentially the same as in protocols described 
earlier. ABDV cycle schedule of drugs and dosages were: Days 1 and 
15, adriamycin, 25 mg/m2 i.v., vinblastine 6 mg/m2 i.v. (max. 10 mg), 
and DTIC 250 mg/m2 i.v.; and Days 4-12, 18-26, bleomycin 2 mg/day 
subcutaneously. From 1975 until 1979, this was the standard treatment 
for Hodgkin's disease patients of stage IIIB, IVA, and IVB, as well 
as certain liB and IliA patients with "unfavorable" prognosis. As 
with other protocols, variations in these drug and dosage schedules 
occurred in individual cases where clinical considerations of toxicity, 
drug intolerance, or disease course overrode research interests. 
The fourth and final protocol relevant to this study (#79-17) 
has been used with stages liB, IIIB, IVA, and IVB at Memorial Hospital 
since 1979. It compares the earlier-mentioned eight-drug schedule 
(#75-104) to a still newer 10-drug regimen. Total treatment time is 
shortened (by lessening the number of cycles given) from 24 months to 
11 months in the late stage group. The drug schedule and dosage of 
MOPP/ABDV cycles is the same as that outlined in the previous protocol. 
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The 10-drug regimen, MOPP/ABV/CAD (MOPP + ABV + CCNU, alkeran, and 
DVA), is administered in the following order (28 day cycles): CAD-
MOPP-ABV-CAD-MOPP-ABV-radiation-two weeks rest-CAD-MOP (no prednisone)-
ABV. Cycle schedule of drugs and dosages are nearly identical to 
other protocols for MOPP, ABDV, and ABV. The CAD cycle schedule is as 
follows: Day 1, CCNU 100 mg/m2 p.o.; Days 1 and 8, DVA 3 mg/m2 i.v.; 
Days 1-4, alkeran 6 mg/m2 p.o. Note that the patient is afforded 
three to four weeks rest in each CAD cycle. 
It is hoped that this fourth protocol, with the addition of new 
agents, will eradicate residual tumor cells resistant to the first two 
combinations (MOPP/ABDV). Less attention is paid to possible late 
toxicologic effects of treatment (e.g., sterility, leukemia, secondary 
non-Hodgkin's lymphoma, chronic carditis) in these late stage treatment 
protocols than in those for early stage disease. 
The continual advent of new cytotoxic agents, and their addition 
to existing chemotherapy combinations, represent an increase in physi-
ological side effects and future health risks to the patients. That is, 
not only are treatments becoming more successful with time, but they 
are also becoming more toxic to the patients. Attention will now 
turn to a brief review of late physiological effects which have been 
associated with these treatments. The discussion will be divided into 
radiation effects and chemotherapy effects. Because late stage 
patients are generally treated with slightly more radiation and always 
receive much more chemotherapy (in dosage and duration), they are 
obviously at higher risk for all that is described in the next two 
subsections. The fact of greater treatment severity in late stage 
patients was one reason for conceptualizing the study hypotheses in 
terms of early versus late stage differences. That is, not only are 
late stage patients "sicker," and therefore closer to death, than 
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early stage patients, they also receive a more aggressive treatment 
with more debilitating and potentially lethal aftereffects. This will 
be discussed later, but is mentioned now for the reader's consideration 
while reviewing delayed treatment effects and risks incurred by all 
patients. 
Radiation treatment: Physiologic effects and potential risks. 
Radiation treatment (RT) for Hodgkin's disease is a focused attempt to 
limit lethal doses of radiation to the area of the lymph nodes and 
organs involved in the disease. The refined techniques of "mantle" 
and "inverted Y" field irradiation have reduced many of the complica-
tions of RT for lymphoma. However, the proximity of the lymph nodes 
to so many vital organs means that risk, while reduced, is by no means 
eliminated. One can consider the risks of RT in Hodgkin's disease 
starting from the most anterior nodes (neck and armpits), moving down 
to the most posterior ones (gonads and groin). Stage I and II 
patients by definition receive RT to one or the other side of the 
diaphragm, while Stage III.and IV patients get RT to both sides. 
Beginning with the most anterior nodes and working downward, 
long-term pituitary and thyroid abnormalities, including alterations 
in serum thyrotropin and reports of thyroid disease, have been assoc-
iated with neck irradiation (Schimpf£, Diggs, Wiswell, Salvatore, & 
Weirnik, 1980). Radiation induced bone sarcoma (Smith, O'Connell, 
Huvos, & Woodward, 1980), malignant peripheral nerve sheath tumors 
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(Foley, Woodruff, Ellis, & Posner, 1980), and radiation myelopathies 
(Word, Kolokhe, Aron, & Elson, 1980) have also been reported. The 
risk of secondary leukemia is also slightly elevated (Desforges et al., 
1979). Increased susceptibility to later infections, especially 
when paired with splenectomy and/or chemotherapy, is another known risk 
of radiation (Donaldson, Glatstein, & Vosti, 1978). Post-treatment 
cardiac and pulmonary complications, such as carditis, pericarditis, 
pericardial effusions, chronic pericardial disease, pneumonitis, and 
transient pulmonary dysfunction have frequently been identified (e.g., 
Cole, Pollack, Sutton, Slawson, Singleton, & Weirnik, 1981; Gross, 
1977). In certain cases, the addition of chemotherapy to radiation has 
an additive effect on radiation complications. For example, prednisone 
after radiation may draw out a latent pneumonitis or pericarditis when 
discontinued abruptly, and bleomycin seems to combine with radiation 
in a way which is hazardous to lung tissue (Desforges et al., 1979). 
A final radiation complication relates to reproductive function. 
In men, aspermia results in 70-100% of patients irradiated below the 
diaphragm, despite efforts to shield the gonads (Speiser, Rubin, & 
Casarett, 1973). Reports of return of spermatogenesis in these 
patients range from 0% to 80% over a three-year post-treatment period. 
Chemotherapy: Physiologic effects and potential risks. The use 
of combination chemotherapy plus radiation therapy in early stage 
Hodgkin's disease is controversial, because evidence for its superior-
ity over radiation therapy alone is mixed, and because it is assoc-
iated with so many more complications. The risk of secondary acute 
leukemia and non-Hodgkin's lymphoma from combined modality treatment 
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has been recognized by many investigators (Arsenaau, Canellos, Johnson, 
& DeVita, 1977; Cadman, Capizzi, & Bertino, 1977; D'Angio, Clatworthy, 
Evans, Newton, & Tefft, 1978). Pedersen-Bjergaard and Larsen (1982) 
staged and treated 391 Hodgkin's disease patients from 1970-1981. Of 
the 312 treated with combined chemotherapy and radiation or chemotherapy 
alone, 17 developed preleukemia or an acute myeloproliferative syndrome 
with bone marrow abnormalities. A Kaplan-Meier estimate of the cumu-
lative probability of leukemic complications was 3.9 + 1.3% five years 
after treatment began, and 9.9 ± 2.9% at nine years. Of the 79 
patients treated with radiation alone none had any leukemic complica-
tions (~ <.01). The risk of non-Hodgkin's lymphoma at 10 years off 
treatment has been reported at 4.4% (Krikorian, Burke, & Rosenberg, 
1979). 
Combination chemotherapy has also been associated with lowered 
immunity against common infections (e.g., Steele & Han, 1978), and 
frequent susceptibility to herpes zoster (Cunningham, Mauch, Rosenthal, 
& Canellos, 1982). Chemotherapy for Hodgkin's disease is connected 
to almost certain sterility in males. The best current estimate is 
between 80-90% sterility three years after treatment (Chapman, Sut-
cliffe, Rees, Edwards, & Malpas, 1979; Schilsky, Lewis, Sherins, & 
Young, 1980; Sherins & DeVita, 1973). A retrospective study of 52 
young adult men over three years off treatment yielded an estimate of 
over 90% sterility in men who had been treated with six cycles of MOPP 
chemotherapy (Cunningham et al., 1982). This 90% figure has been con-
firmed here at Memorial Hospital in a prospective study of 60 men 
treated for Hodgkin's disease over the past four years (Redman, 1983). 
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This is a tremendously significant issue for successfully treated 
young men who are faced with return to "normal life," most often realiz-
ing that they will very likely never father children in a 'normal 1' way 
(Sutcliffe, 1979). What is more, a recent prospective study by Chapman, 
Sutcliffe, and Malpas (1981) found 16 (43%) of 37 men to be functionally 
subfertile before initiation of treatment. A more recent study (Viger-
sky, Chapman, Berenberg, & Glass, 1982) has confirmed this figure, and 
found it to be significantly greater than that in other malignancies. 
This clearly suggests compromised fertility as a result of the disease 
itself, implying that efforts to bank sperm prior to treatment may not 
be a viable alternative for these patients. In the 1981 study,lOO% 
(14 of 14) of the patients tested became persistently azoospermic 
after only two cycles of chemotherapy with MOPP. 
Taken drug-by-drug, in single administration the alkyllating 
agents of chemotherapy (nitrogen mustard, cyclophosphamide, and 
Thio-tepa) have been associated with bone marrow toxicity, nausea and 
vomiting (which can linger on after treatment is over via conditioning), 
myelosuppression, alopecia, and hemorrhagic cystitis (Wittes & Lacher, 
1976). The vinca alkaloids (vinblastine, vincristine) have been linked 
to RNA synthesis inhibition, myelosuppression, and neurotoxicity, 
especially peripheral neuropathies, which can last for life (Wittes & 
Lacher, 1976). Procarbazine is also linked to nausea and vomiting 
which can persist, reduced white blood count from myelosuppression, and 
thrombocytopenia. Prednisone, a glucocorticoid agent, is associated 
with the usual spectrum of steroid-related side effects (Cushingoid 
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symptoms), which are usually reversible. 
In summary of this section, three points were highlighted. Re-
cent years have brought new advances and success to the treatment of 
Hodgkin's disease. Successful treatment generally includes both 
radiation and chemotherapy. The exact combination and intensity of 
treatments are dependent upon the stage of the disease at diagnosis. 
Although treatment has become quite successful, it does exert a more 
general impact on the body which results in unpleasant side effects 
and potential long-term health problems. There is also some question 
about the possible psychological and psychosocial impact of this newly 
achieved successful treatment for Hodgkin's disease. The next main 
section will review the literature relevant to these possible psycho-
logical concerns. 
Psychological Adjustment to Cancer and 
Its Treatment: Literature Review 
Background Literature 
As emphasized in Chapter 1, adaptation to (rather than coping 
with, mastering, or defending against) cancer is the central concept 
of this study. The literature review will focus on the empirical 
research which has been done on cancer survivors off treatment. While 
the crisis model, as introduced by Lindemann (1944) is not central to 
the study, it is intermixed with the idea of adaptation in that all 
individuals with cancer seem to cope through a gradual integration of 
this life-threatening crisis (Holland, 1982b; Weisman, 1976). 
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Therefore, a brief overview of research in coping with cancer survival 
influenced by the crisis theory model will also be presented. 
As early as the 1950's, Sutherland and colleagues had clinically 
identified a heightened incidence of post-treatment anxiety and de-
pression in successfully treated cancer patients (Bard & Sutherland, 
1955; Sutherland, 1956). Their work was primarily with breast and 
colon cancer patients. Systematic investigation of these observations 
pinpointed examples of anxiety about recurrence (including hypochon-
driacal concerns), development of dependent personality features, and 
increases in obsessive-compulsive and paranoid reactions, as well as 
general family strife (Sutherland, 1956). In his discussion of these 
findings, Sutherland postulates that a cancer patient's pattern of 
adaptation, defined as "a system of beliefs and behavior designed in 
order to bring the individual's physical and emotional needs in har-
mony with the demands of the environment," is threatened by cancer. 
With the homeostasis of the organism threatened, the patient is then 
subjected to loss of self-esteem and anxiety secondary to the subjective 
isolation of being a cancer patient. Bard and Sutherland (1955) 
followed 20 breast cancer patients prospectively, from the pre-opera-
tive period to recovery. From their findings, they formulated three 
phases of adaptation to mastectomy (and cancer treatment in general): 
1) anticipatory phase, where the patient speculates with fear and 
uncertainty about the damage to self and disruption of previous levels 
of adaptation; 2) operative phase, where the actual injury (crisis) 
occurs; and 3) reparative phase, where the patient attempts to 
reestablish his or her previous level of adaptation by a variety of 
techniques. This study is intended to focus upon this third, repara-
tive phase of adaptation to cancer. 
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Based upon her review of the psychosocial oncology literature, 
Holland (1981) has outlined eight psychiatric syndromes relevant to 
cancer patients. Six of them hold some relevance to patients off all 
treatment and free of disease; that is, patients in Bard and Suther-
land's (1955) reparative phase. They are: 1) acute stress reactions 
such as reactive anxiety and depression, including prolonged or de-
layed reactions to survival and cure; 2) major psychiatric disorders 
(DSM III Axis I pathology) with onset during or after treatment; 3) 
anxiety disorders such as conditioned nausea, conditioned vomiting, 
phobias, or panic reactions; 4) somatoform disorders such as hypo-
chondriasis; 5) psychosexual disorders resulting from the illness or 
treatment; and 6) personality disorders which can complicate and 
interfere with post-treatment adjustment. "Quality of life" after 
treatment, according to Holland (1981, 1982a, 1982b) depends to a 
great extent upon the patient's prior level of emotional adjustment 
and the presence of emotionally supportive persons in the environment. 
The concepts of crisis and stress management are relevant to 
this study inasmuch as adaptation to cancer survival entails some 
measure of protracted distress. Ever since Hans Selye first formulated 
the concept of "stress" as a syndrome with physiologic correlates and 
potential vulnerabilities to the distressed organism (Selye, 1936), 
researchers have been intrigued by the relationship between stress and 
illness onset (Lazarus, 1974, 1976; Selye, 1975; Tache, Selye, & Day, 
1979). A kind of reversed approach to this involves the 
27 
conceptualization of illness (and treatment) as a stressor in itself 
which can lead to further organism distress (Caplan, 1981; Horowitz, 
1976). Lindemann (1944) pioneered this idea in his study of person-
ality changes due to distress in the bereaved friends and relatives of 
the Coconut Grove fire victims. Application of this idea to cancer 
patients by Horowitz and colleagues (Horowitz, 1976; Horowitz, Wilner, 
& Alvarez, 1979) views cancer adaptation as a process parallel to 
stress-response syndromes in general. In a study of cancer patients 
at the point of diagnosis and during treatment, Horowitz, Wilner, and 
Alvarez (1979) found cancer patients to use alternating combinations 
of intrusive and avoidant thinking styles. They measured this with 
their Impact of Events Scale, a 15-item, self-report inventory. The 
pattern of coping which they detected in their cancer sample was sim-
ilar to, though less dramatic than, that fqund in their stress-
response clinic outpatients. 
Caplan (1981) has presented a model for understanding stress-
response behavior such as that seen in cancer patients. His focal 
construct is '\nastery," defined as behavior which both reduces the 
physiologic and psychologic manifestations of emotional arousal during 
and shortly after the stressful event; and mobilizes the individual's 
internal and external resources, thereby developing new capabilities 
which lead to the person's changing of the environment or his/her 
relation to the environment, so that threat is reduced or so that 
alternate sources of satisfaction replace what is lost. In the case 
of cancer, one's health and certainty about the future are the lost 
entities. 
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Caplan also explains four interdigitating phases of mastery in 
the face of stress: The first is escape or avoidant behavior which 
enables the individual to tolerate the intensity of the stress; the 
second involves acquisition behavior in which the individual attempts 
to change unfortunate circumstances and their aftermath. One can 
easily parallel these first two phases to the general periods of diag-
nosis and treatment of the illness itself. The third and fourth 
phases are more relevant to this study in that they seem to describe 
the post-treatment adaptational challenge. Phase three entails intra-
psychic behavior which defends against intrapsychic emotional arousal. 
Denial or avoidance of anxiety, hostility, depression, and grief are 
the most common mechanisms. The fourth and final phase, according to 
Caplan, involves synthetic intrapsychic behavior which integrates the 
stressful experience (diagnosis and treatment) and its sequelae 
(chronic uncertainties) by internal readjustment. 
Following the general idea of crisis theory that individuals 
resolve crises within six to eight weeks (see Talpin, 1971), Lewis, 
Gottesman, and Guttstein (1979) studied 35 cancer patients over a 28 
week period after surgery. They found this notion of rapid crisis 
resolution not applicable to their cancer sample. Measuring anxiety, 
helplessness, depression, self-esteem, and general level of crisis, 
five variables considered by crisis theorists to be basic indicators 
of crisis, they found that scores were still rising eight weeks after 
surgery, regardless of its outcome. Follow-up at 28 weeks did find 
scores beginning to decline, however. The results suggested either 
the inapplicability of a straightforward crisis model for cancer 
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patients or the need for modification of the time needed for crisis 
resolution in a cancer population. In a follow-up to this study, 
Gottesman and Lewis (1982) compared 31 female cancer surgery patients 
to 15 medical surgery patients and 15 healthy women. Both cancer and 
surgery groups scored higher than healthy women on the Halpern Crisis 
Scale. However, the cancer sample scored as significantly more help-
less than the surgery patients. Discriminant function analysis re-
sulted in 73-82% accuracy of placement into the three groups, suggest-
ing that cancer surgery and non-specific medical surgery may represent 
separate types of crisis. The increase in helplessness in the cancer 
sample was evidence for a different, perhaps more depressive, reaction 
in the cancer patient sample. This provides indirect evidence for 
cancer adaptation as a process which is distinct from and more pro-
longed than adaptation to general medical illness and surgery. Inci-
dentally, this study also found that the average time needed by the 
cancer surgery sample for crisis resolution was 15 weeks; again 
longer than the expected six to eight weeks. 
Studies on the Problems of Return to Premorbid Lifestyle in Success-
fully Treated Cancer Patients 
Chronologically, the first event associated with adaptation to 
cancer survival is the return to premorbid lifestyle immediately after 
treatment ends. The process of reentry of the treated cancer patient 
into society's mainstream and the return to his or her premorbid life-
style has been referred to as the "Lazarus Syndrome." This analogy to 
the biblical character who returned from the dead is not so far-
fetched when one considers the many accounts from patients and 
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clinicians of patients' being treated by significant others as either 
dead or dying during the treatment period (e.g., Sveinson, 1977; 
Zubrod, 1975). The sense of being somehow different from others and 
permanently changed by the cancer experience has been described by a 
cured Hodgkin's disease patient as follows: 11 (the diagnosis of cancer) 
marks the start of a new way of life. Up to this point, the man/woman 
has enjoyed normal health with no major problems. But now, with a 
serious illness, he puts everything else aside. He starts a new 
life" (Sveinson, 1977, p. 83). Thus, the termination of treatment and 
reentry into "normal" life can be seen as a stressor in itself, char-
acterized by a letdown of the struggle against death and the challenge 
of return to normalcy (Holland et al., 1979; Sutcliffe, 1979; Zubrod, 
1975). 
Clinical case reports of post-treatment disruption of basic 
psychosocial areas of socialization, financial security, vocational 
development, and sexual functioning are abundant in the literature 
(e.g., Bronner-Huszar, 1971; Cohen & Wellisch, 1978; McCollum, 1978). 
Some of the intruding factors in this disruption include lowered 
self-esteem (Bronner-Huszar, 1971; Eisenberg & Goldenberg, 1966), 
increased anxiety (Bronner-Huszar, 1971; Gorzynski & Holland, 1979), 
death-related concerns and uncertainty about the future (Clapp, 1976; 
Cohen & Wellisch, 1978; Gorzynski & Holland, 1979; Kagen-Goodheart, 
1977; Spinetta & Maloney, 1975), and disruption of defense mechanisms 
(D'Angio & Ross, 1981; Hackett & Weisman, 1969; O'Neill, 1975). In 
their description of case reports, Cohen and Wellisch (1978) depict 
the surviving patient and family as thrown into a state of chronic 
catastrophe--a psychosocial "limbo"--where current relationships and 
future plans are constantly off balance because of disease uncertain-
ty. Their observations were based upon patients recently completing 
treatment, and so the question of possible abatement of this feeling 
of being in limbo remains unanswered. 
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There have been some systematic empirical studies of cancer 
patients in the six-month period following diagnosis and treatment. 
Weisman and Worden (1976-77) studied 120 cancer patients, 18 of whom 
were Hodgkin's patients, over a 100-day period following diagnosis. 
They found that as treatment progressed, the young adult patients 
viewed their cancer more as a threat to their life plans (career, 
marriage, family) than as a direct threat to their life. They iden-
tified a 100-day post-diagnosis period, called the "existential 
plight," in which fears of abandonment, loneliness, loss of control, 
pain, panic and the unknown were high. These concerns lessened most 
quickly in the Hodgkin's disease (N = 18) and breast cancer (N = 37) 
patients, as compared to lung (~ = 23), colon (~ = 23), and melanoma 
(! = 19) patients. This observation of different peak distress points 
for different cancer sites signified the importance of studying dis-
ease sites separately rather than under one general rubric of cancer 
patients. 
Perhaps the most comprehensive short-term follow-up of treated 
cancer patients has been done at the New York University Medical 
Center (Gordon, Freidenbergs, Diller, Hibbard, Levine, Wolf , Ezrachi, 
& Lipkins, 1979). The authors studied 308 breast, lung and melanoma 
patients at four points in time over a six-month period (point of 
diagnosis, point of hospital discharge, three months after discharge, 
and six months after discharge). Assessment was done by semi-struc-
tured interview (Problem Oriented Record) and a short battery of 
psychological tests. In their sample, the main problem at diagnosis 
was worry about disease, whereas by the time of hospital discharge it 
had shifted to difficulties with negative affects such as depression, 
anxiety and anger. At three- and six-month follow-up, problems were 
more widely distributed (and reduced in intensity) across the follow-
ing areas: physical discomfort, concern about treatment, mobility, 
finances, family/marital problems, social problems, worry about dis-
ease, negative affects, and disturbed body image. 
Many investigators have attempted to identify patients at high 
risk for maladaptation to cancer treatment and survival. Two general 
approaches to this have been the study of defenses or coping style in 
good versus poor adjusters, and empirical efforts to correlate pre-
treatment psychological test scores with post-treatment adjustment. 
The first approach has, in almost every investigation, identified the 
ubiquitous and highly adaptive nature of denial during the treatment 
and early post-treatment periods (Chodoff, Friedman, & Hamburg, 1964; 
Hackett & Weisman, 1969; Penman, 1979). However, the functional 
adaptabilityofdenial lessens as remission extends, and some inves-
tigators have identified actual increases in psychological distress 
and disturbance in the off-treatment period, presumably due to the 
lifting of denial and exposure of the denied affects of depression, 
anxiety, and hostility (OtNeill, 1975; Spinetta & Maloney, 1975). 
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It has been suggested that the ability to ultimately externalize 
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previously denied affects is associated with longer survival, possibly 
due to the release of distress. Derogatis, Abeloff, and Melisaratos 
(1979) studied 35 women with metastatic breast cancer, and found that 
those women Who lived one year or longer had higher psychological symp-
tom profiles and higher levels of dysphoric affects than those who 
died within one year, on the SCL-90-R, Affects Balance Scale, and the 
Global Assessment Scale. A negative correlation between psychological 
distress and likelihood of recurrence was also documented in melanoma 
patients (Rogentine, VanKammen, Fox, Rosenblatt, Docherty, & Banney, 
1978). Perhaps, then, the unleashing of previously constrained emo-
tionality may not only be of high incidence in the cancer survivor, it 
may actually be a partial prophyllactic against relapse through some 
cathartic mechanism of stress reduction. This hypothesis would be 
consistent with the claim by other investigators that the best mechan-
ism of coping with cancer and survival is not blind (unconscious) 
denial, but a conscious suppression of negative affects only after 
they are acknowledged and felt (Koocher & O'Malley, 1981; Weisman & 
Worden, 1976-77). These "suppressors," then, can be described as 
people who are able to put their worries as.ide and go on with their 
lives while in crisis. The survival period would then be a time for 
further integration and resolution of that which had previously been 
suppressed. 
The above formulation of optimal coping over time is one which 
has received widespread empirical support. However, there are some 
data which are inconsistent with this. These would include accounts 
that psychological distress tends to drop over time (D'Angio & Ross, 
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1981), and that longer survival times have also been associated with 
patients who have been able to maintain smooth relationships with 
family and friends (Weisman, 1975). 
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The second general approach to studying post-treatment psycho-
social difficulty is the attempt to identify patients at high risk for 
psychological distress in the post-treatment period with the use of 
pre-treatment parameters. Using examiner ratings of post-treatment 
distress in patients six months off-treatment, Weisman and Worden 
(1977) were able to account for 40-60% of the variance of psychological 
distress with knowledge of disease stage and prognosis. That is, 
medically sicker patients were significantly more distressed six months 
off~treatment. This is contrasted to studies which have found little 
(Gordon et al., 1979) or no (Hyerowitz, Sparks, & Spears, 1979) rela-
tionship between disease or treatment severity and post-treatment dis-
tress. Some studies (Horris, Greer, & White, 1977; Schonfield, 1972) 
have found pre-treatment anxiety and depression to be better predictors 
than disease or treatment severity, of post-treatment distress in 
patients less than one year off-treatment. 
A comprehensive study by Sobel and Worden (1979) followed 133 
cancer patients, including 20 with Hodgkin's disease, over a period of 
six months. They found pre-treatment HHPI scale scores (especially on 
the "neurotic triad" of hypochondriasis, depression, and hysteria) 
accounted for 41% of the overall variance of the dependent measures of 
emotional distress. Dependent measures included the Profile of Mood 
States' Index of Vulnerability, Inventory of Current Concerns (six 
problem areas), and actual number of physical symptom complaints. 
They were able to correctly place 75% of their 133 patients into high 
or low distress groups, on the basis of pre-treatment MMPI scores. 
35 
This concludes the review of the literature in this subsection: 
studies on cancer patients' difficulties with smooth return to premor-
bid lifestyle. The focus of this subsection was on the treatment and 
early post-treatment periods. Psychosocial disruption and difficulty 
in the treatment and reentry periods has been extensively documented. 
Not only has a relatively high prevalence of such disruptions as 
negative affects, low self-esteem, and psychosocial dysfunction been 
established, some investigators have successfully identified poorer 
post-treatment copers on the basis of pre-treatment symptomatology 
and personality profile. There is little doubt that the six-month 
period after treatment is difficult for a great many patients. The 
focus of study in this group of patients tends to be on the identifi-
cation of high risk patients and determination of correlates to 
psychosocial dysfunction. Psychosocial research is not so advanced 
in patients who are farther off treatment, however. 
The review will now turn to a discussion of studies which have 
addressed longer-term issues in cancer survival. To a great extent, 
this division of the review is artificial in that the process of 
adaptation is believed to begin with diagnosis (if not onset of first 
symptom) and move continuously through life. What follows is a 
summary of available literature on psychological adjustment to cancer, 
limited to the period of disease-free survival of longer than six 
months. 
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Studies on Psychological Adjustment to Long-Term Survival from Cancer 
Of greatest relevance to the present study is that body of 
research which has examined long-term adjustment to survival from 
cancer. Since so little research has been done on Hodgkin's disease 
patients in particular, the review will include other more commonly 
studied populations: mixed diagnostic groups and breast cancer 
patients. 
Psychosocial studies of cancer .survival: Mixed diagnostic 
groups. Many investigators have reported quite favorable overall 
psychological adjustment to successful cancer treatment (Brown, Had-
dox, Posada, & Rubio, 1972; DeRugna & Buchheim, 1979; Holmes & Holmes, 
1975). In a study examining the prevalence of general post-treatment 
difficulties, Iszak, Engel, and Medalie (1973) surveyed 345 patients, 
91 of whom were considered "cured" at the time of assessment. They 
found, predictably, that the cured subgroup had the greatest need for 
vocational services and the lowest need for medical services. Prob-
lems identified in the cured group, as assessed by the authors' 
"Ability Index" questionnaire, were continued difficulty with physical 
stamina and with the "psychological trauma" posed by diagnosis and 
treatment. Need for social services, including both practical 
assistance and psychotherapeutic intervention, was acknowledged in 
33% of 345 patients (Iszak, Engel, & Medalie, 1973). 
A similar prevalence study of psychosocial problems acknowledged 
by 810 patients off-treatment for an average of 2.5 years found 93% 
of them still struggling with problems of fatigue (Greenleigh Assoc-
iates, Inc., 1979). Of this 93%, one in five viewed the fatigue to 
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be incapacitating. The authors speculate that, in the absence of any 
legitimate physiological reason for this high figure, it may provide 
indirect evidence for lethargy as a depressive equivalent in this pop-
ulation. All patients were over 45, 70% were women, and around half 
had either breast or uterine cancer. Patient historical accounts 
revealed an apparent six-month lag from treatment cessation to the 
development of depressive symptoms, again suggesting gradual relaxa-
tion of defenses (cf. O'Neill, 1975; Spinetta & Maloney, 1975). 
Sexual dysfunction was the most frequently cited marital problem (47 
of 567 married subjects). Other problems included spouse anger or 
fear of cancer, financial difficulty, spouse withdrawl or spouse al-
coholism. While 23% complained of deterioration in their family role 
satisfaction, 35% claimed their situation had improved as a result of 
their cancer experience. Health and life insurance readjustments were 
problematic for 24% of the patients. The percentage of patients 
employed dropped significantly, from 54% (premorbid level) to 47%. 
The areas of work adjustment and work discrimination have re-
ceived a good deal of attention in the literature. The available 
evidence on work discrimination is split between reports of little or 
no overt or covert discrimination toward the cured cancer patient 
(Reynolds, 1977; Stone, 1975), and assertions of both outright 
(Feldman, 1978) and subtle (American Cancer Society, 1976) work and 
hiring discrimination. In the American Cancer Society study, out of 
130 of the most employable recovered cancer patients (age 25-50, 
employed at the time of diagnosis, and skilled), 22% reported one or 
more job rejections. Many on-the-job reports of subtle mistreatment 
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such as hostility from co-workers, unnecessary transfers to encourage 
resignation, lack of salary advances and health benefit rejection were 
common (American Cancer Society, 1976). 
Research on work adjustment in post-treatment patients also 
delivers mixed results. For example, Gordon and colleagues found one-
third of 136 patients off treatment to be experiencing vocational 
adjustment difficulties (Gordon, Freidenbergs, Diller, Hibbard, Levine, 
Wolf, Ezrachi, & Francis, 1977), while Wheatleyandothers found 74 
off-treatment cancer patients to be no different from other employees 
at the Metropolitan Life Insurance Company in absenteeism, turnover, 
job performance, or insurance costs (Wheatley, Cunnick, Wright, & Van 
Keuren, 1974). Not one of the 74 patients was fired for any reason. 
They had been off treatment for a range of one month to 25 years. One 
explanation for this difference between study findings in the area of 
work adjustment could be the method of data collection: Gordon and 
colleagues used patient self-report while the Wheatley et al. study 
used employer records. It could be, therefore, that the patient 
experiences a sense of difficulty in adjusting which is not easily 
detected by gross measures of work performance kept by employers. 
Alternately, it could be that the patients truly are adjusting well, 
and their subjective sense of maladjustment might represent a more 
non-specific problem of general distress. 
Schonfield (1972) has attempted to predict those patients who 
will experience post-treatment work readjustment difficulty. In his 
study of 42 male and female patients, using 63 items of the MMPI and 
an anxiety questionnaire given before starting treatment, he 
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demonstrated that pre-treatment anxiety (especially about situational 
concerns) and a low morale loss score on the MMPI were good predictors 
of later difficulty returning to work. All but nine of 42 patients 
returned to work within nine months of treatment. Stage of disease 
and severity of treatment were not effective predictors of successful 
return to work. 
In a more general study, Mages andMendelsohn (1979) examined 60 
patients with various cancer sites, most of whom had received a radi-
ation-only treatment regimen. Some of these patients were three- to 
six-year survivors. Their findings indicated marked increases in self-
image, values and physical capacities over time, but little change in 
level of dysphoria on the Gaugh-Heilbrun Adjective Checklist. They 
also reported improvements in distractibil~ty, absent-mindedness and 
concentration, as well as an increase in focus on home and family 
concerns over time. Women were more able than men to preserve their 
sense of self-esteem over time off treatment. The authors comment 
that in their young adult patients, the cancer experience impeded the 
development of their self-sufficiency and resulted in delay and dis-
ruption of the smooth establishing of adult roles. 
A study by Kennedy, Tellegen, Kennedy, and Havernick (1976) 
examined 22 advanced cancer patients (various sites), aged 20-69, 
5-20 years off treatment. They found the men to have a significantly 
higher mean stress-reactivity level on the Differential Personality 
Questionnaire. Women had a higher mean social closeness score. That 
is, women particularly valued close and friendly personal relationships, 
while the men appeared at higher risk for post-treatment distress. 
Interestingly, all cancer patients in their study showed a greater 
appreciation for life, people, time, and interpersonal relationships 
when compared to matched samples of chronic diabetes patients and 
normal (healthy) controls. They were less concerned than the compar-
ison groups.with the 'non-essentials" of life. The authors conclude 
that cancer, when met with successful treatment, is a good catalyst 
for character development. They base this conclusion on the finding 
of generally positive adjustment without significant psychosocial 
distress, as measured by physician assessment, semantic differential 
ratings, the Differential Personality Questionnaire, and unstructured 
interview (Kennedy et al., 1979). 
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A final psychosocial study of diagnostically mixed cancer 
patients assessed 20 patients aged 29-78, 1-33 years post-diagnosis 
(Shanfield, 1980). Based upon data from unstructured interviews, the 
author concluded that fear of cancer, then fear of significant object 
loss, were the numbers one and two concerns, respectively, of the 
surviving cancer patient. Mild depression was detected in 25% of the 
sample. Physical vulnerability was named as a consequence related to 
the fear of recurrence. Shanfield also identified a sense of exis-
tential resolution with death which the successfully treated patient 
feels. With this sense of resolution comes a heightened sense of life 
appreciation, according to Shanfield's data. 
Psychosexual studies of cancer survival: Mixed diagnostic 
groups. In accord with other studies (Greenleigh Associates, 1979; 
Shanfield, 1980), Sutherland (1960) identified the fear of rejection 
as the main source of anxiety in the off-treatment cancer patient. 
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According to Sutherland, this fear of rejection or abandonment can be 
expected to show itself through sexual dysfunction. Golden and Golden 
(1980) have suggested that the frequently observed desexualization of 
the cancer patient is often an interpersonal (rather than personal) 
dysfunction in that it is often the healthy partner who initiates, or 
at least actively colludes with, disengagement. Lamb and Woods (1981) 
have discussed the public image of cancer which, despite the many 
recent treatment advances, is still one of a terminal or chronic 
passive illness. This would militate against an unconflicted accep-
tance of the recovered patient's return to an active, vigorous sex 
life. 
Many authors (e.g., Grinker, 1976) have emphasized the primary 
influence of psychological rather than physiological causes for 
impotence·and general sexual dysfunction in cancer patients. One 
piece of evidence for this assertion is that sexual dysfunctions often 
continue well into the post-treatment period, virtually nullifying the 
possibility of drug- or disease-related etiology. These reported 
post-treatment dysfunctions have been attributed to decreased libido, 
concern over performance, defective body image, fear of rejection, 
gender identity disturbance, fear of disease contagion, and depression 
(Chapman, 1982; Grinker, 1976; Schain, 1982; Sutcliffe, 1979; Wise, 
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1978). 
The bulk of the writing in the area of sexual dysfunction in 
cancer patients of mixed diagnostic categories has been based upon 
case reports and clinical experience. The absence of systematic 
empirical attention to this area is striking. However, there have been 
careful studies of sexual dysfunction in the specific diagnostic 
classes of Hodgkin's disease and breast cancer patients. These will 
be discussed later, along with psychosocial studies of those specific 
groups. 
Before discussing breast cancer and Hodgkin's disease patient 
studies in particular, one empirical study of male and female cancer 
patients (various sites) in treatment will be described, because it 
holds relevance to one of the study's aims. This study explored 
communication and fulfillment of affectional needs in 36 patients and 
their spouses (Leiber et al., 1976). Based upon ~he results of an 
Affectional Needs and Behavior Scale and upon interview material, 
the authors concluded that desire for sexual intercourse decreased in 
37% of all patients, while the desire for non-sexual physical close-
ness increased in 49% of patients. Women patients were more likely 
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to have their affectional needs met than men. They were also the most 
depressed of the four groups of subjects (male patients, female pa-
tients, husbands and wives). An interesting finding which holds 
direct relevance to the current study was that male patients exper-
ienced the greater disparity of needs and alteration of sex roles in 
relation to their wives, as compared to female patients. Therefore, 
they had greater potential for marital tension and discord. The 
authors speculate that it is more difficult for the young adult man 
than the young adult woman to assimilate the passivity and dependency 
of the patient role. The young man's burgeoning sense of competence 
may be more acutely threatened by·the impact of untimely disease. 
This is one reason for selecting men as the focus of study in this 
investigation: they may be at higher risk for psychosocial and 
psychosexual maladjustment. 
In summary of previous investigations of cancer survival, many 
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of the studies on mixed diagnostic groups have been quite extensive 
with regard to sample size, but very global when one considers the type 
of inquiry. Previous studies have tended to focus on the presence of 
general depressive symptomatology and quality of life as reflected in 
self-report. Findings have been inconsistent, surely due in part to 
differing methodologies and unclear criteria for "disturbance." Re-
search reports on the impact of cancer in the survival period have 
run the full gamut of conclusions, from positive character growth 
through no significant change to heightened risk of depression, 
anxiety, fatigue, work maladjustment and discrimination, and inter-
personal difficulties. Reports of post-treatment psychosexual dys-
function in the general cancer population have been more impression-
istic and superficially documented than carefully empirical in their 
basis. Systematic exploration of this particular area is notably 
lacking in the general psychosocial oncology literature. 
Psychosocial and psychosexual studies of cancer survival: 
Breast cancer patients. The fact that breast cancer, if detected 
early, has long been amenable to successful treatment with combined 
surgery and radiotherapy has led to extensive psychological study of 
survival .in this particular disease group. The insult of cancer upon 
such a culturally valued sexual body part can have potentially far-
reaching psychosexual ramifications (Derogatis, 1980). The following 
44 
studies will only highlight the many studies in the area of psycholog-
ical adjustment to breast cancer survival. Characteristic 
of research in this area, these studies reveal a pattern of mixed 
results. 
Eisenberg and Goldenberg (1966) tested 252 breast cancer patients 
immediately after mastectomy and 18 months later. They found persis-
tent decrements in self-esteem and an actual drop over time in the 
percentage of patients who held a positive attitude toward their 
future, from 54% down to 39%. This drop may again represent a lifting 
of defenses in the recovery phase of survival. 
In an extensive mail survey of 826 breast cancer patients ran-
domly selected from the Memorial Hospital registry of 5,472 patients 
treated for breast cancer between 1949-1962, 84% of survivors off 
treatment for five or more years had, by their own criteria, fully 
resumed their premorbid lifestyles (Schottenfeld & Robbins, 1970). 
Many of this group (14%) said that it took them over six months post-
treatment to do so. This suggests that around 30% of these patients 
failed to successfully resume premorbid functioning within six months 
of completing treatment. Comparing five-year survivors to 10- and 
15-year survivors, they found that severity of disease did tend to 
slow down the process of return to earlier occupational status: With-
in the five-year group only, ratings of women with regionally spread 
disease were lower than those with localized disease. 
A very well-controlled study has compared 134 breast cancer 
patients, most of whom were five or more years off treatment, to 139 
age-matched controls and 121 neighborhood controls (Craig, Comstock, 
& Geiser, 1974). All were given the same 28-item general health and 
quality of life questionnaire. There were no significant differences 
in level of employment, attitude toward life, view of the future, 
leisure activities, or psychiatric symptoms. The only differences 
between groups which reached significance were that the cancer pa-
tients rated their current health as poorer and rated themselves as 
more physically disabled than the two control groups. Both of these 
differences have clearly realistic bases, and were therefore not seen 
as signs of maladjustment in these women. 
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A prospective investigation, using the "Ability Index" from an 
earlier study (Iszak & Medalie, 1971), followed 221 breast cancer 
patients over a three-year off-treatment period (Iszak, Feller, Brenner, 
Medalie, & Tugendreich, 1975). All patients, including 90 with stage 
I and 131 with stage II disease, had the same treatment: Radical 
mastectomy plus radiation. One year after treatment, 201 (91%) were still 
living; 167 (75%) were still alive at three years. General problems 
surveyed by the Ability Index included subjective complaints about 
medical treatment, reduced ability to support themselves, change in 
relationships with family and friends, and emotional well-being vis-
a-vis health concerns. Comparing survivors one year off treatment to 
themselves three years off treatment, they identified a slight drop 
(21% to 15%) in patients with ambulatory limitations, increases in 
sexual disturbances over time (12% to 18% fr~quency), improvement in 
ability to support oneself financially over time (30% disabled to 20% 
disabled), and a slight drop in social (extrafamilial) contact over 
time. There was no change noted in familial relationships over time~ 
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lending support to the common notion that one aspect of adpatation to 
cancer survival entails some withdrawal from the milieu of friends and 
increased focus on family togetherness. Patients at both times of 
assessment demonstrated difficulties in lack of self-confidence, fear, 
frustration, and anger about the future, at a frequency of approximate-
ly 25%. 
The results from this comprehensive study (Iszak et al., 1975) 
reflect a mixed picture of adaptation. There is some indication of 
life enhancement from the cancer experience, but somewhat more evidence 
for mild psychosocial disruption. Another study has supported this 
figure of 25% psychological distress after one year off treatment, but 
asserts that this figure drops over the following four years (Maguire, 
1976). Morris, Greer, and White (1977), on the other hand, reported 
that 30% of their 69 breast patients were psychologically distressed 
one year after treatment, and that this figure did not drop in the 
second year. They used psychological tests and a different structured 
interview, so the different measures and different criteria for dis-
tress (self-report vs. test scores) could explain why one group found 
this drop and the other did not. The study by Morris and colleagues 
compared 69 breast cancer patients to 91 women with benign breast 
disease both cross-sectionally and longitudinally. Two years after 
diagnosis and surgery, 83% of the cancer group and 76% of the benign 
group had successfully resumed premorbid work and marital functioning. 
A final study to be reported here, exemplary of research in 
breast cancer survival, examined 49 post-mastectomy patients four 
years after treatment (Woods & Earp, 1978). Through structured 
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interview they determined that women who complained of more physical 
symptoms during and after treatment were also those who were in ~reater 
psychological distress. Incidence of sexual dysfunction remained high 
four years off treatment for these women, and was related to marital 
discord. The authors conclude that social support (including family 
and social service assistance) has a buffering effect upon the psycho-
social adjustment difficulties of the cured breast cancer patient. 
Psychosocial and psychosexual studies of cancer survival: 
Hodgkin's disease patients. Very little has been done in the specific 
study of Hodgkin's disease patients off treatment. The greatest 
emphasis has been on psychosexual adaptation, since the known steril-
izing effects of combination chemotherapy and radiation have led 
oncologists to be concerned about psychosexual dysfunction which might 
arise from this impairment. Once again, the research in this area 
has yielded mixed findings. 
In conjunction with their initial trials of }IDPP chemotherapy, 
Sherins and DeVita (1973) found 16 treated Hodgkin's disease patients 
to experience normal ejaculation in the face of abnormal spermatogen-
esis. In a larger study, 74 Hodgkin's disease patients were assessed 
an average of 27 months after treatment (Chapman, Sutcliffe, Rees, 
Edwards, & Malpas, 1979). Compared to a rate of 74% during treatment, 
46% of all patients complained of decreased libido and sexual perfor-
mance in the post-treatment period. Few of this 46% were subjectively 
distressed about their difficulty, however. Six of 54 men were 
rendered impotent. Four of these cases had no physiologic basis for 
their impotence. 
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In a related study, Chapman, Sutcliffe, and Malpas (1981) inter-
viewed 47 male Hodgkin's patients about general quality of life and 
subjective personality changes as well as psychosexual dysfunction. 
Most of these patients were studied prospectively, from the pre-treat-
ment period through treatment cessation. Twenty-one of them were post-
treatment patients who made retrospective ratings of the treatment 
and survival periods. Half of all patients stated their libido had 
not returned to pre-treatment levels. They did, however, acknowledge 
a gradual increase in libido and general quality of life over the 
years while in complete remission. Other findings of the study in-
cluded a tendency toward increase in violent behavior and irritability 
in the post-treatment period. Irritability, for example, was given 
as a "status quo" affect in 84% of patients recently off treatment, as 
opposed to 16% of pre-treatment patients. The authors concluded that 
the emotional response of a young man becoming ill may represent a 
particular vulnerability in that the dependency of illness and the 
sterilizing effect of treatment are decidedly "unmasculine" exper-
iences which can challenge the smooth transition into adulthood (cf. 
Leiber et al., 1976). 
In a larger study (Cunningham et al. , 1982) , 156 male Hodgkin's 
patients, ranging from 43-141 months off treatment, were interviewed. 
Most of them (112) were between the ages of 15-40. Using gross career 
criteria and patient comparisons of lifestyle changes contrasting 
retrospective pre-treatment ratings to current ratings, they concluded 
that nearly all of the sample had led "normal" p.ost-treatment lives. 
Of 263 (male and female) patients, four had severe physical 
complications and only two displayed serious psychiatric disturbance 
(Cunningham et al. , 19 82) • 
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Two other psychosocial studies with Hodgkin's disease patients 
also hold importance for the current study. The first was a mail sur-
vey of socialization skills in 30 adolescents an average of three 
years off treatment (Mitchell, 1982). Using the Aschenbach Child 
Behavior Checklist, the author found that adolescents with Hodgkin's 
disease did not show the predicted decrease in socialization abilities. 
Mitchell did determine that patients who had more severe disease, and 
·therefore were subjected to more aggressive combined modality treat-
ment, displayed lower activity levels than those who had less severe 
disease. This suggested some element of fatigue, or perhaps develop-
mental lag, secondary to greater isolation from the peer group in 
recovered adolescents with later stage disease. All patients showed 
restriction in their drive for independence, presumably related to the 
dependency induced by the sick role (cf. Chapman et al., 1981; Leiber 
et al., 1976). 
The final study relating specifically to Hodgkin's disease 
patients compared 37 Hodgkin's patients aged 18-45 to 28 young adult 
parents of leukemic children (Morrow, 1980). Morrow used the "PAIS," 
or Psychosocial Adjustment to Illness Scale (Morrow, Chiarello, & 
Derogatis, 1978). The parent group was shown to have greater overall 
psychological distress than the Hodgkin's group. Of the 37 Hodgkin's 
patients, 32 were off treatment for two or more years (M = 5.5 years). 
Morrow (1980) also found that both the parents and the 32 Hodgkin's 
patients more than two years off treatment had higher anxiety scores 
on the Gottschalk-Gieser (1969) Content Analysis Scale than the 
scale's normative sample. Unlike the parent group, however, the 
Hodgkin's patients did not score any higher than the normative sample 
on level of hostility. 
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To summarize, the research done with Hodgkin's disease patients 
specifically has often been superficial in its methodology and has pro-
duced inconsistent results. Some studies have identified reduced 
libido, fatigue, anxiety, irritability, and depression which linger 
on into the post-treatment period. Others have denied the presence 
of such problems. 
While not strictly a study of Hodgkin's disease survivors, one 
final investigation will be discussed in this section. Koocher and 
O'Malley (1981) undertook an extensive investigation of childhood 
cancer survivors which offers data relevant. to understanding the 
long-term adjustment difficulties of survivors of Hodgkin's disease 
as well as other childhood cancers. 
The realization that no study had comprehensively assessed 
mental health or psychological adjustment in childhood cancer survivors, 
led Koocher and colleagues to initiate extensive investigation of this 
area (Koocher & O'Malley, 1981; Koocher, O'Malley, Gogan, & Foster, 
1980; O'Malley, Koocher, Foster, & Slavin, 1979). Koocher and 
O'Malley's (1981) book, titled "The Damocles Syndrome," takes its 
name from the story of Damocles, who assertedly was forced to sit at 
a banquet in the court of Dionysus under a sword suspended by a single 
hair, to depict the precariousness of his fortunes. Such uncertainty 
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is presented by the authors as the dilemma which all successfully 
treated cancer patients face during the initial years following treat-
ment, if not for their entire lives. 
Since the conceptualization and execution of Koocher and O'Malley's 
work has contributed greatly to the thinking behind the current inves-
tigation, it will be summarized in some detail. The book presents the 
results of their intensive examination of 117 childhood cancer surviv-
ors and a comparison group of 22 children with various chronic dis-
eases. The children with cancer had either neuroblastoma, leukemia, 
osteosarcoma, non-Hodgkin's lymphoma, or Hodgkin's disease. Mean age 
at diagnosis was 5.5 years, and mean age at testing was 18. All 
children were at least five years post-diagnosis. 
The authors of the study identified "uncertainty of survival" as 
the chief independent variable. Thus, they did not pay close atten-
tion to time off treatment or disease severity as potential factors. 
They did, however, compare different diagnostic categories to each 
other on some of the measures. Dependent measures were administered 
to all subjects and included Srole's (1962) Combined Adjustment Rating 
Scale, a standardized interview including mental status examination, 
Rutter and Graham's (1968) Standardized Psychiatric Interview (for 
the 7-12 year old subjects), the Wechsler Intelligence Scale's Infor-
mation, Similarities and Vocabulary subtests, the Vineland Social 
Maturity Scale, Conte's (1975) Self-Rating Depression Scale, Conte's 
(1975) Death Anxiety Questionnaire, the Bendig (1956) short form of 
the Taylor Manifest Anxiety Scale, Bills' (1961) Index of Adjustment 
and Values (a self-esteem measure) and TAT cards 1, 3GF, 8BM, 13B, 
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and 14 as well as Waechter's (1971) four drawings of hospital scenes. 
These nine stories of each participant were scored for content r~flect­
ing sadness, loneliness, individual_ reflection, and story resolution. 
The principal (global) finding of their study was that 47% of 117 
long-term survivors of childhood cancer showed some degree of adjust-
ment difficulty as measured by the Combined Adjustment Ratings of two 
independent raters (interrater Pearson's ~ = .85). This percentage was 
significantly greater than that for the smaller group of children with 
chronic illness. Within the cancer group, the highest incidence of 
adjustment difficulty was in the Hodgkin's disease subgroup (64%). 
The authors proposed two interpretations for this. One was that be-
cause this was the oldest subgroup of patients, it may indicate that 
psychosocial adjustment to childhood cancer is more problematic for 
older children and adolescents than for younger children. This makes 
intuitive sense in that the developmental tasks of adolescence are 
in direct opposition to the dependency which sickness and recovery 
engender. The second interpretation offered was that the more pro-
longed treatment which Hodgkin's disease patients receive by compari-
son to other childhood cancers may increase the sense of uncertainty 
and danger which the young patient experiences. A related issue is 
that many Hodgkin's patients receive splenectomies which can prolong 
immunodeficiencies. Successfully treated Hodgkin's patients may 
therefore be required to take antibiotics as immunotherapy long after 
treatment ends; an ever-present reminder of continued vulnerability. 
In this same investigation (Koocher & O'Malley, 1981), no dif-
ferences were found between the general cancer group and the chronic 
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illness comparison group in verbal intelligence or social maturity. 
Likewise, cancer patients did not show elevated death anxiety, manifest 
anxiety, or depression. Self-esteem as measured by self-report was 
not significantly lower. Multiple regression analysis showed higher 
intelligence and higher socio-economic status to be good predictors of 
positive adjustment. As implied earlier, age at diagnosis was also a 
good predictor of positive adjustment, with younger patients faring 
better. Time since diagnosis, while not built into the hypotheses of 
the study, did show itself to be a good predictor of adjustment (the 
more time elapsed, the better). Disease severity did not. 
Koocher and 0 'Halley conclude their book with a formulation of 
adaptation to cancer based upon their empirical findings and their 
review of the literature. They conclude that the "stress" of cancer 
is greatest at the point of diagnosis and initiation of treatment, and 
that it slowly diminishes over time, nearly reaching baseline at five 
years post-diagnosis. During the course of this decline, various 
events such as recurrence, symptom distress or death in the family can 
disturb the settling process and initiate elevations in stress. The 
patient, in a state of heightened vulnerability due to the protracted 
working through of the impact of cancer and its treatment, is likely 
to be more easily over-excited and distressed. This, according to the 
authors, is optimally dealt with through adaptive denial which is 
best described as a conscious suppression of feelings, and an increase 
in activity to counterbalance the passivity of illness. The almost 
universal use of denial, in 99% of patients (O'Halley et al., 1979), 
is again a powerful testimony to its effectiveness if not necessity. 
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Psychosocial and psychosexual studies of cancer survival: Sum-
mary. In general, the research on cancer survival, Hodgkin's disease 
patients included, has yielded mixed results. Quite often, protracted 
and exaggerated psychological symptomatology such as depression, 
anxiety, somatization, fatigue, and irritability have been reported. 
Evidence for significant psychosexual dysfunction, particularly as it 
is affected by body image and interpersonal concerns, has been pre-
sented. Psychosocial areas of occupational functioning and marital 
satisfaction have also been cited as problematic. On the other hand, 
.there are investigators who deny the presence of significant psycho-
social or psychosexual disruption in the cancer survivor. Some have 
even emphasized the positive, growthful aspects of having suffered 
through and endured the ordeal of successful cancer treatment. In 
some studies, both positive and negative effects have been known to 
coexist, possibly exerting separate influences upon adaptation. 
There are several problems with the experimental methodology 
to date which may contribute to the inconsistencies and inconclusiveness 
of the results outlined. First, investigations have differed greatly 
in their use of control or comparison groups. Some have used no com-
parison group at all, opting to compare their findings to established 
base rates, normative data, or mere common sense~ Second, measurement 
of dependent variables has often been global, and has tended to rely 
upon non-standardized interview responses rather than structured 
questionnaires or more in-depth projective tests. A third problem 
with past research is that the groups being studied have often been 
quite heterogeneous. Many studies have neglected to differentiate 
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diagnostic categories within the cancer variable. Of those which have, 
efforts to isolate effects of disease stage, treatment severity, or 
length of time off treatment have usually been minimal or non-existent. 
Therefore·, more extensive study of cancer survival, focusing on specif-
ic diagnostic groups, specific treatment regimens, and clearly delin-
eated survival periods seems necessary to help clarify the current 
confusion about the psychosocial aspects of cancer survival. 
Hypotheses of the Study 
The present study attempts to identify psychosocial and psycho-
sexual liabilities which may accompany survival from successful cancer 
treatment. Unlike most other studies, it limits itself to the study 
of one diagnostic group, Hodgkin's disease, so that the variables 
of diagnosis and treatment may be held relatively constant. Also, 
unlike other studies, it focuses exclusively upon young adult men, a 
group of patients identified in the literature as at high risk for 
psychosocial and psychosexual distress. The selection of a "good 
prognosis" cancer minimizes the realistic threat to survival so that 
the study of patient uncertainty will be, as much as possible, a 
psychological one. 
The three independent variables of interest are: 1) history of 
Hodgkin's disease and treatment (N = 60 patients vs. N = 20 age-
matched non-patients); 2) severity of illness and treatment (N = 30 
early stage vs. N = 30 late stage patients); and 3) length of time 
off treatment (N = 30 less than 24 months vs. N = 30 more than 30 
months off treatment). This is the first.known study which systemat-
ically examines the combined contribution of these variables to 
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adaptation in cancer survival. 
Guided by the literature just reviewed, the following hypotheses 
were generated prior to the study: 
1. Patients will appear more disturbed than non-patients on 
self-report measures of psychosexual functioning, psychological symptom 
distress, self-esteem, death anxiety, and coping adequacy, and on 
interview ratings of global adjustment. Because of conflicting studies 
reporting both increased need for interpersonal closeness and decreased 
ability to achieve this, it was hypothesized that patients would show 
different (perhaps higher, perhaps lower) capacity for intimacy than 
non-patients. 
2. On semi-structured interview, patients will show greater 
difficulty in work adjustment, a heightened appreciation for life, and 
higher self-ratings of overall quality of life than the non-patient 
sample. 
3. Late stage patients will appear more disturbed than early 
stage patients on self-report measures of psychosexual functioning, 
psychological symptom distress, self-esteem, death anxiety, and 
coping adequacy, and on interview ratings of global adjustment. They 
should also be different than early stage patients in intimacy capac-
ity (motivation). 
4. On semi-structured interview, late stage patients will show 
greater difficulty with work adjustment, a lower appreciation of life, 
and lower self-ratings of overall quality of life than the early stage 
patients. Late stage patients are also expected to show greater sub-
jective disturbance in physical stamina, sleep, eating habits, and 
concentration abilities (possible depressive equivalents). Addition-
ally, they should have greater difficulty with the prolongation of 
conditioned nausea and anxiety during the off-treatment period. 
5. Patients recently off treatment will appear more disturbed 
than those off treatment for longer periods of time, on self-report 
measures of psychosexual dysfunction, psychological symptom distress, 
self-esteem, death anxiety, and coping adequacy, and on interview 
ratings of global adjustment. They also should be different from 
patients distantly off treatment in capacity for intimacy (intimacy 
motivation). 
6. On semi-structured interview, patients recently completing 
treatment should show greater difficulty with work adjustment, a lower 
appreciation for life, and lower self-ratings of overall quality of 
life than those patients distantly off treatment. Patients recently 
completing treatment are also expected to show greater subjective 
disturbance in physical stamina, sleep, eating habits, and concentra-
tion ability (possible depressive equivalents). They should also 
acknowledge a higher incidence of conditioned nausea and anxiety 




The study sample consisted of 80 men ranging in age from 21 to 
46 years at the time of assessment. Sixty of these men were Hodgkin's 
disease patients at Memorial Sloan-Kettering Cancer Center, off all 
treatment and showing no clinical evidence of disease for at least six 
months. The other 20 participants were age-matched healthy volunteers 
who had never suffered any life-threatening physical illness or debil-
itating medical treatment. 
Patients potentially eligible for study were Memorial Hospital 
male Hodgkin's disease patients between 18 and 50, who had received 
their diagnosis before age 45. With this as a starting point, treat-
ment protocol records of 151 patients listed as at least six months 
off treatment were reviewed. In this review, 33 patients were exclud-
ed for the following reasons: recent relapse (15), death (5), formal 
psychiatric history which predated cancer diagnosis (3), serious 
(life-threatening) physical illness in addition to cancer diagnosis 
(2), and non-fluency in English (2). "Formal psychiatric history" 
was defined as prior hospitalization or outpatient medication, but 
not outpatient psychotherapy alone. Of the remaining 118 patients, 
14 were placed on low priority eligibility because they were between 
24 and 30 months off treatment. This was done to help separate 
patients more cleanly into the two time-off-treatment cells. None of 
these 14 patients had to be approached for study. 
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Patients were placed into one of four mutually exclusive cells 
for analysis. The design was essentially a 2 (disease stage) by 2 
(time off treatment) factorial layout with an appended comparison 
group (see Figure 1). The disease stage variable was broken down 
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into "EARLY" (IA, IB, IIA, IIIA) and ''LATE" (IIB, IIIB, IVA, IVB), as 
is the custom at Memorial Hospital. The time off treatment variable 
was broken down into "RECENT" (6-24 months off treatment) and "DISTANT" 
(over 30 months off treatment). The combination of these two factors 
resulted in four patient groups: Early stage recently off treatment 
(ER); early stage distantly off treatment (ED); late stage recently off 
treatment (LR); and late stage distantly off treatment (LD). 
From the pool of 104 eligible patients, prospective partici-
pants were recruited either by phone or in person when they came in 
for their check-up. The last 10 patients were carefully selected to 
ensure equal cell sizes. Of 69 patients asked, 62 agreed to parti-
cipate. Six of the seven refusals came from men who stated that they 
would prefer not to be reminded of the treatment experience. The 
seventh refuser would not say why he declined. Two of the 62 patient 
participants were excluded from all analyses because they withdrew 
themselves from the study midway through their session. 
The age-matched non-patient group was subjected to the same 
background inclusion criteria: age 20 to 46, absence of formal psy-
chiatric history, absence of life-threatening physical illness, and 
fluency in English. Sixteen of them were either friends (12) or 
relatives (4) of the patients. This method of recruitment through 
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by similarity and to reduce the potential bias of volunteerism. After 
canvassing the entire sample of patients for volunteers, four compari-
son participants were still needed. These were obtained through extra-
hospital contacts. The interviewer knew none of them personally. 
Table 2 contains the demographic and socioeconomic characteris-
tics of the sample. The apparent equivalence across the five groups on 
race, marital status, religion, family income bracket, and presence of 
children has been confirmed by non-significant x2 tests of statistical 
dependence. The only variable which differed significantly across 
cells was the Hollingshead Two-Factor Index of Social Position (Hollings-
head, 1957), IC1,74) = 3.19, E <.05. This Two-Factor Index combines 
education (weight = 3) and occupation (weight = 5) into an estimate of 
social position. Mean comparison determined that the non-patient group 
had a somewhat higher social status than the combined patient sample, 
and the ''Late Recent" patient group was somewhat lower than the other 
three patient groups. 
Returning to the patient sample, all but four were treated accord-
ing to one of the four Memorial Hospital treatment protocols discussed 
in the literature review. Of these 56 patients, 29 (52%) were treated 
with combined MOPP and involved field (local) radiation, 16 (28%) were 
treated with eight-drug chemotherapy (MOPP/ABDV) and local radiation, 
six (11%) with 10-drug chemotherapy (MOPP/ABV/CAD) and local radiation, 
and five (9%) with MOPP and local radiation followed by 8- or 10-drug 
chemotherapy and local radiation after relapse. The other four 
patients were treated before these protocols existed. Two received 
radiation alone, and two were treated with MOPP chemotherapy alone. 
The mean time off treatment for the patients in the two "recent" 
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Table 2 
Socio-Demographic Characteristics of the Sample 
Variable Patients Non- Total 
Patients 
Early Early Late Late 
Recent Distant Recent Distant (N=20) (N=80) 
(,!!=15) (N=l5) (,!!=15) (N=l5) 
AGE M=31.5 M=32.0 M=30.5 M=32.5 M=29.4 M=31.1 
SD=7. 0 SD=7. 8 SD=7 .6 SD=5.0 SD=5.2 SD=6.5 
RACE 
white 14 14 14 14 20 76 
hispanic 1 1 1 1 0 4 
MARITAL STATUS 
single 7 (46%) 6 (40%) 8(53%) 3 (20%) 11 (55%) 35 (44%) 
married 8(53%) 8(53%) 6(40%) 11 (73%) 8 (40%) 41 (41%) 
sep. I div. 0(0%) 1 (7%) 1(7%) 1 (7%) 1 (5%) 4 (5%) 
CHILDREN 
yes 6 (40%) 6(40%) 7(47%) 4(27%) 5 (25%) 28(35%) 
no 9(60%) 9(60%) 8(53%) 11 (73%) 15 (75%) 52(65%) 
RELIGION 
Catholic 10(67%) 8(53%) 8(53%) 8 (53%) 12(60%) 46 (57%) 
Protestant 1 (7%) 6(40%) 5 (33%) 3 (20%) 4 (20%) 19(24%) 
Jewish 4(26%) 1(7%) 1 (7%) 4(27%) 4 (20%) 14 (18%) 
none 0(0%) 0(0%) 1(7%) 0(0%) 0(0%) 1(1%) 
INCOME BRACKETl 
$0-10,000 1(6%) 2 (13%) 4 (27%) 0(0%) 2 (10%) 9 (11%) 
$10-20,000 4(27%) 3(20%) 3 (20%) 5(33%) 4 (20%) 19(24%) 
$20-30,000 4(27%) 3 (20%) 7 (4 7%) 2 (14%) 4 (20%) 20(25%) 
$30-50,000 4 (27%) 6 (40%) 1(6%) 3(20%) 7 (35%) 21 (26%) 
over $50,000 2(13%) 1(7%) 0(0%) 5 (33%) 3 (15%) 11(14%) 
HOLLINGSHEAD M=45.6 M=40.4 M=37.7 M=48. 9 M=50.6 M=45.1 
INDEX SD=l2.5 SD=l2.3 SD=l2.1 sn=l4.2 SD=ll.2 sn=l2.4 
1 ) 
Annual family income 
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groups was 13.2 months (11.8 months for late stage patients and 14.6 
months for early stage patients). The mean time off treatment for the 
two "distant" groups was 55.4 months (50. 7 months for late stage 
patients and 60.1 months for early stage patients). Within the time 
off treatment variable, differences across stage were not significant 
for both comparisons. 
Materials 
The dependent measures were organized into three categories: 
patient responses and ratings in interview, objective self-report 
measures, and experimenter ratings. These three categories will be 
described separately. 
Interview Ratings and Responses: A Revised Problem Oriented Record 
The Problem Oriented Record (POR) is a structured clinical inter-
view which surveys 12 areas of life performance: problems with medical 
treatment, hospital service, mobility and housework, vocational problems, 
financial, family and social problems, worries regarding disease, and 
problems with affect, body image, and communication (Gordon, Freiden-
bergs, Diller, Hibbard, Levine, Wolf, Ezrachi, & Lipkins, 1978). 
Each problem is scored for two components: problem existence 
(yes or no) and severity weighting of a problem (1-10 scale). The 
interview constructors selected this format because it provided spe-
cific scores for known problem areas of the cancer patient, and also 
lent sufficient flexibility to allow patients to "talk through" any 
uncomfortable feelings aroused by the interview. The POR has been 
demonstrated as useful with three separate cancer diagnoses: breast, 
lung, and melanoma (N = 136). 
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Because FOR was designed for use with cancer patients currently 
in treatment and only recently off treatment, substantial revision of 
the record was necessary. Some treatment-relevant questions were 
omitted, many questions were reworded to accommodate the sample, and 
some questions were added because they were believed to hold special 
relevance for the surviving patient (e. g., 11Do you feel that you appre-
ciate life more fully than you did before your illness? 11 ; "How worried 
are you about having a recurrence?") • Appendix A shows the revised 
version of the FOR used in this study. 
Self-Report Measures 
Derogatis Sexual Functioning Inventory (DSFI). The DSFI (Dero-
gatis, 1975,1978) is a 256-item inventory broken down into 11 subscales 
of psychosexual and psychological functioning. Nine of these scales 
(information, experience, drive, attitudes, gender role, fantasy, 
body image, satisfaction) tap sexual domains and the other two (psy-
chiatric symptoms and affects balance) measure psychological domains 
which correlate with sexual functioning. The eight scales designated 
as relevant to this study were drive, gender role, fantasy, body image, 
satisfaction, global satisfaction, psychiatric symptoms, and affects 
balance. High scores on the drive, fantasy, satisfaction, global 
satisfaction, and affects balance subscales are associated with posi-
tive adaptation, or low impairment. The reverse is true of the body 
image and psychiatric symptoms subscales, where high scores reflect 
high impairment. A high gender role score indicates hypermasculinity, 
and a low score, hyperfemininity (in men). Appendix B shows the DSFI. 
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Internal consistency and test-retest reliability coefficients of 
the primary symptom dimensions are generally quite high, ranging from 
.56 to .97. Construct validity was demonstrated (~ = 380) by principal 
components analysis, separating normals from known sexual dysfunction-
ing patients, using subscale factors to account for 52% of the variance. 
Discriminant function analysis achieved a 77% hit rate using the same 
sample of 380 (Derogatis & Melisaratos, 1979). 
Brief Symptom Inventory (BSI). The BSI is a delineated version 
of the psychiatric symptoms subscale of the DSFI. This 53-item index 
(Section V of the DSFI) is a shortened form of the more familiar 
Symptom Check List-90 (SCL-90). Psychiatric symptoms subsumed under 
nine dimensions (somatization, obsessive-compulsiveness, interpersonal 
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid 
ideation, and a psychoticism) are rated by the participant on a 5-point 
Likert-type scale of intensity for the time period of the past two 
weeks by the participant. There are also summary scores of global 
severity of symptoms (total score ~ 53), positive symptom total (total 
#of symptoms endorsed), and positive symptom distress index (average 
rating per symptom endorsed). Internal consistency (! = 719) and test-
retest reliability (~ = 60) coefficients for the nine dimensions and 
three global indices range from .68 to .91 (Derogatis & Spencer, 1982). 
Concurrent validity with the SCL-90 has been shown in a sample of psy-
chiatric outpatients (! = 500) through correlation coefficients above 
.90 for all dimensions and indices. Convergent validity with the MMPI 
was demonstrated with 209 symptomatic volunteers (Derogatis & Spencer, 
1982). The dimensions relevant to this study are somatization, 
interpersonal sensitivity, depression, phobic anxiety, paranoia, hos-
tility, anxiety, global severity of symptoms, and positive symptom 
total. 
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Impact of Events Scale (IES). The IES is a 15-item measure of 
response to stressful life events along two constructs, intrusion and 
avoidance (Horowitz, Wilner, & Alvarez, 1979). The scale designers 
have found it useful in studying a person's response to the same trau-
matic event over long periods of time. Each item describes a reaction 
to the identified stressor (in this study, the diagnosis of cancer) 
which the subject endorses as present or absent along a weighted 4-
point scale, with "O" = not at all, "1" = rarely, "3" sometimes, and 
"5" = often. A high score is thus associated with high distress. 
Internal consistency (.78, .82) and test-retest (.89, .79) reliability 
of the intrustion and avoidance scales, respectively, were amply demon-
strated on a sample of traumatized outpatients suffering from.post-
traumatic stress syndromes (~ = 66). Construct and discriminant valid-
ity as well as test sensitivity were demonstrated in comparing this 
high distress group to 110 normal medical students recently after their 
first exposure to cadaver dissection, !(1,172) = 212.1, E <.0001 for 
intrusion and !(1,172) = 73.0, ~ <.001 for avoidance (Horowitz et al., 
1979). 
Rosenberg Self-Esteem Scale (RSES). The RSES is a 10-item 
inventory of self-esteem (Rosenberg, 1965). It is intended to measure 
the more conscious "self-acceptance" aspect of self-esteem. The scale 
was constructed with 5,024 adolescents, using the Guttman procedure, 
and thus the conditions of unidimensionality of scale and cumulativeness 
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of the items underlie the scoring. The 10 items revolve around liking 
or disliking of self, and are answered on a 4-point Likert-type scale 
(strongly agree, agree, disagree, strongly disagree) which forces 
agreement or disagreement on each item. The 10 items are collapsed 
to six levels of self-acceptance, and thus each subject can receive a 
score ranging from 0 to 6. Low scores are associated with high self-
esteem. Rosenberg (1965) achieved a Guttman scale reproducibility 
coefficient of .92. Test-retest coefficients (! = 28) have been 
reported at .85 (Silber & Tippett, 1965). The same authors found the 
RSES to correlate from .56 to .83 with several similar measures (N = 
44), suggesting acceptable concurrent validity. 
Death Anxiety Questionnaire (DAQ). The DAQ is a 15-item inven-
tory of attitudes toward death and dying (Conte, Bakur-Weiner, & 
Plutchik, 1975). Each item is rated on a 3-point scale from 0 ("not 
at all") to 2 ("very much"). A high score reflects high death anxiety. 
Split-half reliability of scores on a heterogeneous adult sample (! = 
100) has been reported at .76. Internal consistency (coefficient 
alpha) on a separate sample (! = 230) was found to measure .83. Con-
current validity coefficients were .51 and .58 when compared to the 
Templer Death Anxiety Scale and the Dickstein Death Concern Scales, 
respectively (N = 40). Somewhat lower but still significant correla-
tions with the Manifest Anxiety Scale (~ = .27) and an age-corrected 
Zung Self-Rating Depression Scale (~ = .40) confirm the clinical ob-
servation that death anxiety is related, though not equivalent to, 
anxiety and depression (Conte, Bakur-Weiner, & Plutchik, in press). 
This lends the DAQ sufficient construct validity for research 
usefulness. The scale has been demonstrated as useful with pediatric 
cancer patients by Koocher and colleagues (Koocher, 0 'Halley, Gogan, 
& Foster, 1980) as well as by its authors. 
Experimenter Ratings 
Global Assessment Scale (GAS). The GAS is a rating scale for 
evaluating the overall psychological functioning of a subject during 
a specified (one month in this study) time period (Endicott, Spitzer, 
Fleiss, & Cohen, 1976). The scale values range from 1 to 100. Ten 
anchor points are given at 10 decile intervals. The rater first 
selects the decile of best fit, then pinpoints the placement within 
that decile according to impression. Higher scores represent greater 
psychological health. The GAS was designed to improve upon the com-
parable Health Sickness Rating Scale (HSRS) of Lubarsky (1962) by 
providing more anchor points and more behavioral descriptors, and by 
eliminating diagnostic constraints. It covers three major dimensions 
of psychopathology, impairment in daily functioning, reality testing, 
and potential for suicide or violence. One great advantage of this 
scale is the proportion of the score range which relates to non-
psychiatric persons. Scores from 61 to 100 apply to people who are 
generally considered by those around them to be psychologically 
healthy. It was expected that most participants would score within 
this upper range. 
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Five studies of interrater reliability have yielded intraclass 
correlation coefficients from • 69 to • 91. Concurrent and discriminant 
validity are reported as adequate when the GAS is compared to the HSRS, 
Mental Status Examination, and to ratings by relatives (Endicott et 
al., 1976). 
The experimenter trained himself in the rating of GAS scores by 
listening to taped GAS interviews of 10 breast cancer patients done 
at the same institution. After this, 15 interviews were rated while 
blind to the expert's GAS score. Interrater agreement was sufficient 
(£ = .95) to stop with confidence after 15. The GAS interview itself 
is unstructured, with the experimenter responsible for adequate ques-
tioning into recent disturbances of sleep, appetite, mood, psycholog-
ical symptoms, self-esteem, social and work activities, interpersonal 
relationships, and the like. 
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Intimacy Motivation. This is a relatively objective, content-
based scoring system applied to the story productions of six (in this 
study) TAT-like cards (McAdams, 1980), Intimacy motivation is defined 
by its author as "a recurrent preference or readiness in an individual 
for experiences of warm, close, and communicative exchange with others" 
(McAdams, 1981, p. 1). It has been demonstrated to be a more uni-
dimensional analogue to the affiliation motive of Atkinson, Heyns, and 
Veroff (1954), because it emphasizes measurement of only the more 
positive (approach) aspects of the affiliation motive. The theoretical 
bases for specific categories of the intimacy motive came from the 
writings of H.S. Sullivan, A. Maslow, D. Bakan, and M. Buber (see 
McAdams, 1980). These underpinnings were integrated with the now-
traditional approach of using the Thematic Apperception Test (TAT) to 
measure various social motives. The first such approach was by 
McClelland and colleagues on achievement motivation (McClelland, 
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Atkinson, Clark, & Lowell, 1953). 
The scoring system consists of 10 thematic categories which are 
applied to each story. At least one of two "prime" categories (rela-
tionship produces positive affect; non-instrumental dialogue) must be 
present for scoring to continue on that story. The eight subcategor-
ies are: psychological growth and coping gained from a relationship, 
commitment to or concern for another, time-space transcendence, union 
of characters, harmony in a relationship, surrender to outside control, 
escape to intimacy, and connection with the outside world. Each cat-
egory receives 1 point for its presence, making 0-10 the range of 
possible scores per story. The scoring system as outlined in the 
manual is quite detailed and objective, thereby yielding high inter-
rater reliability coefficients: 92% category agreement for the two 
"prime" categories, and Spearman rho = • 89 for N = 60 stories (McAdams, 
1980). Internal consistency has been demonstrated by principal com-
ponents factor analysis which found six categories loading heavily 
on an intimacy factor and accounting for 30% of the total score var-
iance. Construct validity has been supported by high correlations 
between Intimacy Motive Score and behavioral ratings of intimacy, r 
(41) = .70, E <.001 (McAdams & Powers, 1981). 
The experimenter trained himself according to the instructions 
in the scoring manual, reviewing 210 practice stories in sets of 30, 
comparing scores to expert scoring along the way. On the last 60 
stories, category agreement for the two prime tests was£= .93 for 
the "relationship produces positive affect" category, and r = .90 for 
the "non-instrumental dialogue" category. Rank-order agreement between 
experimenter and expert on the last 60 stories was rho = .92. 
The six pictures used in this study depicted the following: 
a) two figures sitting on a park bench near a river, b) a young woman 
and an older man walking through a field with horses and a dog, c) a 
man and a woman on a trapeze, d) a ship officer speaking with another 
man, with a ship in the background, e) a man covering his eyes, stand-
ing near a bed with his hand outstretched over a younger man lying 
on a couch (TAT Card 12M). Pictures a and c can be found in McClel-
land and Steele (1972). Pictured can be found in McClelland (1975). 
Procedure 
Assessment Session 
After a patient was determined by chart review to be eligible 
for study, he was either telephoned or approached in person at the 
Memorial Hospital lymphoma clinic. Each patient was then told that 
the departments of hematology and psychiatry were involved in "a 
study of the psychological aspects of successful treatment for Hodg-
kin's disease," and that his participation would be appreciated. 
He was informed that the study was voluntary, would entail two to 
three hours of his time, and could be scheduled at his convenience. 
Upon verbal consent, an appointment was then scheduled. The location 
of interview and testing was either the clinic itself, the patient's 
home, or the experimenter's office. 
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All patients were seen in one session. At the outset of the 
session, the rationale and purpose of the study were explained briefly, 
and consent received (see Appendix C for consent forms). To facilitate 
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good rapport, patients were interviewed first. After collecting basic 
demographic information, data for the Problem Oriented Record and the 
Global Assessment Scale were collected. Each patient was then given 
four short questionnaires: Rosenberg Self-Esteem Scale, Death Anxiety 
Questionnaire, Impact of Events Scale, and a measure of stressful 
recent life changes (Holmes & Rahe, 1967). The purpose of this fourth 
questionnaire was to ensure similar levels of external stress as 
measured by recent life changes in the five study groups. Non-signi-
ficant t-tests across groups on this measure confirmed no differences 
in stressful life events (e.g., recent divorce, recent death in the 
family) across groups. Participants were allowed to fill out the 
above four questionnaires in any order they chose. The examiner 
remained present for this period with all participants. 
Upon completion of the short questionnaires, each participant 
was given the Derogatis Sexual Functioning Inventory (which includes 
the Brief Symptom Inventory) and the TAT cards. These also could be 
filled out in any order. Instructions for the DSFI are in the test 
booklet. For the TAT, instructions were as follows: "Here are six 
pictures. I'd like you to write down an imaginative story for each 
picture. The story you tell is entirely up to you but it should have 
a beginning, middle, and end." In cases where patients were seen in 
the clinic, the experimenter frequently left the patient alone while 
he completed these more time-consuming tasks. The GAS ratings were 
done after termination of the assessment session. At the end of the 
session, patients were asked if they would be willing to ask a friend 
or relative of similar age to participate in the same study. 
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Potential non-patient subjects were contacted by telephone and 
asked to participate "as a member of a comparison group in a study of 
the psychological aspects of Hodgkin's disease and its treatment." 
After verbal consent, appointments were scheduled at their convenience. 
After obtaining written consent (see Appendix C, control form), the 
session proceeded in much the same fashion as with the patients. The 
essential differences were that the POR was shortened to include only 
demographic information and current rating on quality of life, and 
that the IES was anchored to more varied events. Specifically, eight 
rated their reactions to physical or medical stressors (e.g., recent 
separated shoulder), four rated reactions to psychosocial stressors 
(e.g., separation from wife), three to the death of a loved one, three 
to the near death of a loved one, and two to a recent career change. 
Because of the shortened POR, sessions with control subjects were 
nearly one hour shorter than with patients. 
Scoring the Data 
All measures except the TAT intimacy motive and the GAS rating 
are objectively scored and therefore resistant to possible biases 
from an hypothesis-wise scorer. Because the GAS interviewer and 
rater was the experimenter who was aware of the hypotheses of the 
study, this measure was conceptualized as global rating of secon-
dary priority in the data analysis. Significance on this measure 
could conceivably augment other findings, but it was decided that 
significance on such a measure alone would hold suspicious validity. 
The two-tailed nature of the experimenter's thinking on cancer 
survival; that is, that survival from such trauma may have a positive, 
growthful impact on some as well as a more negative impact on others, 
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would argue against any systematic bias in his ratings, however. 
Regarding the TAT scoring, any possible bias was eliminated by a 
procedure which blinded the scorer to the participant's identification. 
All 480 stories (80 participants x 6 stories/participant) were cross-
referenced by code number, then shuffled together in random fashion. 
Scoring of each story then proceeded with the experimenter unaware 
of its author. 
RESULTS 
This study has examined the psychological sequelae of successful 
treatment for Hodgkin's disease in 60 young men, by comparing them to 
a non-patient age-matched group of 20 men, and by exploring the effects 
of disease stage and time off treatment within the patient sample. The 
dependent measures included self-report inventories of sexual dysfunc-
tion, psychological symptomatology, coping style, self-esteem, and 
death anxiety, an experimenter rating of global adjustment, interview 
self-ratings, and a projective test measure of intimacy motivation. 
The data were conceptualized in terms of a 2 X 2 factorial lay-
out of patients (~ = 15/cell) with a single comparison group (~ = 20). 
Analysis of variance (ANOVA) was selected as the most appropriate 
statistical procedure. This design, a "p x q + 1," has been discussed 
by Winer (1971, pp. 468-473). Because it has an "unwanted" cell in 
the crossed layout, Winer recommends pooling the sum of squares with-
in the comparison group with the error sum of squares and then includ-
ing in the final ANOVA table a sum of squares representing the contrast 
between the comparison and experimental groups. Something very similar 
to this can be done using the SPSS "ONEWAY" procedure with planned 
orthogonal contrasts (Nie, Hull, Jenkins, Steinbrenner, & Bent, 1975). 
Even though technically the package is conducting a one-way ANOVA 
with five levels of one variable, the planned contrasts, if set up 
orthogonally, will produce independent and error variance-corrected 
tests for two main effects (stage and time off treatment), for the 
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interaction of these two effects, and for a comparison of the patient 
group as a whole (~ = 60) to the comparison group (N = 20). The 
ONEWAY design and the planned contrast values are presented in Table 
3. 
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The presentation of analyses will be organized according to 
dependent measures beginning with the self-report inventories. All 
planned comparisons were performed through orthogonal contrast weights 
which assessed differences between patients and non-patients (contrast 
1), the main effect of disease stage within the patient group (con-
trast 2), the main effect of time off treatment within the patient 
group (contrast 3), and the stage X time interaction (contrast 4). 
As suggested earlier, the independence of these contrasts from each 
other and the fact that they are comparisons based on a priori hy-
potheses eliminate the risk of increase in experiment-wise error rate 
due to multiple comparisons. Except in the case of the TAT ratings, 
where the study hypotheses were non-directional, one-tailed signifi-
cance levels will be reported. 
The study hypotheses follow the idea that disease (and there-
fore also treatment) severity and time off treatment are factors which 
contribute to level of measureable disturbance. Thus, the early 
stage-distant and the late stage-recent patients would fall on oppo-
site ends of the continuum from low risk to high risk, respectively. 
For this reason, it was decided to study these two groups more close-
ly in certain analyses, especially where the overall analysis 
approached significance (i.e., .05 < ~ < .10). Because of its con-
sistency with the study's hypotheses, this approach was considered 
Table 3 
SPSS ONEWAY Treatment of Data With 
Planned Orthogonal Contrast Values 
VARIABLE 
Group 
Early Early Late Late Non-
Recent Distant Recent Distant Patients 
(~=15) (~=15) (~=15) (N=15) (~=20) 
Contrast 11 
(patient vs. non-patient) +1 +1 +1 +1 -4 
Contrast 2 
(stage effect) +1 +1 -1 -1 0 
Contrast 3 
(time effect) +1 -1 +1 -1 0 
Contrast 4 
(stage x time) +1 -1 -1 +1 0 
1Because of unequal cell sizes, this contrast is not orthogonal 
to the others. SPSS ONEWAY makes a weighted adjustment for 
this. 
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justified on an a priori basis. 
Self-Report Measures 
Derogatis Sexual Functioning Inventory (DSFI). The following 
subtests of the DSFI were analyzed as dependent variables on the 
ANOVA: drive, gender role, fantasy, body image, satisfaction, glo-
bal satisfaction, psychiatric symptoms (BSI- GSI), and affects 
balance. Although in some subtests the means fell in the order pre-
dicted, none of the differences was statistically significant (see 
Table 4 for means). Near significance was obtained in comparing 
patients to non-patients on the number of sexual fantasies acknow-
ledged, with the patient group being lower, !(1,75) = 3.25, £ <.10. 
Within the patient group, the difference was accounted for by the 
fact that the early stage patients had a more constricted sexual fan-
tasy life than the late stage patients, !(1,75) = 4.29, £ <.05. In a 
follow-up test between early stage patientsandnon-patients on the 
DSFI fantasy score, early stage patients were significantly lower, 
~(48) = 3.37, £<.OS. 
Brief Symptom Inventory (BSI). As with the DSFI, close examin-
ation of group mean scores on the BSI found some of them to order in 
a way consistent with the hypotheses (see Table 5). Most differences 
in means for the relevant BSI subscales were, however, also non-
significant. One example of this is the BSI global severity index 
(GSI), which is the same as the psychiatric symptoms subscale of the 
larger DSFI (refer to Table 4). From the study hypotheses, one would 
expect the early-distant group (ED) to score as the least disturbed 
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Table 4 
Mean Scores on the Derogatis Sexual Functioning 
Inventory Subtests for the Five Study Groups* 
Late Early Late Early 
Recent Recent Distant Distant Non-Patients 
Drive 18.4 18.1 20.5 17.5 18.9 
Gender Role 4.0 6.9 5.7 7.6 6.0 
Fantasy 7.01,2 5. 61,2 8.11,2 5. 81,2 8.51 
Body Image* 18.3 19.3 18.1 18.6 17.8 
Satisfaction 7.9 7.7 6.7 8.2 7.7 
Global 
Satisfaction 5.1 5.2 4.9 4.9 4.7 
Psychiatric 
Symptoms(GSI)* .573 ~483 .483 .413 .463 
Affects 
Balance 1.4 1.5 1.1 1.6 1.2 
*H1gh scores on the Body Image and Psychiatric Symptoms (GSI) 
subtests reflect high impairment. On all other subtests, lower 
scores reflect more disturbance. 
1c1: 60 patients vs. 20 non-patients, !(1,75) = 3.25, £ <.10. 
2c2 : 30 early stage patients vs. 30 late stage patients, !(1,75) 
= 4.29, £ <.05. 
3These scores are not significantly different from each other, but 
worth noting is that the mean of the patient scores ( .49) is one 
full standard deviation (T score= 60) above that of the test's 
normative sample (! = 344, M = .18). 
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Table 5 
Mean Scores on the Brief Symptom Inventory 
Subtests for the Five Study Groups* 
Late Late Early Early 
Recent Distant Recent Distant Non-Patients 
Somatization .49 .37 • 39 • 32 .23 
Interpersonal 
Sensitivity .58 .40 .58 .43 .64 
Depression .65 .46 .59 .38 .52 
Phobic Anxiety .391,2 .161 .091 .171 .172 
Hostility .62 .41 .52 .48 .39 
Anxiety .59 .71 .42 .52 .54 
Paranoia • 73 .68 .68 .57 .61 
Psychiatric 
Symptoms (GSI) 3 .57 .48 .48 .41 .46 
Positive 
Symptom Total 20.1 18.5 16.2 16.9 18.6 
* On all subtests, higher scores reflect higher impairment. 
lc4: Follow-up of stage X time interaction: 15 late recent 
patients vs. 45 other patients, £(58) = 2.41, ~ <.01. 
2Fifteen late recent patients vs. 20 non-patients, £(33) = 
1.46, ~ = .077. 
3see Table 4, footnote 3, for explanation. 
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and the late-recent group (LR) to score as the most disturbed of the 
patient groups, with the other two patient groups (ER & LD) in between, 
The non-patients (NP) would be expected to score slightly better than 
the ED group. On the GSI, ~R = .57, ~R = .48, ~D = .48, ~D = .41, 
and ~p = .46. It is worth noting that these patient scores on the 
GSI <~atient = .49) fall one full standard deviation above the mean 
of the BSI's normative sample of 344 male non-patients (~ge = 46, 
SD = 15)(Derogatis & Spencer, 1982). This is one standard deviation 
in the direction of higher disturbance than the principal normative 
sample of the BSI. It is, however, also nearly one standard devia-
tion below the mean GSI score of 425 male psychiatric outpatients 
(~ge = 31, SD = 12). 
A trend toward significant lowering of phobic anxiety as measured 
on the BSI was detected when comparing patients recently completing 
treatment to those distantly off treatment, F(l,75) = 2.92, £ <,10. 
A test of the significant stage X time interaction (C4) showed the 
difference to be largely attributable to the very high score for the 
late-recent group (M = .39) as compared to the other patient groups 
combined (~ = .14), ~(58) = 2.41, £ <.01. This late-recent group 
mean score (.39) was not significantly higher than the control group 
score (M = .17), but there did appear to be a trend toward this, t(33) 
= 1.46, £ = .077 (see Table 5). 
Impact of Events Scale (IES). The IES yields two separate 
scores: intrusive thinking and avoidant thinking, which can be com-
bined to a total score. Among the planned contrasts, a difference 
between patients and non-patients on avoidant thinking was confirmed 
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(see Table 6). In following up that difference, the Least Significant 
Difference procedure (LSD) was applied to the range of scores across 
the groups for avoidant thinking, and the early-recent group mean was 
significantly greater than the non-patient group mean (£ <.05). In 
keeping with the earlier identification of a probable "low risk 
group" (ED) and a probable "high risk group" (LR), the same LSD test 
was applied to the intrusive thinking scale, with attention paid only 
to the comparisons of these two groups' means. The difference was 
significant (£ <.05), suggesting that there may be some additive 
effect of stage and time off treatment in influencing coping style 
and intrusive thinking. See Table 6 for mean scores and relevant 
comparisons. 
When contrasts were set up to compare the early-distant group 
to the other patients, excluding non-patients, they were found to be 
significantly more well-adjusted than the other groups combined with 
regard to intrusive thinking, ~(58) = 2.28, £ <.05, and with regard 
to the overall IES score, ~(58) = 1.89, £ <.05, but not with regard 
to the avoidant thinking score. 
Rosenberg Self-Esteem Scale (RSES). This is a 10-item scale 
which measures the self-acceptance aspect of self-esteem. Lower 
scores reflect higher self-esteem. There were no significant differ-
ences between groups in any of the four planned contrasts. One 
difference between means which neared significance involved the early 
stage group's tendency to score higher on self-esteem (!! = • 80) than the 
late stage group (M= 1.37), !_(1,75) = 2.47, .E.. <.10. 
Table 6 
Impact of Events Scale: Mean Comparisons 
Patient Groups Non-Patients 
Late Late Early Early 
Recent Distant Recent Distant 
Intrusive 
Thinking** 8.47b 7.53 7.27 3.07b 5.00 
Avoidant 
Thinking* 7.47 8.07 ll.OOa 6.00 4.32a 
Total** 15.94 15.60 18.27 9.07 9.32 
*Cl: Patients scored significantly higher than non-patients, 
!(1,74) = 5.61, E <.05. 
**Early Distant (low risk) group significantly lower than other 
patient groups combined. 
aLeast Significant Difference (LSD), significant at~ <,05. 
bLSD significant at E <.05. 
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Death Anxiety Questionnaire (DAQ). This is a 15-item scale of 
attitudes toward death and dying. Higher scores reflect higher death 
anxiety. As was the case with much of the DSFI and BSI, the order of 
means (especially for the time off treatment effect) is in the dir-
ection predicted. However, no planned comparisons yielded significant 
differences on the DAQ. Within the patient group, ~ecently off treat-
ment = 8.44, and ~istantly off treatment= 7.43. 
To summarize this section, planned statistical analyses of the 
self-report data provided minimal support for the study hypotheses. 
While the ordering of means across groups often was in the predicted 
direction, rarely did the differences reach significance. Follow-up 
statistical handlingof these non-significant-but-predicted ordering 
of means for all dependent measures will be described at the end of 
this chapter. 
Confirmed hypotheses were the following: Early stage patients 
demonstrated more constricted sexual fantasies than non-patients on 
the DSFI. Patients in general also tended to use a more avoidant 
thinking style than non-patients in reference to a past traumatic 
event. While patients did not differ from this study's comparison 
group on psychiatric symptomatology, they did score an average one 
standard deviation above the DSFI normative male sample. Within the 
patient group, late stage patients recently off treatment had signi-
ficantly higher phobic anxiety than the other patient groups combined. 
They also showed more intrusive thinking about their cancer than the 
early-distant patient group. The low-risk, early-distant group did 
appear to be more well-adjusted than the other three patient groups 
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on the Impact of Events Scale (intrusion and total scores both lower). 
Experimenter Rating: Global Assessment Scale (GAS) 
Like the self-report measures, the GAS data were analyzed via 
the ANOVA with four planned contrasts. The GAS is a global rating, 
between 1 and 100, of overall psychological health and adjustment, 
based primarily upon recent symptomatology. 
The order of means on the GAS, from lowest to highest score, 
was as follows: ~R = 70.0, ~R = 74.9, ~D = 75.7, ~D = 77.5, ~p = 
78.4. This is the predicted order, but again the differences between 
means only approached significance. For the patient to non-patient 
comparison (Cl), f(l,75) = 1,88 ( NS ); and for the recent to distant 
time off treatment comparison (C3), !(1,75) = 2.16 ( NS ). The dif-
ference between means of the low risk (ED) versus the high risk (LR) 
groups was statistically significantly; however, ~(28) = 1.88, ~ <,05. 
the high risk (LR) patients also had significantly lower GAS scores 
than the non-patient group, ~(33) = 2.02, ~ <,05. 
The GAS data, while they do not directly confirm the study 
hypotheses, do provide further illumination. The ordering of means 
and pursuant significance testing lends further support to the iden-
tification of low risk (ED) and high risk (LR) patient groups. 
Projective Testing: TAT Intimacy Motivation 
All statistical handling of intimacy motivation involved two-
tailed probability distributions for significance testing. This was 
because of the open-ended nature of the study hypotheses for this 
measure due to the contradiction in the existing literature. 
As seen in Table 7, patients' intimacy motivation as scored on 
the TAT was significantly lower than that of the non-patient group, 
!(1,75) = 5.34, ~ <.05. The absence of other significant within-
patient comparisons suggests that this lowered intimacy motivation is 
a patient-wide phenomenon which is not necessarily exacerbated by 
severity of disease or ameliorated by time. A closer look at each 
story across the five groups was done to help determine if any could 
be found to be more discriminating than the others. Indeed, it 
appears that the third picture (trapeze), while it yielded low scores 
in all groups, did discriminate patients from non-patients in a way 
similar to the total (six story) score, £(78) = 2.36, ~ <.05. The 
open field scene scores also yielded a higher patient to non-patient 
difference, but the difference did not reach statistical significance. 
Table 8 presents the mean intimacy motivation scores for all patients 
compared to non-patients for each story. 
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In summary thus far, support for the polarization of early stage 
patients distantly off treatment and late stage patients recently off 
treatment into low and high risk groups, respectively, has been pro-
vided by the BSI phobic anxiety subscale, the IES and the GAS. In 
addition, the projective measure of intimacy motivation has revealed 
an apparent reduction in need for intimacy in the cancer sample in 
general. 
Interview Data: Revised Problem Oriented Record (POR) 
Most of the POR was not intended for use as a dependent measure 




Planned Comparisons of Mean 
TAT Intimacy Motivation Scores (! = six stories) 
Disease Stage Non-Patients 
Early Late ~ime 
Recent M=3.73 ,!:!=5.47 M=4.60c 
(!=15) (!=15) <!=30) 
M=6.15a 
(!=20) 
Distant ~3.20 ~4.53 M=3.87c 
(N=l5) (!=15) (!=30) 
~tage ~3.47b ~5.ooh a ~ot=4.23 (N=30) (N=30) (~60) 
aCl: patients to non-patients, ~(1,75) = 5.34, £ <.05 
hc2: early to late stage patients, ~(1, 75) = 3.42, .E.< .10 
cc3: recent to distant time off treatment, F = NS 
C4: stage x time interaction, F = NS 
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Table 8 
Patient to Non-Patient Comparisons on Mean Intimacy 
Story 
1. River Scene 
2. Open Field Scene 
3. Trapeze 
4. Ship Captain 
5. TAT 13MF 




Motivation Scores by Story 
Mean Mean Non-
Patient Score Patient Score 
1.83 2.15 

























aid in systematic collection of demographic and patient treatment 
information, to gather patients' retrospective accounts and ratings 
of their treatment experiences which might prove to be useful in 
identifying key treatment issues vis-a-vis adaptation to illness, and 
to establish problem incidence rates in the post-treatment period 
with the four treatment groups collapsed into one group of 60 (see 
Appendix A). That is, most of the questions asked in the POR were 
not expected to show meaningful differences between patient groups. 
They were intended for the most part as frequency tabulations of 
target problems. 
There were, however, 16 items on or added to the POR which were 
designated as testable, with predicted outcomes. These will now be 
summarized under three categories: Quality of life ratings, pre-
and post-treatment self-ratings, and conditioned symptoms (including 
survival concerns). After this summary of planned comparisons is 
presented, qualitative and quantitative summaries of patient responses 
to selected interview questions, with statistical handling of differ-
ences when appropriate, will be given. 
Quality of life ratings. Unlike other categories, the quality 
of life category consists of patient-to-non-patient comparisons as 
well as patient-to-patient comparisons. In order to accomplish this, 
non-patient participants were asked the same questions, controlling 
for time by having 10 of them discuss their response to a stressful 
event six months to two years ago (M = 13.4 months), and 10 to an 
event three to seven years ago (M = 67.3 months). 
It was found that non-patients, on the average, were working 
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2.5 hours per week more than they had been prior to their "stressful 
event." The patient sample, on the other hand, was working 5. 7 hours 
less per week than before diagnosis. This difference was significant, 
~(68) = 1.77, ~ <,05, and the bulk of this drop in patient return to 
work was accounted for by the "high risk" late-recent group. They were, 
on the average, still working 12.5 hours less than their pre-illness 
levels. The difference was significantly different (£ <.05) from 
non-patients, using the least significant difference test (see Table 
9). There were no significant differences across groups in the par-
ticipants' interview ratings of sexual or marital satisfaction, 
The other quality of life indicators designated for study were 
three ratings of life appreciation and overall satisfaction. On the 
first question, significantly more patients (85%) than non-patients 
(55%) acknowledged an increase in life appreciation, x2 (1) = 7.74, 
~ <.01. There were no differences within the patient group on this 
rating, however, though the means did order in the predicted direction 
for time off treatment. This heightened sense of life appreciation in 
the patient sample is further supported by the second rating, a 1 to 
10 scaling of "how much rnore" each participant appreciated life. 
Mean ratings by patients (M = 6.13) and non-patients (M = 3.25) also 
differed significantly, F(l,75) = 11.56, £ <.001. The third rating 
is the POR "Life Scale" rating. This asks each participant to corn-
pare the overall quality of his current life on a "-10" to "+10" 
scale, with 0 as the "no change" point, to that before his illness 
("two" or "sixu years ago in the case of non-patients). Patients did not 
differ from non-patients on this measure, nor did early and late 
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stage patients differ from each other. However, the patients recently 
off treatment had lower ratings than those distantly off treatment 
(M= 2.3 versus 4.7, respectively), K(l,75) = 4.80, ~ <.os. The 
life scale ratings of this group recently off treatment were also 
lower than non-patients ( ~= 4.6), !_(48) = 1.84, ~ <.05. 
Pre- and post-treatment self-ratings. These four ratings apply 
to patients only. They include the patients' subjective sense of 
current physical stamina, sleep patterns, eating habits, and concen-
tration ability (depressive equivalents) as compared to their recall 
of pre-illness functioning (Table 9). In all cases, disturbance was 
expected to be higher in the late stage and recent treatment groups. 
Overall, 57% of the patient groups (34 of 60) believed that they had 
not yet regained premorbid levels of physical stamina, 27% of them 
(16 of 60) felt that they were sleeping worse than before their ill-
ness, 13% (8 of 60) thought they were eating worse, and 27% (16 of 
60) believed they had lost some concentration ability in the time that 
had elapsed. This compares to 5% (3 of 60) who felt they were in 
better physical shape now, 10% (6 of 60) who stated they were sleeping 
better, 21% (13 of 60) who said they were eating better, and 17% (10 
of 60) who acknowledged better concentration. Neither disease stage 
nor time off treatment was a discriminating variable for these ratings. 
Because of the non-significance of the main effects, data were col-
lapsed across groups to highlight prevalence rates of these four 
problems (see Table 9). 
Conditioned symptoms and survival concerns. This section also 
refers to patients only. Therefore, a more focused 2 X 2 ANOVA was 
Table 9 
Qualify of Life Ratings (~=80) and Patient 
Self-Ratings of Depressive Equivalents (~=60) 









Life Appreciation 55% 
--percent acknowledging 
increase 
--1 to 10 rating of 
increase 
Life Scale Rating 


















t (48)=1. 84' 
- .E. <. 05 
PATIENT PRE-POST RATINGS OF DEPRESSIVE EQUIVALENTS (~=60) 
Physical Stamina* worse 57% 
better 5% 
Sleep Patterns* worse 27% 
better 10% 
Eating Habits* worse 13% 
better 21% 
Concentration worse 27% 
Ability* better 17% 
*Disease stage and time off treatment did not differentiate patients 
on any of these variables. 
**LSD = Least Significant Difference 
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performed on these particular data. This was done in order to provide 
an analysis with a more appropriate error term by eliminating the 
unused non-patient group. Each patient was asked about the presence 
(scored 1) or absence (scored 0) of nausea or related gastrointestinal 
symptoms to the three conditioned stimuli: various smells (e.g., 
rubbing alcohol, cleaning fluids), being in the treatment clinic, and 
"anything else" (e.g., certain foods, songs, colors, people). Thus, 
each patient received a score ranging from 0 ("no conditioning") to 
3 ("conditioning in at least three areas") for symptoms of nausea. 
The same inquiry and scoring criteria were applied to actual vomiting; 
and to anxiety, defined as "feeling of nervousness, or being upset 
emotionally but not necessarily physically." There had to have been 
an incident within the past five months for any symptom to be scored. 
The three scores were also combined to yield a total conditioning 
score for each patient. Table 10 presents the summary tables of the 
treatment-related conditioning data. As the table suggests, there 
does appear to be a significant lessening of conditioned symptoms over 
time. The total conditioning score was higher in the later stage 
patients (p <.05). Closer examination of the contributions to this 
total conditioning score revealed quite clearly that the stage and 
time effects are almost completely accounted for by the nausea score, 
where both later stage patients and those recently off treatment show 
significantly greater disturbance. Actual vomiting was expectably 
rare (4 of 60 patients) and therefore non-significant across patient 
variables. The fact that conditioned anxiety does not appear to drop 
off significantly over time and is no less a problem in the early 
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Table 10 
Analysis of Variance Summary Tables for Patient Conditioning Scores 
Dependent 
Variable Source df Mean Square F Ratio 
Total Conditioning Score Main Effects 
--stage l 9.60 3.32+ 
--time 1 13.07 4.52* 
Interact ion 
--stage x time 1 .07 .02 
Residual 56 2.89 
Nausea Sea re Main Effects 
--stage 1 3.27 4.27* 
--time 1 3.27 4.27* 
Interaction 
--stage x time 1 .27 .35 
Residual 56 .77 
Vomit Score Main Effects 
--stage 1 .07 1.04 
--time 1 .07 1.04 
Interaction 
--stage x time 1 .oo .00 
Residual 56 .06 
Anxiety Score Main Effects 
--stage 1 1.07 .89 
-time 1 2.40 2.00 
Interaction 
--stage x time 1 .07 .06 




stage patients of this sample runs counter to the study hypothesis, 
and will be discussed in the following chapter. 
The final three planned comparisons from the FOR relate to 
patients' concerns with survival as reflected in: 1) their rating 
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of how fearful they are of recurrence (1-10 scale); 2) the presence 
of heightened attention to one's body (e.g., checking for enlarged 
nodes while in the shower); and 3) somatic anxiety, defined as "be-
coming upset over little aches and pains which never would have 
bothered you before." The mean fear of relapse rating, where 1 = "not 
at all," and 10 ="extremely so," was 4.92. A two(stage)by two (time) 
ANOVA revealed no significant differences among patient groups. Re-
garding the presence of heightened health awareness (which most 
patients reported was not coupled with anxiety), 85% of 60 patients 
acknowledged that their awareness of their health and concern for 
symptoms had increased because of their having had cancer. The dif-
ference between early and late stage patients (with more late stage 
patients being attentive) approached significance, x2 (1) = 3.40, £ < 
.10. Of 60 patients, 63% reported some degree of somatic anxiety when 
day-to-day functioning was disrupted by minor aches and pains. This 
was especially true when no explanation could be found for a new-found 
pain or ache. Disease stage and time off treatment were not discrim-
inating factors in the chi-square analyses of these data. 
A review of the planned comparisons on interview data revealed 
generally solid support for the following: 1) late stage patients 
recently off treatment had the greatest difficulty with work adjust-
ment as measured by return to premorbid number of work hours; 2) all 
patients, especially those off treatment for longer periods of time, 
show a heightened appreciation for life. However, the patients 
recently off treatment rated their current life with significantly 
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less improvement than both the non-patients and the patients distantly 
off treatment; 3) all patients, regardless of stage or time off treat-
ment, demonstrated high frequencies (greater than 25%) in three out of 
four of the "depressive equivalents" surveyed in the interview; 4) 
conditioned nausea appears to be worse for later stage patients (as 
predicted), and tends to diminish over time (as predicted); 5) condi-
tioned anxiety does not appear to have the same predictability (and 
is therefore perhaps more a trait measure); and 6) disease stage and 
time off treatment did not discriminate patients on ratings of recur-
rence fear, somatic self-awareness, and somatic anxiety (again 
suggesting a possible trait factor). 
Following is a summary of problem areas identified by the POR 
interview which were not built into the study hypotheses. The summary 
will be divided into three parts: Retrospective treatment ratings, 
ratings of treatment and post-treatment difficulties, and patient 
fertility data. While not directly relevant to the study hypotheses, 
these data are added here because they indirectly bear upon questions 
under investigation in that they provide further information about 
the concerns and experiences of patients off treatment. 
Retrospective treatment ratings. Patients were asked many 
questions about their reactions to diagnosis and treatment. For 
example, they were asked to rate, on a 1 to 10 scale, the intensity 
of their reaction to their disease symptoms before they knew of their 
diagnosis (!!_ = 3.12, SD = 2.9). This can be compared, for instance, 
to their reaction to being told the diagnosis of Hodgkin's Disease 
(!!_ = 6.25, SD 3.0), suggesting something akin to a doubling of 
distress when the signalling of illness becomes identified as a life 
threat. A similar comparison emerges from patients' retrospective 
ratings of their view on the seriousness of their illness (1 = "noth-
ing at all, 11 10 = "life and death" illness) at various points along 
their treatment. Means order downward from the point of diagnosis 
(!!_ = 6.73), to the treatment period (M = 5.12), and finally into the 
present (!!_ = 2.20). 
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Of the three treatment modalities used (surgery is included 
here) the patients' rating of emotional reaction to chemotherapy 
appears to be the most highly distressed (M = 6.0), with radiation 
and surgery remembered as somewhat less distressing (M = 4.3 and 4.2, 
respectively). 
Ratings of treatment and pgst-treatment difficulties. Tables 
11 and 12 are summary tables which present the percentage of patients 
who acknowledged the presence of various difficulties during treatment 
and in the post-treatment period. In reference to Table 11, informal 
comparison of the change in percentages, from the treatment period 
to the post-treatment period, suggests there is a drop in social irri-
tability, depressed mood, sleep disturbance, concentration difficulty, 
marital discord and sexual dysfunction after treatment ends. The 
drops in sleep disturbance and concentration difficulty are less 
dramatic than the others. Also, in light of the low base-rates 
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Table 11 
Patient Frequencies of Symptoms and 
Psychosocial Difficulties Acknowledged In- vs. Off-Treatment 
SYMPTOMS In-Treatment Off-Treatment Chi Square 
Irritability 68% 35% x2 (1)=13.36*** 
Depressed Mood 83% 62% x2 Cl)= 7. 06** 
Sleep Disturbance 50% 27% xz (1)= 6.90** 
Concentration Difficulty 47% 27% xz(l)= 5 .18* 
Suicidal Ideation 7% 10% NS 
Contact with Mental Health 17% 18% NS 
Psychotropic Medication 22% 13% NS 
PSYCHOSOCIAL DIFFICULTIES 
Change in Relationship ~rse=45% worse=22% x2 (2)= 8.36* 
with Significant Other better=l8% better=35% 
Change in Sexual worse=62% worse=l8% x2 (2)=30.60*** 
Functioning better=7% better=44% 




Patient Frequencies of Post-Treatment Difficulties 






Negative Post-Treatment Reaction by s/o** 
Family Problems 
Change in Family Relationship(s) 
Friend Problems 
Change in Friend Relationships 
OCCUPATIONAL 
Occupational Choice Influenced by Illness 
Still in Debt 
Employer Treats Differently Because of Illness 
Co-Workers Treat Differently Because of Illness 






30% (13 of 43) 
38% 
worse = 13% 
better = 23% 
30% 
worse = 13% 
better = 25% 
worse = 27% 
better = 5% 
42% 
14% (6 of 43) 
22% (11 of SO) 
2% (1 patient) 
*Except where indicated, all patient percentages are based upon 
an ! of 60 patients. 
**s/o = Significant Other 
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suggested by the non-patient responses to these two areas (10% com-
plained of sleep disturbance and 5% complained of concentration 
difficulty), there is some indication that sleep and concentration 
difficulties tend more often to continue to plague the surviving 
Hodgkin's patient over time. These conclusions are impressionistic, 
based only on frequency tabulations and unplanned post hoc com-
parisons. 
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Table 12 presents only post-treatment ratings. Two out of every 
three patients have acknowledged physical symptoms which have been 
distressing to them because they bring on a fear of recurrence ("symp-
tom distress" item). These symptoms were typically stiff neck, swollen 
glands, common flu or cold symptoms, or fatigue. One may note the 
similarity of these symptoms to the B symptoms of Hodgkin's disease. 
Nearly half (48%) of them have complained of some physical discomfort, 
which many of them attributed to lingering chemotherapy or radiation 
effects. Nearly one in five, as compared to none of the non-patient 
sample, have acknowledged significant post-treatment sexual readjust-
ment difficulty, but most felt they had overcome this by the time of 
the interview. Neither disease stage nor time off treatment were 
associated with varying frequencies in these areas. The 55% frequency 
of sexual dissatisfaction in the patient sample (see Table 12) is 
compared to a figure of 65% in the non-patient sample. Thus, this 
high figure is probably more a function of the suggestive nature of 
the question than of any unusually high prevalence of sexual dysfunc-
tion. 
As Table 12 illustrates, psychosocial problems with family and 
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friends were not numerous. What is more, many of those patients who 
experienced them felt they had overcome their difficulties by the. 
time of the interview. What was more striking was the fact that one-
fourth of the sample felt that the experience of cancer had brought 
them closer to certain friends and family members. As one patient put 
it: "It forced me to set my priorities in people. to see who I 
really cared about and tell them." Such relationships were commonly 
seen in the post-treatment period as much more solid because of the 
heightened intensity of the relationship during the treatment period. 
Regarding the occupational area, three patients changed careers 
in a positive way because of their illness. One, for example, took 
up nuclear medical technology because he was so fascinated by the 
radiation treatment process. However, 27% of the men felt that their 
careers had suffered in some unmeasurable (often unprovable) way. 
Most such men would comment on the fact that they have avoided career 
risks in favor of the security (i.e., insurance benefits) which their 
pre-morbid job provided. }~ny were still in debt for incurred medical 
expenses. Very few people felt their employers or co-workers treated 
them overtly differently because of their illness. Of those who did, 
the "different" treatment was usually in a more favorable direction 
(e.g., not making him work as hard, being more understanding about 
days off, etc.). In conclusion, then, very few complained of 
overt discrimination or occupational mistreatment, but a substantial 
number lamented what they perceived as missed career opportunity 
because of their own felt need to retain job security. 
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Patient fertility data. This section will close with a brief 
summary of the data collected on patient fertility. As indicated_by 
the fact that 62% of the patients interviewed would like to have 
children, and by the patients' frequent admission of distress in this 
area, the issue of compromised fertility in young men treated for 
Hodgkin's disease is a critical one. This study's finding that 90% 
(20) of the 22 patients who had recent sperm counts remain sterile is 
in agreement with the sterility figures of the Redman study (Redman, 
1983) and others. The 38 patients who had not been tested for fer-
tility were asked their current belief on their own status (see Table 
13). A great proportion of them (61%) believed that they had either 
regained or had never lost fertility. It is unclear whether this is 
due to patient optimism, lack of information, or the result of a 
doctor-patient relationship in which patients are encouraged to think 
positively. The level of distress measure in Table 13 refers to the 
entire sample of patients, giving their rating (1-10) of how upsetting 
their sterility is to them as well as to their significant other 
(when the patient had a significant other). The scores presented 
are underestimates in that there were some patients who were extremely 
upset by this (e.g., six "10" scores). 
Conclusion 
The self-report measures, particularly the Impact of Events 
Scale, the BSI Phobic Anxiety subscale, and the DSFI Fantasy subscale, 
provided a small degree of support for the study hypotheses, and 
somewhat more evidence for a justified grouping of high risk (late-
Table 13 
Patient Fertility Data 
Number of Patients Who Want Children in the Future 
Sperm Count Data: Patients Tested as Fertile 
Patients Tested as Sterile 
Patients Not Tested 
Untested Patients' Belief in Their Fertility: 
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62% (37 of 60) 
3% (2 of 60) 
33% (20 0 f 60) 
64% (38 of 60) 
Believe Fertile (actual probability 61% (23 of 38) 
= .10) 
Believe Sterile (actual probability 34% (13 of 38) 
= .90) 
Won't Say 5% (2 of 38) 
Mean Sterility Distress Rating (1-10 Scale) 
Patients 2.8 
Patients' Rating of Significant Other 2.7 
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recent) and low risk (early-distant) patients. This was corroborated 
by the Global Assessment Scale. Projective testing and interview 
responses, on the other hand, have given much stronger support for the 
following conclusions about Hodgkin's disease patients in general: 
1) lowered capacity for intimacy in personal relationships; 2) 
heightened life appreciation which increases over time; 3) high in-
cidence of symptoms which are possible depressive equivalents; 4) a 
trend toward lessening of these and other symptoms and difficulties 
over time; 5) significant post-treatment conditioned nausea which 
abates over time; and 6) significant post-treatment conditioned 
anxiety which does not lessen significantly over time. 
It was asserted at many points in this chapter that the mean 
differences on various dependent measures, while not significant, 
were aligned in the predicted order. Because it seemed that the 
predicted ordering of means occurred more often than expected by 
chance, a post hoc analysis of the data was performed. Essentially, 
this entailed calculation of a z score based upon the binomial proba-
bility of achieving significantly more predicted mean-orders than 
attributable to chance. This analysis was done for all hypotheses 
which applied to patients and non-patients. TAT data were not in-
cluded because their hypotheses were not unidirectional. 
A binomial z (Siegel, 1956) was calculated for both independent 
variables, disease stage and time off treatment. Each variable had 
three levels: early (E), late (L), and non-patient (NP) for stage; 
and recent (R), distant (D), and non-patient (NP) for time off treat-
ment. There were 25 comparisons with unidirectional hypotheses which 
included non-patients: Four in the interview, 15 on the DSFI (in-
cluding the BSI), three on the IES, and one each for the DAQ, RSES, 
and GAS. 
For the disease stage variables, eight of the 25 sets of mean 
orders were in the predicted direction. Chance probability would be 
one in six, so 
z = 
8 - 1/6(25) 
--=----:--:----,--,-- = 2 • 06 (E. < • 05) • 
125 X 1/6 X 5/6 
For the time off treatment variable, 10 of the 25 sets of mean 
orders were in the predicted direction, so 
10 - 1/6(25) 
z = _r.;:-_-;::-__ -_--=----==----_---:-:--:-;--- = 3.13(_p_ <.05). 
lz5 X 1/6 X 5/6 
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Thus, the trends noted throughout this chapter receive some 
secondary statistical support. While differences between means, even 
when correctly ordered, rarely showed significance (except in the 
interview material), the fact that the means arrange in the predicted 
order far greater than chance expectation lends credence to the notion 
that the impact of cancer and its treatment upon the individual, while 
often subtle, is apparent and demonstrable. 
DISCUSSION 
The present study has provided a comprehensive overview of adapta-
tion to survival from cancer. Globally, the results of this study are 
heartening in that very little severe psychopathology in the patient 
sample was uncovered by the self-report measures, experimenter ratings, 
or interview data. In fact, the majority of patients acknowledged a 
heightened sense of life appreciation and purpose as a result of the 
cancer experience. However, one must also note the significant adapta-
tional difficulties and moderate disruptions identified by this study 
which balance if not outweigh the growthful component of the experience. 
The findings of this study agree only in part with three disparate 
conclusions about cancer survival gleaned from the literature: 1) that 
cancer survival is associated with heightened psychosocial and psycho-
sexual dysfunction (e.g., Holland, 1981, 1982b; Koocher & O'Malley, 
1981); 2) that cancer survival is associated with greater life apprec-
iation and character growth (e.g., Kennedy et al., 1976); and 3) that 
cancer survival is not associated with significant change in either a 
positive or negative direction (e.g., Craig, Comstock, & Geiser, 1974; 
Holmes & Holmes, 1975; Li & Stone, 1976). As the bulk of the literature 
review had suggested, there appears to be some amount of truth in each 
of these assertions. At the same time, however, these assertions cannot 
be offered without exceptions and qualifications. 
The severity of disease at the time of diagnosis and the amount of 
time elapsed since the termination of treatment both showed themselves 
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to be important factors in selected areas of psychological functioning 
and basic well-being. This was demonstrated most convincingly when 
these two factors were combined to create, out of four patient groups, 
a "low risk" group (early stage at diagnosis-distantly off treatment) 
and a "high risk" group (late stage at diagnosis-recently off treatment). 
That is, there was substantial evidence for high risk patients showing 
more adaptational difficulty than low-risk patients. 
This discussion will elaborate upon these general conclusions, 
and speculate about the adaptational challenges of Hodgkin's disease 
survival. To accomplish this, the study results will be presented in 
two sections: differences between patients and non-patients, and dif-
ferences within the patient group across independent variables of dis-
ease stage and time off treatment, including the prevalence of problems 
within the patient group in general. 
Differences Between Patients and Non-Patients 
Of 25 planned comparisons between patients (~ = 60) and non-
patients(~= 20), five produced statistically significant results. 
Many of these comparisons were made possible by the anchoring of non-
patient responses to past stressful events in their own lives. Two of 
these five significant results were "positive" findings: that more 
patients displayed a heightened appreciation for life in the post-treat-
ment period when compared to non-patient self-ratings, and that the 
extent of increased appreciation for life was significantly greater in 
the patient sample. These findings are consistent with those of Kennedy 
and colleagues (1976) as well as Shanfield (1980). This suggests that 
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the cancer experience acts as a catalyst to mobilize awareness of one's 
mortality and subsequent improved attitude toward life. The presence of 
heightened life appreciation in the successfully treated cancer patient 
is not one which is greatly contested in the literature. The more con-
troversial issues are with regard to the presence or absence of other, 
more disruptive consequences which can significantly hamper the quality 
of the survivor's post-treatment life. 
To the extent that quality of life can be measured by return to 
pre-morbid work functioning, there would appear to be significant dis-
ruption. Patients (especially late stage recently off treatment) showed 
far greater difficulty returning to work after treatment than non-
patients did after comparison trauma. Granted, the stressors for the 
non-patient group, such as divorce, physical injury, or death of a loved 
one, do not match the intensity of the stress of diagnosis and treat-
ment of cancer. However, in defense of the conclusion of hampered 
return to premorbid work level in cancer patients, one goal of this 
study is in fact to establish that these stressors (diagnosis and treat-
ment) constitute something more intense than the non-patient group's 
various stressors. Further support was lent to the conclusion that 
post-treatment work functioning suffers by the observation that 27% of 
the patient sample admitted to choosing job security over potential 
career advancement because of the insurance and employment risks involved 
in career change. 
Another major finding was that patients demonstrated significantly 
more avoidant thinking on the Impact of Events Scale. Again, this is 
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tempered by the fact that patients and non-patients had anchored their 
responses to very different stressful past events: Patients to their 
cancer diagnosis and non-patients to a variety of physical and psycho-
social events. It was the intention of this study to investigate the 
notion that the stress of diagnosis and treatment of Hodgkin's disease 
continues through the survival period to inflict demonstrable demands 
upon the person's adaptational capabilities. Thus, when patients off 
treatment for one (and even five) years use more avoidant thinking with 
regard to their illness than non-patients do with regard to other 
(albeit milder) past stressors, it is safe to say that the patients in 
this sample still show a strong tendency to defend themselves against 
the potential disruption which could result from thinking about their 
treatment experiences. While true of all patients, this was most true 
of those recently completing treatment, suggesting a tapering, though 
not elimination, of avoidant thinking over time. Intrusive thinking 
seems to taper more quickly, as demonstrated by the high intrusion sub-
test score for late stage-recent patients as opposed to very low scores 
in the early stage-distant group. 
While avoidant thinking is not strictly the same as denial, the 
observation that patients in general tend to use avoidant thinking is 
consistent with previous reports of denial as a principal coping mechan-
ism in cancer adaptation (e.g., Hackett & Weisman, 1969; O'Malley et 
al., 1979). It would also appear that the hypothesized lifting of 
denial in the service of integration as the survival period extends 
received little support in that patients distantly off treatment tended 
to be less avoidant but less intrusive than those recently off 
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treatment. The early stage patients distantly off treatment had signi-
ficantly less intrusive breakthrough than the late-recent group in par-
ticular and all patients in general. This suggests that the group 
distantly off treatment does not show more psychiatric symptomatology, 
however, as might have been predicted by Derogatis, Abeloff, and Melisai-
atos (1979), or by Rogentine and others (1978). The formulation of 
Koocher and O'Malley (1981) and Weisman and Worden (1976-77) seem to 
fit this study's data better. They would suggest that denial is impor-
tant in the beginning stages of cancer diagnosis and treatment, and 
that it gradually lifts, while the patient paces his integration of the 
experience according to his capability. Actually, optimal denial might 
be better termed "suppression," as it involves the capacity to identify 
distress yet minimize it through activity and gradual integration. 
Vaillant (1976), in his discussion of the dynamic development of char-
acter and defense structure, has also identified this defense of sup-
pression as particularly adaptive and healthy in the face of stress, 
as it combines awareness of difficulty and conflict with stoicism and 
mastery. 
Another significant difference between patients and non-patients, 
and what is considered to be a major finding of this investigation, was 
that patients were found to have lowered intimacy motivation, as meas-
ured by their projective story-telling. There were no differences with-
in the patient group, suggesting this is a patient-wide decrease. This 
result was also corroborated by informal comparison of patient mean 
scores to normative sample mean scores on those pictures (river, field, 
trapeze, ship) which had nofmative data available (McAdams, 1981). 
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In its broadest sense, this result would suggest that a constric-
tion of one's availability for warm interpersonal exchange is par~ of 
the lingering aftermath of successful cancer treatment in young men. 
A speculative explanation for this could be that the cancer experience 
sets these young men apart from their peers and age-mates, and that this 
sense of separateness can have a socially isolating effect. In tl:e 
interview, many patients stated that the ordeal of cancer and their 
struggle to conquer it gave them a feeling of superiority over others. 
They felt special, at times even "chosen" to live on. One patient in 
his mid 30's likened the ordeal to his Viet Nam experience. He felt 
embroiled in battle with his disease, and developed special, very close 
relationships with his treatment staff. However, just like a soldier 
returning from war, he realized upon re-entry to "normalcy" that he had 
been changed by the experience, and he did not seem to fit in. He came 
to feel that anybody who was not with him during the treatment could 
never really understand its impact. It is conceivable, then, that this 
displaced but special feeling may contribute to difficulty engaging in 
satisfying interpersonal relationships, especially in young men who do 
not go through treatment with a significant other close at hand. 
Another possible explanation for lowered intimacy motivation in 
the patients could relate to apprehension and uncertainty in the face of 
disruptions of their role functioning. As suggested by Kennedy and 
others (1976), Leiber and others (1976), and Sutcliffe (1979), and 
referring to Erikson's (1950) general comments about young adulthood in 
men, the impact of cancer and treatment upon a young man's role function-
ing may indeed show itself through interpersonal constriction. These 
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investigators would agree that the dependency and passivity induced by 
cancer treatment constitute an impetus for counterdependent maneuvers 
in the service of denial of need and reinforcement of masculine role 
functioning. It would make sense, then, that these men would tend to 
constrict their motivation toward interpersonal warmth and closeness, 
as a protection against the threat of the passive patient role. Why, 
then, would so many of them say that their relationships with their 
wives has improved (35%), or that they feel genuinely closer with their 
extended family (23%), since treatment ended? It may be that some men, 
especially those who begin the treatment ordeal with strong object ties, 
actually experience enhancement of their interpersonal lives without 
threat to their role-related self-esteem. This would be consistent with 
Weisman's (1975) finding that satisfying and constructive interpersonal 
relationships during and after treatment were associated with longer 
survival time. On the other hand, those who are either single or un-
happily married might experience drops in intimacy capacity of a pro-
portion great enough to lower the grand mean of all 60 patients on inti-
macy motivation. The fact that 22% of patients believed that their 
relationship with their significant others had worsened since treatment 
ended, and that 38% experienced "family problems,'' might indirectly 
support this formulation. As one patient's wife said to the investigator 
upon completion of the patient interview: "You should interview the 
spouses in this study; then you'd really find out how miserable these 
patients are to live with." 
In a similar vein, it is possible that the experience of dependency 
and surrender in personal relationships is threatening to the post-
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treatment patient in that it bespeaks a return of the vulnerability to 
illness felt during treatment. It would make sense, then, that self-
report measures of death anxiety, somatization, and psychosexual func-
tioning, which are under more conscious control than projective measure-
ment of intimacy motivation, would not be significantly different than 
in non-patients, because patients would be invested in denying this 
vulnerability. It is conceivable that this TAT projective test 
measure was necessary to detect this somewhat subtle but important dis-
tinction between cancer survivors and age-matched men. Another study 
result which is consistent with this was the trend (£ <.10) toward 
patients' displaying a more constricted sexual fantasy life on the DSFI 
(early stage patients were significantly lower than non-patients, E <.05). 
There is, then, accumulating evidence for a post-treatment interpersonal 
withdrawal and constriction which is probably subtle and non-pathologi-
cal, and therefore indicative of normal psychological adaptation to can-
cer survival in young men. 
Other non-significant patient versus non-patient trends in this 
investigation included: 1) patients' mean global assessment scores of 
psychological functioning tended to be lower than non-patients; 2) 
patients' mean somatization, phobic anxiety, and paranoia BSI subtest 
scores tended to be higher (more impaired) than those of non-patients; 
and 3) while patients and non-patients did not differ from each other 
on the extent of psychological symptomatology in the DSFI (BSI-GSI), 
both groups scored significantly higher (more impaired) than the test's 
normative sample, with means differing by one full standard deviation. 
The first trend noted speaks for itself: patients off treatment 
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(means within the patient group ordered as predicted) tend toward global 
psychological dysfunction when compared to an age-matched sample .. The 
fact that the rater was hypothesis-wise, however, casts doubt upon this 
as an impressive result without corroborating evidence. Some such evi-
dence is suggested, though, by the second and third trends noted above. 
It is interesting to note that these subtests of the BSI which seem most 
sensitive to patient/non-patient differences are ones which are disease 
and recurrence related. Somatization, phobic anxiety, and paranoia 
are a cluster of symptoms which might depict a chronic state of appre-
hension and vigilance toward body concerns. This idea, that patients 
off treatment seem to be engaged in measurable, though subtle and non-
pathological, amounts of constant concern over their bodies also re-
ceived some support in the POR interview. Specifically, 67% of all 
patients acknowledged feeling distressed over the presence of symptoms 
which remind them of their illness during the off-treatment period. 
More than 80% reported a conscious increase in self- and body-awareness 
with regard to physical health. Nearly half of them have complained of 
generalized post-treatment physical discomfort, and 57% complained of 
decreased physical stamina which has lingered on in the months and years 
following treatment. They also readily admitted that the potential for 
relapse is a chronic concern of theirs, although this fear does not 
generally intrude upon their daily functioning. 
To summarize, then, it would seem that the patients in this study 
are living with a chronic, low-grade awareness of their physical vulner-
ability and life's uncertainty which results in heightened vigilance 
toward their body. Just as with the apparent lowering of intimacy 
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motivation, this heightening of self-awareness and attention to one's 
body appears subtle; to an extent which does not seriously threaten 
the overall psychological health of the successfully treated patient. 
Putting these two observations together in a simplistic way, one can 
speculate about a slight retraction of oneself from others and a trend 
toward increased focusing of oneself upon one's body, during the cancer 
survival period. 
A final comment in this section refers to the observation that 
patients and non-patients scored one full standard deviation above the 
BSI normative sample on psychological symptomatology. Three explana-
tions for this will be proffered. One possibility is demographic, that 
the age and geography of the current sample is different from the nor-
mative. Norms for the BSI were collected on a combined urban and subur-
ban population in the Baltimore, Maryland area. Mean age of the norma-
tive sample was 45. The study sample was derived from the New York 
metropolitan and surrounding area. Their mean age was 31. It is con-
ceivable that somewhat higher psychological symtomatology is normative 
in the faster-paced New York City area. Also, increasing age could be 
associated with decrease in symptomatology. Both of these demographic 
explanations are weak, however, because other DSFI and BSI subtest 
scores did fall within one standard deviation of the normative mean, 
and because the idea of lessening psychological symtomatology from age 
30 to age 45 runs counter to established developmental psychological 
theory (Levinson, 1978; Vaillant, 1976). 
A second possible explanation for elevated psychological sympto-
matology in both patients and non-patients when compared to normative 
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data is that the small sample size of non-patients has resulted in 
inflation of the group's mean score owing to the influence of one_or 
two outliers in this small group. While it is true there were two non-
patients who scored quite high on the BSI-GSI, the variances of the 
patient and non-patient samples did not differ significantly, suggest-
ing that this also is an inadequate explanation. 
The third possibility would of course be that both patients and 
non-patients truly have elevated psychological symptom profiles, which 
fall between normalcy and the mean for the BSI psychiatric outpatient 
sample. Recalling that the non-patient group was selected by asking 
patients to pick "men like (themselves), of similar age," this possi-
bility is quite conceivable. The experimenter attempted to be method-
ologically conservative by selecting non-patient comparison subjects 
lvho were "informally matched for similarity" to the patients. Perhaps 
successful matching has been verified by these mutually elevated symptom 
profiles. The price paid would then be a false negative study result. 
This would imply that there is in fact an elevation of psychiatric 
symptomatology in the successfully treated Hodgkin's patient during the 
years off treatment. 
In summary, the patient to non-patient comparisons revealed little 
evidence for severe psychopathology i~ the cancer sample. However~ there 
were clearly some unique concerns and adaptational difficulties within 
the patient group. Some of these included lowered intimacy motivation, 
continuation of avoidant thinking toward their illness, and elevation 
of disease-related concerns. While exploration of these patient to non-
patient scores has been of great interest, it was recognized from the 
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inception of the study that separate control of factors such as dis-
ease, specific diagnosis, and treatment would be impractical. Thus, 
patient to non-patient comparisons have been viewed as a relatively 
loosely controlled inquiry into the general experience of past cancer 
and treatment taken together. The core of the investigation, however, 
related to the patient group only. In a more tightly controlled design, 
the 60 patients were separated into four cells identified by the two 
(disease severity) by two (time off treatment) factor matrix. This 
allowed the experimenter to examine closely the effects of disease 
stage (early vs. late) and time off treatment (recent vs. distant), upon 
the same dependent measures, within the patient group. The next section 
will summarize the findings of this more carefully controlled inquiry. 
Differences Within the Patient Group 
In the most global sense, the preponderance of non-significant 
findings on self-report measure comparisons would suggest that substan-
tial differences do not exist between early and late stage patients 
or between patients recently and distantly off treatment. If one were 
to judge the impact of patient variables solely on the basis of planned 
significance testing, the conclusion of very little difference would be 
justified. However, it was noticed that many of the differences between 
patient groups, while not statistically significant, were in the pre-
dicted direction. The two independent variables within the patient 
sample were disease (or treatment) severity and time off treatment. It 
was predicted that late stage patients would appear more disturbed than 
early stage patients, who in turn would appear more disturbed than non-
patients. Similarly, it was hypothesized that patients recently off 
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treatment would be the most disturbed, followed by patients distantly 
off treatment and non-patients, in that order. 
The post-hoc binomial ~ calculations demonstrated, for both in-
dependent variables, the presence of a subtle impact. The ordering 
of mean scores across the three levels (non-patients included) of each 
independent variable occurred in the predicted direction more often 
than attributable to chance. Therefore, while not of primary statis-
tical significance, the numerous correct orderings lend indirect 
support to the hypothesis of mild, subtle impairment in all patients. 
This impairment would seem to be slightly greater in later stage pa-
tients as well as in those patients recently off treatment. It may be 
that larger sample sizes would be sufficient to boost some of these 
non-significant trends to significance. Alternatively, these trends may 
be further evidence for only mild, non-pathological disruption of 
psychological functioning. This reaffirms the adaptational model of 
understanding survival, which emphasizes dynamic change within normal 
limits; change which assimilates external insults and reorganizes 
internal psychic structures to accommodate new demands (Silberfarb, 
1982; Sutherland, 1956; White, 1976). 
The self-report measures proved useful in the affirmation of low 
risk and high risk patient groups, in many cases where early stage 
patients distantly off treatment (low risk) were compared to late stage 
patients recently completing treatment (high risk). Global psycholog-
ical adjustment (GAS s-core), intrusive thinking about diagnosis and 
treatment, phobic anxiety, and depressive symptomatology were all 
significantly more impaired in the high risk group. This appears 
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sufficient to identify late stage Hodgkin's disease patients in the 
first two years off treatment as at significant risk for measurable 
psychosocial maladjustment. The reader may recall that the high risk 
group showed the greatest difficulty returning to full-time work, even 
when compared to all 45 other patients. The fact that all patients 
recently off treatment, including early stage patients, rated their 
current life situation as significantly lower than patients distantly 
off treatment (and non-patients as well) on the FOR Life Scale Rating 
is considered to be a related but more general result in that it 
applied to all patients recently completing treatment. 
In summary of the low risk-high risk distinction, the study re-
sults suggested that disease stage and time off treatment only tended 
to differentiate patients (as seen in the post hoc binomial z calcula-
tion). However, the identification of high and low risk groups based 
on these two factors in combination was justified on the basis of 
quality of life and coping style differences. This would suggest an 
additive effect of these two variables. So, for example, having had 
severe disease and treatment may not be accompanied by significant dis-
ruption three to six years off treatment, but it represents a much more 
palpable vulnerability in the first two years following treatment. 
This does not seem to be as clearly the case for earlier stage disease, 
Where fewer dependent measures were elevated, even in the recently-off-
treatment condition. The wake of the treatment ordeal does appear to be 
more problematic for later stage patients. 
One exception to this low risk-high risk distinction was the study 
data on conditioned symptoms. Compared to all early stage patients, 
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all late stage patients had significantly more conditioned nausea to 
treatment-related stimuli such as rubbing alcohol, perfume, cleaning 
fluids, and sights of the hospital or clinic setting. This makes clear 
intuitive as well as theoretical sense, since conditionability has been 
associated with severity of the unconditioned stimulus, in this case 
the severity of treatment (Morrow, 1982). Evidence for the tapering, 
though not elimination, of conditioned nausea over time was provided 
by the study's determination that patients recently off treatment had 
far more conditioned nausea than those distantly off treatment. This 
again confirms intuition and conditioning theory on extinction (Redd, 
Burish, & Andrykowski, 1983). The removal of the noxious unconditioned 
stimulus (treatment) results in repeated exposure to the associated 
(conditioned) environmental cues alone (smells, usually). The passing 
of time, and repeated exposure to the now-unpaired stimulus (i.e., the 
conditioned stimulus is experienced alone, without the unconditioned 
stimulus) results in the depotentiation of the learned associated. 
Therefore, patients appear to be able to "unlearn" most of their con-
ditioned nausea. 
It was mentioned that smells usually mediated the conditioned 
nausea. This has often been recognized as the chief mediator of con-
ditioned nausea (Love, Nerenz, & Leventhal, 1982; MOrrow, 1982; Redd & 
Andrykowski, 1982). It may in fact be that this smell-mediated con-
ditioning, because it is so visceral in its connection to taste and 
gustatory function, is not only the most learnable (Love, Nerenz, & 
Leventhal, 1982) but also the most "unlearnable." This is suggested, 
in part, because of this study's determination of no reduction over 
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time in conditioned anxiety, which is more sight-mediated. It seems, 
. 
then, that the gradient of extinction of conditioned anxiety is less 
steep than that of conditioned nausea. This would imply that, given 
enough time, the strength of the association between now harmless cues 
and anxiety will diminish. There are three problems with this argument. 
First, the constant pairing of conditioned and unconditioned stimuli 
in treatment would be more likely associated with rapid extinction off 
treatment because of the weak nature of this pairing schedule. Second, 
considering that taste aversions are among the most resistant to extinc-
t ion (Redd & Andrykowski, 1982), one might conclude that this is an 
example of that principle. The problem with this reasoning is that 
conditioned nausea, which did show significant extinction, is more 
taste-mediated than anxiety. There is a third weakness in the conclus-
ion that the anxiety measured in the patient sample represented truly 
conditioned anxiety which is slow to extinguish. This is that late 
stage patients (who were treated far more aggressively) were no more 
anxious than early stage patients. If this were simply a learned 
response to noxious treatment, one would have expected more aggressive-
ly treated patients to have learned more powerful associations to re-
minders of that treatment, as was the case with nausea. This did not 
happen with anxiety. 
These flaws in the conceptualization of post-treatment anxiety 
as a conditioned response which is resistant to extinction lead to 
speculation about an alternative explanation. It may be that post-
treatment anxiety is a trait characteristic and therefore evenly dis-
tributed across patient groups. That is, patients who are anxious upon 
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entering treatment experience further anxiety in response to cues 
associated with noxious treatment. This anxiety would not then be ex-
pected to diminish significantly over time, because it is as much a 
reflection of premorbid disposition as it is recent conditioning. In-
deed, patients who are more anxious upon entering treatment may be at 
higher risk for increase and continued elevation of treatment-related 
anxiety. The data from this study do not resolve this question, so only 
speculation is possible. It has been shown elsewhere, however, that pa-
tients who are anxious upon entering treatment are more easily and more 
strongly conditioned than those who are less anxious (Holland, 1982b; 
Love, Nerenz, & Leventhal, 1982). 
In summary of the data on conditioned nausea and anxiety, evi-
dence to support lessening of conditioned nausea in less aggressively 
treated patients and with the passing of time was quite convincing. 
The data fit very well that which would be predicted by learning theory 
and previous literature on the factors which contribute to conditioning. 
On the other hand, the data for conditioned anxiety do not fit this 
paradigm. Patients were undiscriminable as to disease stage and time 
off treatment. Given the prevalence of anxiety in the sample, it is 
suggested that "conditioned 11 anxiety may in fact better be understood 
as trait-related anxiety exacerbated by the treatment experience rather 
than strictly a learned response. Such patients, incidentally, might be 
expected to manifest more 11conditioned11 nausea than the non-anxious 
patients, since pre-treatment anxiety has been associated with increased 
risk of conditioning while in treatment (Holland, 1982b; Love, Nerenz, 
& Leventhal, 1982). This is potentially a very fruitful area for 
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future investigation. It would be very useful to know if patients at 
high risk for extended off-treatment anxiety related to treatment 
reminders can be predicted on the basis of pre-treatment anxiety. 
This section will conclude with a discussion of the prevalence of 
psychosocial problems surveyed in the patient sample which might relate 
to depression or negative affects in particular. The term "depressive 
equivalents" was used in this study to refer to symptoms or difficul-
ties not typically identified by the lay public as reflecting negative 
affective states. It was hypothesized that whereas patients might 
deny depression overtly (or even be unaware of it themselves) in an 
effort to look good, they would have less of an ability to deny depres-
sive equivalents if unable to recognize them as such. 
When patients' current off-treatment ratings were compared to 
their own retrospective in-treatment self-ratings, they were found to 
be significantly less irritable and depressed, and to be having much 
less difficulty with sleep and concentration. This is hardly surpris-
ing, given the clear disruption to smooth life functioning which treat-
ment can impose. Across-patients comparisons were somewhat different. 
Patients recently off treatment were no more depressed or symptomatic 
than those distantly off treatment (Table 9). This runs counter to 
the conclusion of D'Angio and Ross (1981) which states that psycholog-
ical distress drops over time. On the other hand, the fact that they 
were also no less depressed or symtomatic is in disagreement with 
other findings (Derogatis et al., 1979; Rogentine et al., 1978). Thus, 
this study's results of patient ratings on "depressive equivalents" 
suggested neither increase nor decrease of symptomatology over time or 
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across disease severity. 
While there is no way of confirming this with normative or corn-
parison group data, the frequencies of patient symptomatology seem high. 
An incidence rate of 57% complaining of decreased stamina is striking, 
although not as high as the Greenleigh Associates' (1979) 93% 
figure. This is especially significant in light of the on-
cologist's contention that toxic chemotherapeutic and radiologic physi-
cal aftereffects should be eliminated within the first six months off 
treatment. Sleep disturbance and concentration difficulty were 
problematic in just over one-quarter of the patient sample (27% each). 
The fourth "depressive equivalent, 11 eating habits, was only problematic 
in 13%, and had actually improved in 21% of patients. One speculative 
explanation for high incidence of fatigue, sleep difficulty and con-
centration difficulty, along with low incidence of eating disturbance 
is that of the four functions mentioned, eating is the one which 
probably has the most conscious control. Thus, the recovered patient, 
in an attempt to "do something" in order to adapt to his situation and 
counteract chronic uncertainty and potential dysphoria, might embark 
on a course of improved nutrition. Frequently, patients would comment 
that they had made concerted efforts to continue their struggle against 
poor health in general and relapse in particular by seeking nutritional 
consultation and change in eating habits. Eating well is something 
they can do to stay healthy (and deny dysphoria), while sleeping well, 
feeling strong, or concentrating effectively are not so easily done. 
The exploration into depressive equivalents was undertaken as an 
indirect inquiry into negative affects in the surviving cancer patient. 
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It appears that adaptation to cancer is truly multidimensional and it 
is therefore difficult to identify clear generalizations. The exper-
iences of diagnosis, treatment, and then extended remission constitute 
major events with probable far reaching consequences. In order to 
highlight this conclusion, the next section will present three brief 
case vignettes which exemplify the different vicissitudes of adaptation 
and adjustment. This will be followed by the final section which makes 
suggestions for future research. 
Case Examples 
The first gentleman, John (a pseudonym), is a 32-year old single 
man, three years off treatment for late stage illness. By his own 
description, he was an anxious, self-involved "neurotic" prior to his 
illness, who had been in psychoanalytic psychotherapy for two years 
before diagnosis. He had many friends but felt close to nobody. Dur-
ing treatment he was extremely anxious and fearful of death. He de-
veloped severe anticipatory nausea and vomiting. As he began to get 
positive signs from his physician, that he was free of any evidence of 
disease, for example, he started to feel quite proud of himself and 
internally strengthened. When treatment ended, he threw himself into 
his career as a film maker and teacher. He cut off contact with many 
acquaintances and focused his energies into deepening friendships which 
were more important to him. After agreeing with his therapist, he 
terminated his therapy one year after cancer treatment ended, resolving 
that he had accomplished a satisfactory amount. 
John rated himself presently as more self-confident and content 
than ever in his life. As he put it, "the sense of worth I got from 
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beating this illness taught me to like myself more and accept myself. 
I'm not so picky about things anymore. And I choose my friends differ-
ently now. I look for respect and support." This vignette no doubt 
paints a positive adaptational picture. However, there was evidence of 
continued conflict in the area of fertility. During the interview, he 
joked that the experimenter's questions about his infertility and desire 
for children were upsetting the balance he had achieved to date: "I'm 
not ready to deal with that one yet," he said. "It's still a budding 
issue for me now, so I can't talk about it too much or it'll upset me 
and it will be your fault (laugh)." 
The second case is a 39-year old married man with three children 
who will be called Michael. Michael is a man with early stage disease, 
off treatment for seven years. He has a long premorbid history of 
chronic dysphoria and low self-esteem. His father was an alcoholic and 
mother was described as particularly ungiving, demanding, and unaccept-
ing. Michael was married and had three children at the time of diagno-
sis. He was a passive, dutiful husband who felt trapped in an office 
job which he loathed but could never leave because of his sense of 
responsibility. As he put it, "I have always felt that my purpose in 
life was to do people favors and keep them happy." 
When Michael heard of his diagnosis he hardly reacted. "I just 
figured I'd see what would happen. It didn't really upset me, I took 
it in stride." During treatment he became fascinated with the technol-
ogy of the radiation therapy equipment~ and this fascination fueled a 
career change. When treatment ended, he went on public aid (against 
his wife's wishes) so that he could study nuclear medical technology: 
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"It was the first thing I really did just for me. No one could under-
stand it, but like one of my friends told me, it's too bad I had to 
almost die to get out of the work I hated." Michael's essentially 
dysphoric character was relatively unchanged by the impact of cancer 
and treatment, but the cancer experience did apparently free him from 
the long-felt shackles of job dissatisfaction. He is now a successful 
nuclear medical technologist. 
The third case example, Timothy, is a 29-year old physician with 
early stage disease, 11 months off treatment. Timothy is single and 
lives with his parents and younger brother in a suburban home out of 
which he practices. He agreed to participate in the study because he 
felt he owed it to his treating physicians, but the prospect of dis-
cussing his reactions to his illness frightened him. He had no signi-
ficant premorbid psychiatric history, but has had a spectrum of diffi-
culties which began in treatment and have persisted until the time of 
the interview. For instance, the repeated intrusion of suicidal 
ideation while driving his car and standing in high places troubled 
him during the treatment and early post-treatment periods. Related to 
this obsessional reaction was the recent emergence of a need to be sure 
all his bureau drawers are closed whenever he gets an article of cloth-
ing. Symptoms such as this emerged unpreceded by evidence of a pre-
morbid obsessive-compulsive disorder. Recurring nightmares with 
repressed content also still occurred once or twice per month. When 
asked how he knew the nightmare was recurring if he could not recall 
the content, Timothy explained that the feeling he has upon awakening 
is the same. When he wakes up from these nightmares, his thoughts are 
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invariably "of cancer and death." 
In a follow-up phone call to Timothy two weeks after the inter-
view, he stated that the interview and testing were difficult exper-
iences for him. The three-hour session revived intense anxiety feelings 
he had just begun to master in the past three to six months. He added 
that the disturbance he felt from the interview was ephemeral, lasting 
two to three days, and that things were now back to normal. "Normal" 
for him is a state of steady reorganization and restabilization which 
finds him gradually able to be more focused on his work and personal 
life as time goes on. His practice had been cut to three days per 
week, but he hoped to be up to full time within another year. 
One can see from these three case examples that the impact of 
cancer and treatment is not universally similar and is largely deter-
mined by personal character and predisposition as well as life circum-
stances. As the study data also indicated, it is difficult to accur-
ately generalize about the cancer experience. Much of adaptation 
to survival seems to be determined by individual differences in coping 
style and interpretation of the meaning which the illness carries. 
Future research in this area could be very useful in more clearly 
identifying the factors contributing to poor adjustment to cancer sur-
vival. Some suggestions for further investigation are offered in the 
next section. 
Suggestions for Future Research 
The results of this study, as well as the literature review 
which preceded them, point to certain need for further investigation 
into the area of psychosocial adaptation to cancer survival. This 
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study attempted to add to the fast-growing base of data by introducing 
the following unique characteristics: Focused study of a single diag-
nostic group and sex; and isolation and examination of the effects of 
disease stage and time off treatment upon adaptation to survival. It 
would be quite valuable, then, to extend the inquiry, first to female 
Hodgkin's disease patients, then to other age groups in order to deter-
mine the replicability and generalizability of this study's findings. 
Second, it would be useful to study other diagnostic cancer groups, 
preferably those with comparably favorable prognoses first. It will 
then become interesting to study survivors of poor prognosis cancers, 
to see if they might look more psychologically troubled. 
It has been emphasized that patient-wide generalizations about the 
long-term sequelae of successful cancer treatment are difficult to make. 
Some of the patient variables which seem to contribute to adaptation 
are the meaning which the patient ascribes to the cancer experience and 
the defensive characteristics and coping styles which they employ. It 
would be useful to isolate these variables and compare patient adapta-
tion across them. 
More specific study suggestions include replication and refine-
ment of the major results of the current investigation. The lowered 
readiness of cancer survivors to engage in warm, personal relationships 
has potentially far-reaching implications. It would be useful to deter-
mine whether this lowered intimacy motivation is indeed associated with 
a heightened attention to one's body and a sense of physical vulner-
ability; or if it is related to a counterdependent reaction against 
the passivity of the patient role, or both. 
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Another study result which could benefit from further investiga-
tion was the determination that conditioned nausea tended to follow a 
predictable course of decline, based upon knowledge of disease stage 
and length of time off treatment. However, the same was not true for 
so-called "conditioned anxiety." If, in fact, post-treatment anxiety 
in response to associated environmental cues is more a reflection of 
trait susceptibility than associative learning, there may be only 
insignificant lessening of disease- and treatment-related anxiety in 
the post-treatment period. It would therefore be beneficial to identify 
these high risk patients during the treatment period, so that preven-
tive measures could be taken early. Perhaps high pre-treatment anxiety 
will show itself to be a reliable predictor of continued post-treatment 
"conditioned" anxiety. 
S~RY 
This study examined the psychological functioning of 60 men, aged 
20-47, who had been treated for Hodgkin's disease, and compared them to 
an age-matched sample of 20 physically healthy men. All patients were 
off treatment and free of any sign of disease for at least six months. 
Besides the cancer variable, the independent variables of interest (with-
in the patient group) were disease stage (early vs. late) and time off 
treatment (6-24 months vs. 30 or more months). There were 15 patients 
in each of the four groups comprised by the above two variables. Can-
cer survivors were expected to show heightened psychological disturbance 
due to the prolonged stress of diagnosis and severe treatment, and be-
cause of uncertainty about the future. Within the patient group, those 
with later stage disease and those recently completing treatment were 
hypothesized to show greater disturbance. Dependent variables of inter-
est were psychosexual functioning, psychiatric symptomatology, intrusive 
and avoidant thinking toward the past stressor of diagnosis, self-esteem, 
death anxiety, global psychological adjustment, intimacy motivation, and 
interview ratings of psychosocial problems and quality of life. 
Patients were compared to non-patients and to themselves across 
the variables of disease stage and time off treatment, in a 2x2+1 fac-
torial ANOVA design. The hypothesis of greater psychosocial morbidity 
in the general cancer sample was partially confirmed by the significant-
ly lowered intimacy motivation scores and a trend toward more constrict-
ed sexual fantasy lives in the cancer patients. Patients also showed 
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significantly more avoidant thinking toward the stressful event of 
their diagnosis than the non-patients (NP's) did toward self-selected 
past stressors. Patients tended to appear more disturbed than NP's 
on many self-report and interview measures, as indicated by the frequent 
predicted ordering of non-significant mean differences. On the other 
hand, all patients were significantly more appreciative of life than 
NP's. It was concluded that disease stage and time off treatment were 
important variables in the post-treatment adaptation of successfully 
treated male Hodgkin's patients. The identification of "low risk" and 
''high risk" groups suggested a possible additive impact of disease 
severity and recent treatment cessation. A dramatic study result was 
the lessening of treatment-related nausea over time and across disease 
stage. The same was not true of "conditioned anxiety," suggesting it 
may be trait-related anxiety exacerbated by treatment and its reminders. 
It was concluded that the experience of cancer survival does seem 
to carry with it heightened psychosocial risks which do not generally 
extend beyond the boundaries of normal adaptation. However, there 
was some suggestion that extended remission also brings significant life 
appreciation and perhaps even character growth. Thus, generalizations 
about cancer survival are difficult to make, as adaptation seems to be 
strongly influenced by individual differences. 
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APPENDIX A 
ID NUMBER 
PROBLEM ORIENTED RECORD 
(revised) 














age at diagnosis: 
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1-10 = patient's rating of severity, on 
a 1 to 10 scale, with 1 being 
"not at all a problem," a;1d 10 
being "an extremely severe 
problem." 
date treatment began: --------
date treatment ended: ------
Diagnosis: 
Stage: 
Treatment info (chart) Months off treatment: 
------------------
THE FIRST THING I NEED TO DO IS GET SOME SPECIFIC FACTS FROM YOU, LIKE YOUR 
BIRTHDATE, FOR EXAMPLE. 
1. SEX-----
2. DATE OF BIRTH -------- 3. AGE ____ _ 




other (specify) ___ _ 
5. t~arital Status and Dates: 
never married 
married once 
married 2 or more 
divorced 
separated 
___ living with anyone? #years: __ _ 
for how long? ---
---separation/divorce dates: # yrs new marriage: 
when? new s/o? 
--- when? new s/o? __ _ 
widowed ___ when? new s/o? Cause of spouse's death: 
Spouse/ s/o occupation (even if deceased): 
Age of spouse: 
6. SIBLINGS Name Sex Age (indicate any deaths) 
7. PARENTS: Mother: alive 




8. CHILDREN: Name Sex 
9. Education: 
no formal education I some graduate school 
grammar school graduate 
high school graduate I equivalency 
some college 
college graduate 





~ Financially Financially DeQendent IndeQendent 
10. Current occupation: Same as before illness? ______ _ 
full time: paid leave: 
part-time:= unpaid leave: __ _ 
# hrs./week: looking for work: yes ___ 
SES: 0-10 10-20 20-30 30-50 50+ no ___ 
(in thousandS) if married, include-spouse. 
disability/ 
public assistance: ___ __ 
amount: 
# hrs work pre-ill? lwk 
# hrs work in tx? -~.:.:..:.:...-
_!.Y!Js_ 
11. Whom do you now live with and what are their relationships to you? 
12. Religion?-----------
Practicing? Yes __ No __ # of times been to service in past month: 
---
Can you tell me your diagnosis? Stage? 
----------------------- --------
13. What serious illnesses, injuries, etc., have you had? 
(indicate any that occured after initial diagnosis with an"*".) 
Dates Hospitalized? After Dx? 
Do you remember when your illness was first diagnosed? ---------
/ 
Who told you? 
----- Where was it? ---------------
What were the circumstances that led up to this? 
-------------------
When did l9J:!. first notice something was wrong?--------------
When did you first consult a physician?-------
What were your symptoms then? -------------------------------
What was the initial medical treatment before diagnosis? ____ _ 
How upset were you about these symptoms at that time? {1-10) ------
What was your reaction when you were told your diagnosis? ---------
FOR THE FOLLOWING QUESTIONS, PLEASE RESPOND IN TERMS OF THE TREATMENT YOU 
RECEIVED FOR YOUR ILLNESS. 
Were you hospitalized at all during your medical workup or treatment? _____ _ 
(if yes) When and for what? ---------------~How 1 eng? __ _ 
When did you start actual treatment? ________ When finish? ________ _ 
What treatment did you have for your illness? ------·-------------
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Surgery? No Yes What was done? ------------------
--------------Physical discomfort severity?(l-10) __ _ 
How upsetting? (1-10) __ 
Chemotherapy? No __ Yes_ What drugs do you remember?-----------
Physical discomfort severity?(l-10) __ _ 
How upsetting?(1-10) __ _ 
Radiation? No Yes Where? _____________ , _____ _ 
How long/how many times? ______ Physical discomfort severity?(1-10)_ 
How upsetting?(1-10) __ _ 
Any other treatment (e.g., other medicine, transfusions, etc.)? No Yes 
What? -------------Physical discomfort severity?(l-10) __ 
How upsetting?(l-10) __ 
Overall, how much distress did the treatment itself cause you?(l-10) 
Please rate the physical discomfort (1-10) and level of distress ·(1-10) 
which any of the following possible side effects of treatment may have 




No_ Yes_ Physical discomfort?(1-10)_ Upsetting?(l-10)_ 
No_ Yes_ Physical discomfort?(l-10)_. Upsetting?(l-10)_ 
diarrhea No_ Yes_ Physical discomfort?(l-10)_ Upsetting?(l-10)_ 






bad taste in mouth 
No_ Yes_ Physical discomfort?(l-10) __ Upsetting?(1-10)_ 
No_ Yes_ Physical discomfort?(l-10)_ Upsetting?(l-10)_ 
No_ Yes_ Physical discomfort?(l-10) __ Upsetting?(1-10)_ 
No_ Yes_ Physical discomfort?(l-10)_ Upsetting?(1-10)_ 
No_ Yes_ Physical discomfort?(l-10)_ Upsetting?(1-10)_ 
No Yes Physical discomfort?(l-10)_ Upsetting?(l-10)_ 
8. Did you find the general hospital care to be a problem, e.g., admitting pro-
cedures, etc? No_ Yes_ How much of a problem?(1-10) __ 
10. Did you find the care given by the nursing staff to be a problem (e.g., long 
waits for service, indifference, etc.)?No_ Yes_ How much a problem?(l-10) __ 
43. Was taking time off from your home activities to be in treatment a problem? 
No_ Yes_ How much a problem?(l-10) __ How many days? ---·----
Was taking time off from work to be in treatment a problem for you? 
No Yes How much a problem?(l-10) __ How many days? _____ _ 
97. Was the treatment a difficult experience in general for you? 
No_ Yes_ How much of a problem? (1-10) __ 
68. Did you have any financial burdens as a result of your treatment or illness? 
No_ Yes_ How much a problem?(1-10) __ Still in debt? No_ Yes_ 
What% of medical expenses were paid for by insurance/public assistance? 
0% 5-25% 26-50%_ 51-75% 76-95% 100%_ 
Did your illness or treatment result in a loss of job or income for you? 
No_ Yes_ Explain How much a problem?(1-10) __ 
117. While in treatment, did you experience yourself as being more irritable or 
on edge in your relations with people? 
No_ Yes_ How much a problem?(1-10) __ 
116. While in trea-ment, did you go through periods of feeling low, down, or 
blue? No_ Yes_ How long {%of time)? How much a problem?(l-10) __ 
119. While in treatment, did you have any trouble sleeping? 
No_ Yes_ How long (% of time)? How much a problem?(1-10) __ 
121. While in treatment, did you have any trouble concentrating? 
No_ Yes_ How long (% of time)? How much a problem?{l-10) __ 
While in treatment, did you ever take any medicicine for your mood or sleep? 
No_ Yes_ What/how long? ------------------
During the treatment period (including pre-treatment wait), did you have any 
contact with a professional counselor (e.g., psychiatrist, psychologist, 
social worker, clergy)? 
No Yes How much? For what? _________ _ 
73. While in treatment, were there any changes in your relationship with your 
spouse (s/o)? No Yes What? 
- - ----------------------
------------How much a problem?(1-10) __ 
70. Did you talk to your spouse (s/o) about what was wrong with you? 
No_ Yes_ Was it helpful? ____ _ 
Did your sex life change during treatment? No Yes_ How? _____ _ 
------------------How much a problem?{l-10) __ 
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IF NO S/0: 
ALL: 
Did your dating habits during treatment change? No_ Yes_ How? ____ _ 
--------------- HJw much a problem?(l-10) __ 
Did your sex life change during treatment? No Yes How? 
---------------How much a problem?(l-10) __ 
Was there any other major life change you experienced while you were in 
treatment? No Yes What? 
------------------
-----How much a problem then?(1-10)_~ Problem now?(1-10) __ _ 
NOW I'D LIKE TO ASK YOU SOME QUESTIONS ABOUT YOUR DOCTOR(S): 
Who was your main doctor during your treatment? 
Same as your follow-up doctor? __ if no, follow-up M.D.: _____ _ 
Did your treating doctor explain your illness and treatment to you? __ _ 
What would you say about the amount of information given to you by the 
doctor who explained the treatment? 
_far too much for me to absorb 
_somewhat more than necessary 
_just about the right amount 
_not quite enough 
_far too little 
Please rate your treating doctor (1-10) on each of the following qualities: 
Understanding of my feelings (l-10) __ 
Available to talk to (1-10) __ 
Informative about my illness and treatment (1-10) __ 
NOW I'D LIKE TO SHIFT OUR DISCUSSION TO THE PERIOD BETWEEN THE END OF YOUR 
TREATMENT AND RIGHT NOW. 
Since you completed treatment, have you noticed any symptoms that have 
concerned you? No_ Yes_ What? _________________ _ 
115. How concerned are you about what is wrong with you now?(1-10) __ 
Has your doctor been concerned about a recurrence or other serious 
complication? No_ Yes_ When and What? _____________ _ 
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Have plans for follow-up after treatment been a problem for you? 
No Yes In what way? ____________________ _ 
-------------How much a problem?{1-10) __ 
Have there been times when you have felt left on your own (abandoned) by 
your doctor or the hospital staff since you completed treatmer1t? 
No_ Yes How much a problem?{l-10) __ 
How often do you come in for follow-up? _____________ _ 
W~.at medical procedures have been done since you have been off treatment? 
(e.g., x-rays, blood tests, angiograms, etc.) 
96. Did you find these procedures upsetting in any way? 
No_ Yes_ How upsetting?{1-10) __ 
108. What other procedures are you expecting to undergo? _________ _ 
How worried are you about them?(1-10) __ 
2. Have you experienced any physical discomfort since ending treatment? 
No Yes When? Any in past month? ___ _ 
How much of a problem?{l-10) __ 
116. Since 
blue? 
completing treatment, have you experienced feeling low, down, or 
No_ Yes_ When? _______ in the past month? _____ _ 
How upsetting?(l-10) __ 
Since completing treatment, have you ever thought of hurting yourself on 
purpose? No_ Yes When? Ever before? ________ _ 
Have you taken any medication for pain, mood, or sleep since completing 
treatment? No Yes_ Pain what? in past month? __ _ 
Mood_ what? _______ in past month? __ _ 
Sleep~hat? in past month? __ _ 
117. Since completing treatment, have you ever experienced yourself as being more 
irritable or on edge in your relations with people? 
No_ Yes How much a problem?{l-10) __ 
75. Have you had any sexual difficulties? No_ Yes_ How much problem?{l-10) __ 
76. Is your sex life what you'd like it to be? No_ Yes Problem?(1-10) __ 
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Is your sex life what your partner would like it to be? Yes No_ 
How much a problem for you?(l-10) for partner?(1-10) 
73. Do you find ~changes in your relationship with your partner since you 
completed treatment? No_ Yes_ What? 
----------------------------
-----------How much a problem?(1-10) __ 
69. Has your partner's reaction to your illness been a problem in any way? 
No_ Yes_ How? Problem?(l-10) __ 
Are you talking to your partner about what was wrong with you? 
No ___ Are there times you would like to talk and find you can't? 
No_ Yes_ How disturbing is (was) this for you?(l-10)__ (70) 
Yes_Is it helpful? No Yes How disturbing is this?(1-10) (71) 
Are there times you-woul~like to talk and find you can'~ 
No_ Yes_ How disturbing is (was) this for you?(1-10)__ (72) 
IF NO S/0: 
87. Have there been any changes in your pattern of dating since treatment 
ended? No_ Yes What? ____________________________ _ 
-----------How much a problem?(l-10) __ 
ALL: 
FAMILY (excluding s/o) 
77. Has your family's reaction to all this been a problem for you in any way? 
No_ Yes_ How much a problem now? __ How much problem before?(l-10) __ 
Are you talking to your family about what was wrong with you? 
No Are there times you would like to talk and find you can't? 
-No_ Yes_ How disturbing is this?(l-10)__ (78) 
Yes_ Is it helpful? Yes_ No_ How disturbing is this?(1-10)__ (79) 
Are there times you would like to talk and find you can't? 
No_ Yes_ How disturbing is this?(l-10)__ (80) 
84. Has there been a change in your role in your family as a result of your 
i 11 ness? No_ Yes What? _________________________ _ 
--------- Problem? (1-10) __ 
85. Do you find any changes in your relationships with family members as a 
result of your illness? No_ Yes_ With whom and what? __________ _ 
--------- Problem?(l-10) __ 
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FRIENDS 
94. Have your friends' reactions to your illness and treatment been a problem 
for you in any way? No_ Yes How? 
________________ Problem now? ( 1-10 ) __ 
Are you talking to your friends about what was wrong with you? 
No Are there times you would like to talk and find you can't? 
-No_ Yes_ How disturbing is this for you?(1-10)__ (88) 
Yes_ Is it helpful? Yes_ Nu __ How disturbing is this?(1-10)__ (89) 
Are there times you would like to talk and find you can't? 
No_ Yes_ How disturbing is this for ~ou?(l-10)__ (90) 
Has there been a change in your role (or relationships) with friends as a 
result of your illness? N y --H ? o __ es __ ow. _____________ _ 
------------------ Problem?{l-10) __ 
Did your doctor describe future possible risks to your health which might result 
from treatment? No_ Yes What? __________________ _ 
(if not mentioned) ... mentioned(x) 
Recurrence? No_ Yes_ How upsetting?{l-10) __ 
Future illness {2nd malignancy)? No_ Yes_ How upsetting?{1-10) __ 
Organ failure? No_ Yes_ How upsetting?{l-10) __ 
Infection? No_ Yes_ How upsetting?(l-10) __ 
Sterility? No_ Yes_ How upsetting?(l-10) __ 
Other? How upsetting?(1-10) __ 
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Overall, how much distress did hearing of these risks cause you at that time?(1-10) ___ _ 
How much distress do they cause you now?(l-10) __ 
What, if any, bodily change has occurred as a result of your surgery {treatment)? 
---------------------Problem?(l-10) __ 
How has it affected your sexual activity? _______________ _ 
Has this been a problem for you? No_ Yes_ (1-10) __ 
How about for your partner? No_ Yes_ (1-10) __ 
What exactly were you told about your future capacity to father children? __ __ 
What is your current potential to father children (excluding sperm 
banking)? 
Since your treatment ended, have you had any tests (e.g., sperm counts) to 
see if you could have children? N y o_ es Results? _________ _ 
H01-1 much of a problem is this for you?{l-10) __ for your s/o?(l-10) __ 
Were you offered sperm-banking before treatment began? 
if yes, did you accept? No_ Yes 
Have you had any children since treatment ended? No Yes 
if yes, through sperm banking? No_ Yes 
Are you interested in having (more) children? 
No reason:a already have enough 
-- b-never wanted children 
c wanted once but changed mind 
if c ... did you change your mind because of illness? 
Yes_ What are your plans? __________________ _ 
FOR THE NEXT GROUP OF QUESTIONS, COMPARE YOUR LIFE BEFORE THE FIRST SIGN OF YOUR 
ILLNESS TO RIGHT NOW: 
----
29. Compared to life before your illness, has there been a change in the activities 
you enjoy doing alone? No Yes How much of a problem?(1-10) ___ _ 
30. Compared to life before your illness, ha~ there been a change in the activities 
you enjoy doing with your family? No_ Yes_ How much a problem?(1-10) ____ 
31. Compared to life before your illness, has there been a change in the activities 
you enjoy doing with your friends? No_ Yes_ How much a problem?{l-10}_ __ 
32. Compared to life before your illness, has there been a change in your usual 
housework routine? No_ Yes_ How much a problem?(l-10) ___ _ 
36. Compared to life before your illness, has there been a change in your own 
ability to do personal care? No_ Yes_ How much a problem? __ 
Compared to life before your illness, has there been a change in your 
physical abilities (e.g., running, walking)? No Yes Problem?( 1-l0) ___ _ 
38. (if children) Compared to life before your illness, has there been a change 
in your usual child raising activities? No_ Yes Problem?( 1_10 ) __ 
81. Compared to life before your illness, has there been a change in your 
interactions with family (excluding s/o)? No_ Yes_ Problem?(1-10) ___ _ 
83. Compared to life before your illness, has there been a change in the number 
of phone calls/letters with family? No Yes fewer? Problem?(l-10) __ 
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91. Compared to life before your illness, has there been a change in your 
interactions with friends? N y H h bl ?( 1 10) o_ es_ ow muc a pro em. - __ 
93. Compared to life before your illness, has there been a change in the 
number of phone calls/letters with friends? N y o es fewer? __ 
How much a problem?(l-10)__ - -
119. Compared to 1 ife before your illness, have you had a major change in 
sleeping habits? No Yes What Problem?(l-10) __ 
120. Compared to 1 ife before your illness, have you had a major change in 
eating habits? No Yes What Problem?(1-10) __ 
121. Compared to life before your illness, have you noticed a change in your 
concentrating ability? No Yes What Problem? (1-10 ) __ 
50. (if employed/in school) Compared to life before your illness, has taking 
time off from work or school been a problem? No Yes How much?( 1_1o) 
still a problem? No_ Yes_ How much?(l-10) __ - - --
43. Compared to life before your illness, has taking time off from your home or 
other activities because of your health been a problem for you? 
No_ Yes How much of a problem?(l-10) __ 
68. Do you feel that you curren~ have any financial burdens because of your 
illness and treatment? No_ Yes_ How much a problem?(l-10) __ 
Have you begun contact with a professional counselor (psychiatrist, psychologist, 
social worker, clergy) since treatment ended? 
No_ Do you feel it would be helpful? No_ Yes_ In what way? _____ _ 
Yes For what problem? ______________________ _ 
How much/long? _________ Helpful? __________ _ 
IF EMPLOYED 
Did your career plans change as a result of illness?-=---
51. Are your work responsibilities different from before your illness? 
No_ Yes_ less responsibility? No_ Yes_ How upsetting?(l-10) __ 
Job before illness? ·---------Job now? ________ _ 
Same company? Same fie 1 d? ______ ~---
if yes or no: 
52. Does your current employer know about your illness? No_ Yes_Problem?\1-10)_ 
53. Does your employer treat you any differently because of your illness? 
No_ Yes_ How upsetting is this for you?(l-10) __ 
if yes or no: 
54. Do your co-workers know about your illness? No __ Yes Problem?\1-10) 
55. Do your co-workers treat you any differently because of your illness? 
No Yes How upsetting is this for you?(l-10) __ 
IF LOOKING FOR WORK 
56. Are you encountering any difficulties in looking for work due to your 
illness? No __ Yes_ How much of a problem?(l-10) __ 
58. Are you experiencing any difficulties with employment agencies or prospective 
employers due to your illness? No __ Yes_ How much a problem?(1-10) __ 
~ 
57. Are you telling prospective employers or employment agencies about your 
medical condition? No __ Yes __ How much of a problem?(l-10) __ 
59. Do you need to acquire a new skill or retraining of any kind due to your 
illness? No __ Yes __ How much a problem?(1-10) __ 
IF NOT WORKING OR RETIRED DUE TO ILLNESS 
60. How much of a problem is it for you not to be working?(1-10) __ 
IF NOT WORKING - IN SCHOOL 
61. Did you lose any time from school/training due to your illness? No __ Yes __ 
Explain Problem?(l-10) __ 
63. Does the school administration (including teachers) treat you any differently 
due to your illness? No_ Yes_ How much of a problem?(1-10) __ 
65. Have you told your school administration about your medical condition? 
No_ Yes __ in either case, how much a problem?(1-10) __ 
64. Do your classmates treat you any differently due to your illness? 
No_ Yes_ How much a problem?(l-10) __ 
62. Do your classmates know about your illness? No_ Yes __ Problem?(1-10) ____ 
66. Have you had to change your career plans due to your illness? 
No __ Yes_ How much a problem?(1-10) __ still a problem? 
I'D LIKE TO ASK YOU JUST A FEW GENERAL QUESTIONS BEFORE WE STOP. 
How has the experience of your illness and treatment affected your outlook on 
1 ife? 
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Do you feel that you appreciate life and just being alive more fully than you 
did before your illness? No_ Yes_ How much more?(l-10) __ 
Are you more likely to see people around you as worried over petty vr trivial 
things, as a result of your experience with your illness? No Yes 
do you get impatient with them? No_ Yes_Problem?(1-10L_-
How serious did (do) you feel your illness was (is): 
1. When you were told your diagnosis?(l-10) __ 
2. When you were awaiting treatment? (1-10) __ 
3. When you were gettin~ treatment? {1-10) __ 
4. Now (1-10)_ _ 
1 = not at all serious 
10 = extremely serious 
(life and death) 
What are your plans for the future? -------------------
How much has your illness affected your plans?(1-10) __ 
Do you talk to your partner (or close family if no partner) about the future? 
No_ Yes_ (in either case) How much a problem?(l-10) __ 
Are there any problems we haven't touched on yet? ____________ _ 
During work-up? ______________ __:How much problem?(l-10) __ 
During treatment? How much problem?(l-10) __ 
After treatment? How much problem?(1-10) __ 
Right now? How much problem?(l-10) __ 
Any other co!llllents? ______________________ _ 
LIFE SCALE 
IF A "0" MEANT THAT YOUR LIFE WAS JUST THE WAY IT WAS BEFORE YOU WERE ILL, AND A 
"+10" MEANT THAT EVERYTHING WAS TOTALLY DIFFERENT AND BETTER, AND A "-10" MEANT 
THAT EVERYTHING WAS TOTALLY DIFFERENT BUT WORSE, WHERE WOULD YOU PLACE YOURSELF 
ON SUCH A SCALE? 
-10 9 8 7 6 5 4 3 2 1 0 1 2 3 4 5 6 7 8 9 +1D 
Different but worse Same as before different but better 
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Stimulus Nausea? Vomiting? I 
Anxiety? expla 
tx now tx now tx no~-.· 













Do 1 itt 1 e aches and pains upset you more now than they used to before your 
illness? No Yes Problem?(l-10) 
---
Do you check over your body moreso now than you used to? No Yes 
Prob 1 em? ( 1-10 ) __ _ 
How ~1orried are you about recurrence?(l-10) __ 
If you do have a recurrence, and your doctor recomends returning to treatment, 
will you: 
__ definitely go back 
__ probably go back 
__ really couldn't say (could go either way) 
_____probably not go back 
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INSTRUCTIONS 
Bel~ you will be asked to report certain attitudes and opinions, and provide info~ation 
about· some of your> sexual experiences. These questions are foaused on your thoughts 'lnd · 
feelings. Your answers and responses will be kept in the utmost confidenae, and only those 
members of the staff direatZy involved with your treatment will have aaaess to this infor-
mation. It will not be made avaiZable to anyone else unless you request it. The inven-
tory is divided into 10 sections, and in each seation you are asked something slightly 
different. In some you are asked to answer questions, LJhile in others you are asked to 
desaribe yourself. We also ask about problems you may be having and about some of your 
sexual thoughts, fantasies, and experiences. 
L1ch seation has a brief instruation LJhich will tell you LJhat you are to do in that section. 
Please LJork quiakly, and do not skip any-ttems. If you have any questions, please ask the 
teahniaian to help you. 
SECTION I 
Bel~ are some statements concerning general info~ation about sexual functioning. Please 
read each statement carefully. Once you have read it, indicate !Jhether you agree LJith the 
statement or not by marking TRUE for those you agree with, and FALSE for those you do not. 
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TRUE FALSE 
1. USUALLY MEN ACHIEVE ORGASM MORE QUICKLY THAN WOMEN 
2. HAVING INTERCOURSE DURING MENSTRUATION IS NOT A HEALTHY PRACTICE 
3. THE PENIS MUST BE ERECT BEFORE EJACULATION MAY OCCUR 
4. SIMULTANEOUS ORGASM IS NOT NECESSARY FOR A GOOD SEXUAL RELATIONSHIP 
5. MASTURBATION BY EITHER PARTNER IS AN INDICATOR OF POOR MARITAL ADJUSTMENT 
6. A WOMAN WHO HAS HAD A HYSTERECTOMY CAN NO LONGER EXPERIENCE ORGASM 
7. MEN REACH THE PEAK OF THEIR SEXUAL DRIVE IN THEIR LATE TEENS WHILE WOMEN 
REACH THEIR PEAK DURING THEIR 30'S 
8. A WOMAN CAN BECOME PREGNANT DURING MENSTRUATION 
9. MOST MEN AND WOMEN LOSE INTEREST IN SEX AFTER AGE 60 
10. A MALE'S ORGASM IS MORE SATISFYING THAN A FEMALE'S ORGASM 
11. THE PROPHYLACTIC (RUBBER) PROTECTS AGAINST CONCEPTION AND AGAINST VENEREAL 
DISEASE 
12. LUBRICATION IN THE FEMALE SHOWS SEXUAL EXCITEMENT LIKE THE MALE'S ERECTION 
13. ORAL-GENITAL SEX IS UNHEALTHY BECAUSE IT ENHANCES THE POSSIBILITY OF 
CONTRACTING VENEREAL DISEASE 






















FREQUENCY OF INTERCOURSE IS AN ACCURATE MEASURE OF SUCCESS OF A RELATIONSHIP 0 
A WOMAN MAY BE BROUGHT TO ORGASM BY MANUAL STIMULATION OF HER GENITALS 0 
MENOPAUSE IN A WOMAN CREATES A SHARP REDUCTION IN HER SEXUAL DRIVE 0 
WOMEN DESIRE SEX ABOUT AS FREQUENTLY AS MEN 0 
AN EFFECTIVE FORM OF CONTRACEPTION IS DOUCHING AFTER INTERCOURSE 0 




















STIMULATION 0 0 
21. FEMALES CAN MAINTAIN A SEXUAL RESPONSE THROUGH MULTIPLE ORGASMS 0 0 
22. MOST WOMEN ARE ABLE TO ENJOY SEX EVEN WITHOUT EXPERIENCING ORGASM .0 0 
23. THE BIGGER THE PENIS THE MORE SATISFYING IT IS TO THE FEMALE IN INTERCOURSE 0 0 
24. A WOMAN CAN NO LONGER BECOME PREGNANT ONCE MENOPAUSE HAS BEGUN 0 0 
25. ERECTION IN THE MALE IS BROUGHT ABOUT BY CONGESTION OF BLOOD IN THE PENIS 0 0 




::e:__;:.: are a list of sexual experiences that people have. We would Uke to know which of 
tr:~s~ ~e~,:::" ber4viors you ~~ve experienced. Please indicate those experiences you have 
r:ers~>::::ZZ~· f:ai Cb ;:Z:1ciY~g a chec:k ( [v] ) under the YES column for that experience. If 
~:u nave r~t.~d ;f:e experience place your check under-the NO column. In addition, if you 
r~ve ;;c.:..i :;t:e o;x;:erie;oe during the past two months please place an additional check under 

























:·:ALE LYI:;G PRC:;E ON FD!ALE (CLOTHED) 
.STRCKI::G A:m ?ET'l"D:G YOUR SEXUAL FARTtlER'S GENITALS 
E:RC7IC DlBRACE (CLOTHED) 
I::TERCOURSE-V.ZIGI::AL E:-JTRY FRCM REAR 
UW::;G GE:HTALS CARESSED BY YOUR SEXUAL PARTNER 
!·lUICAL ORAL STI;.IULATION OF GENITALS 
ORAL STI:·!ULATION OF YOUR PAR'I'NER' S GE:-iiTALS 
I:;T£RCOUE.SE-SIDE BY SIDE 
KI.OSI:;G OF s;:;;;siTIVE (NON-GENITAL) AREAS OF THE BODY 
I::IERCOURSE-SITTING POSITION 
:.~;.:..;:: KISSH:G FENALE 'S NUDE BREASTS 
f_;vi:;G YOUR A:<AL AREA CARESSED 
3REAST PETTING (CLOTHED) 
CARESSH;G YOUR PARTNER'S A..';AL AREA 
I:<T£RCOt;RSB-FEi<!ALE StiPERIOR POSITim< 
olU'l"CAL PETTI1<G OF GENITALS TO ORGASM 
u:,v:::G YOt;R GEtaTALS ORALLY STIHULATED 
HUTUAL Lll'iDRE.SSING OF EACH OTHER 
SLEP KISSING 
It:TERCOURSE-HALE SUPERIOR POSITION 
ASAL r:;TERCOURSE 
KISSING ON THE LIPS 
BREAST PETTING (NUDE) 
S~CTI Or-.J Ill 
YES 00 PAST fD DAYS 
[] [] [] 
[ ] [ ] [ ] 
[] [] [] 
[ ] [ ] [ ] 
[] [] [] 
[ ] [ ] [ ] 
[] [] [] 
[ ] [ ] [ ] 
[] [] [] 
[] [] [] 
[ ] [ ] [ ] 
[ ] [ ] [ ] 
YES 00 PAST I1J DAYS 
[ ] [ ] [ ] 
[ ] [ ] [ ] 
[ ] [ ] [ ] 
[ ] [ ] [ 1 
[1 [] [] 
[ 1 [ 1 [ 1 
[] [] [] 
[ ] [ ] [ ] 
[ 1 [ ] [ ] 
[ ] [ ] [ ] 
[ ] [ ] [ 1 
[ ] [ ] [ ] 
2eZow ~'e ~o~Zd Zike you to indicate the frequency with which you typically engage in certain 
ser~z activities. Please indicate how often you experience each of the sexual activities 
ceZow by cr.ecki~g ( [v] ) the category that is closest to your personal frequency. Categories 
ra:r.ge :;rem "::cr ;._;: ALL" to "4 OR :.JORE rn.fES A DAY". Please do not skip any items. 
NOT LESS 4 OR 
AT THA..'I 1 1-2 1 2-3 4-6 1 2-3 MORE 
ALL :·!ONTH MONTH WEEK WEEK V."'EEK DAY DAY DAY 
1. INTERCO\JRSE [ 1 [ ] [ ] [ ] [ ] I ] [ 1' [ ] [ ] 
2. HASTURBATION [ ] [ 1 [ ] [ ] [ 1 [ ] [ 1 [ 1 [ 1 
3. KISSING AND PETTING [ 1 [ 1 [ 1 [ 1 [ 1 [ 1 [ ] [ 1 [ 1 
4. SEXUAL F~'TASIES [ 1 [ 1 [ 1 [ ] [ 1 [ 1 [ 1 [ 1 [ 1 
5. WHAT WOULD BE YOUR IDEAL FREQUENCY OF SEXUAL WTERCOURSE ? 1 
6. AT ;,ru;T AGE DID YOU F.rRST BECOME INTERESTED IN SEXUAL ACTIVITY ? 




BeZc.'.J c;.;'e a seY"':es of stater:er.ts about various aspects of sexuaZ behavior. w'e wouZd Zi~e 
to know to ~"hat e:rtent you agree or disagree with each one. Flease indicate hm; m-.;.ch yc:;_; 
ag-::-ce or C.is-::gr.-e ?.'itl: eaah statement by plaO"~r.g tl:e appropriate nW'"her fnm the aZter-
na::~~'e:s l:eZc-_, in ti:e space alongside the statement. PZease do r.ot s7<.ip GY':d statenents 








AGREE NOR DISAGREE 
1. FFE~!ARITAL INTERCOURSE IS BENEFICIAL TO LATER MARITAL AWUSTMENT 
2. HC~!OSEX"UALITY IS PERVERSE AND L'NHEALTHY 
3. SEX IS ~lC.S.~.LLY RIGP.T ONLY WHEN IT IS INTENDED TO PRODUCE CHILDREN 




5. IT IS m:N.:l.Tl;RAL FOR THE FE!".ALE TO BE THE INITIATOR IN SEXUAL RELATIONS 
6 • 1'J'..STCE3A'IION IS A PERFECTLY NCR'!AL, HEALTHY SE:xt:AL BEHAVIOR 
7 • EXTP.A:·L'L'UT!'L SEX IllEVITABLY LEADS TO SERIOUS PROBLE!-'.S AND GREAT DIFFIITLTY 
IN ::-:.:: ?!.'SF.U.GE 
S. KC:·L~-J SEOULD !-.'"EVER BE CONSCIOVSLY SEDUcriVE Btrr SHOULD t-JAIT UPON TilE ATTE!;TIC~JS 
OF ::;.:: Y..'c."< 
9 • VE\HNG EROTIC FILMS IS ENJOYABLE AND STI:.!ULATING BL."!AVIOR 
"-0 • : ?.LS x:D FEY.;LES SHOULD ASS Ul>:E BOTH ASS£ RTI VE Al:O PASSIVE ROLES DURING n;TE FCOGRSE 
;~:D FCt;.EF U.Y 
11. ~-~CST HC~!OSEXUALS ARE HIGP.LY DISTURBED PEOPLE AND A DA.i.'-:GER TO SOCIETY 
12 • x_;y SEXt-;.L BEHAVIOR BETI·:EEN Tl-10 CONSENTING ADULTS SHOULD BE VIEWED AS NOR!-!AL 
12. ~~C? ... :..:.ITY SHCt:LD ~Jar BE A CO!JSIDERATION IN SEXVAL BEHAVIOR 
14. !:lFESSI:lG IN VARIOUS COSTUMES TO ENHA.i.'<CE SEXUAL ENJOY~NT SHOULD BE VIE':,'ED .'\5 
CP.E:.;!IVE SEX 
15. :SOCKS l·iHICH CONTAIN PASSAGES EXPLICITLY DESCRIBING SEXUAL ACJ'S ARE USUALLY 
JUST T!'.P.SH 
16. C0CFLES THAT HAVE SEX BEF'OP.E MARR!l>.GE t;SUALLY REGRET IT LATER CN 
17. WIIT~l·ll-.PPING IS ACCEPTABLE IF ALL FOUR PARTNERS AGREE 
18. MAr..ES LCSE PESPECT FOR FEI-'.ALES WHO ALLCW TEEM TO HAVE PRH!ARITAL PiTERCOURSE 
19. NLi''JAL HhS'IURBATION IN A MARRIED COUPLE IS A POOR StiBSTITUI'E FOR IN'I'ERCOC:<SE 
20 • PROSTITUTES ARE HJ.:>IO.RAL .";}lD DEGRP.DING A.i."<D HAVE NO PLACE IN SOCIETY 
21. HU:;..' GE!.;ITP.IS AFE SCMEl-iHAT DISGUSTING TO LOOK AT 
22 • HOLDING A..'D TOUCHI:-<G MY PAP;rtlER' S BODY IS EXCITING AND THRILLING 
2 3 • GF-Ot;P SEX IS A BIZARRE AND DIS GUSTING IDEA 
24. EXTF.AY"~RI'I'AL SE:X1JAL AFFAIRS CAN :.'.AKE PEOPLE BETTER :.'.ARITAL PA:RT!:ERS 
25 • COC:rLES S:iOL'LD EXPERIMENT WI7H VARIOUS POSITIONS OF INTERCOURSE TO El\1-l;.:;CE 
':"C:EIR SEXL"AL EX?EFJENCES 
26 • :-:?.STURBA'IION FANTASIES ARE HEALTHY FORMS OF SEXCAL RELEASE 
27 • HO.'!OSEXUALITY IS SIMPLY A QUESTION OF SEXUAL ORIENTATION AND Nor GCOD OR BP.D, 
SICK OR HE.li.LTHY 
28. ORAL-GENITPL SEX IS NOT WITHIN THE RANGE OF NOR!-!AL SEXUALITY 
29 • A PICTURE OF A NCDE WOI-'.AN CAN BE A BEAL'I'IFUL AND EXCITING THING TO LOO.'< AT 
30 • PORNOGRAPHY IS PERVERSE AND DISGUSTING IN GENERAL A.i."lD PARTICULARLY HAR'!FUL 
IN TilE HA.i."JDS OF YOU1lG PEOPLE 
PAGE 4 
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SECT! Ofi V 
::;:_ •. } c.o ~ z:st cf ;:rcbler".t> :~r.d c:cr-rZair.ts tl:a.t peapl€ scr?et-:.r7:es have. PZeaee read each one 
c•:::nc:f:,z:~... h.;'ter ;;c:.;, rune icr.e so, pwcse fiU in cr.e of the r.UJ"'bered spaces to the right 
7:-::::t 2·t:~St .::'".£.~~:J?.Y>. •. 1::;s EO~·; :-!l.-701 THAT PE:CBLE~! H.~ BCTHEPED CR DISTP.ESSED YCU IN THE FAST TWO WEEKS 
r:;~·:r.7_-~l t;G ~-.:,o_:_y. :._'J.::~~ c-·LZ-y a;:;;-7::.J)':te:r~ed s;ace fer ea.e71. f:ecC Zer-7 O:d de not skip any i te.'7'.s-. --
HC\'i :·VCH W!:PE YCXJ 
:son<::F:E.D BY : 
2. FAI:;:;-~·iESS OR DIZZI:-.;ESS 
3. 'IHE ID2.'\. T!:ihT sc:.:r:c::E 
ELSE Cri:l Cct:TP.CL YCt.:R 
:.;r ~iD 
4. FEELI:IG CTHEF.S ?.RE TO 
FLri:-!E F0R :-:JST GF YOGR 
TF.CU3L£S 
5. '!'RO:;'E.:.E ?£~~:C$ER.!~JG 
fin::Gs 






=0= =1= =2= =3= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=C= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
7. Fl\INS r:,; HEART CR CEEST =0= =1= =2= =3= =4= 
8. FEE:I~:G ~..?PAID I~·r :JFi.N 
SF.::..c·ss 
9. T;i.,:.,UG:iTS OF E!':I::I~·iG 
=0= ~1= =2= =3= =4= 
~·~R LIFE =C= =1= =2= =3= =4= 
10. FE~L:~;G 'I'HAT Y':ST :.:~OPLE 
c;~;~~-OT EE "i'RUS l:"ED ==0= =l= =2= =3= =4= 
11. POOR !.?PETITE 
12. S~DDE:-.;LY SC;RED FOR ~0 
REi'.SON 
13. TE:-lFER OU':'BGRSTS THAT 
YGU COULD NOT C01'TRDL 
14. FO:EI.IriG LC:IELY E\·'EN l'.'EEN 
YOU l.P.E (liTH P2CFLE 
15. FEELI:;r; BLO':KED Ill 
GE:L·'i'ING THI~;GS D~:-.~-:E 
16. FEELING LOl'ELY 
17. FI:.ELI:;G BLL'E 
13. FEELH<G :1::; n;:-:::REST 
IN :·HI:iGS 
19. FEELI:;G F£;,RFL'L 
20. YOUR FEELINGS BEING 
EASILY WJll.T 
21. FEELING THAT PEOPLE ARE 
l:c.;FRIE:lDLY OR D:SLIKE 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=G= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2~ =3= =4= 
=0= ~1= =2~ =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=('= =.1= =2= =3= =4= 
YOU =0= =1= =2= =3= =·~= 
22. FEELING I!:FERIOP TO 
OTHERS =0= =l= =2= =3= =4= 
23. :lAUSEA OR UPSET STCI'~;·::H =0= =1= =2= =3= =4= 
24. FEELI~<G TliAT YOU ARE 
v;;,;::;-;Er:: OR ':i'A:..'\.ED ABCCT 
BY ,J:iiERS =0= =~= =2= =3= =4= 
25. TPOCBLE Flo.:,LlNG .;SLEEP =0= =1= =2= =3= =4= 
~6. P ... "·."ii:JG TO C~(:K .:--...'JD 
;y__:.i;b;:.E C:iE::K ~,"H-~.:' YOU DO =0= =1= =2= =3= = <= 
t-:0.'1 r.'IJCH \!ERE YOU 
:bOThERED BY : 











29. FEELING AFRP.ID TO TRP.VEL 
ON Bl'SES, SlB',•:AYS OR 
TRAINS =0= =l= =2= =3= =4= 
29. TP.Ot.:BLE GETTING YOUR 
BREATH 
30. HOT OR COLD SPELLS 
31. E;.VI!'iG 70 AVOID CER'::'IIN 
T~I~GS ?LACES OR ACTI-
VI :'IES EE:CACSE TI-IEY 
FRl 3:17E~J YQU 
3 2. Y::CR ~-~::~;r;, GOING BL;..l;K 
33. ::-i..·~.s~~ss JR Tr~:::~:.::~c; :::~ 
P.:-.RTS OF :n::P. 2CDY 
"'0= =l.= =2= =3= =4= 
=0= =l= =2= =3= =4= 
=C= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
iCR YJGR s:~s =0= =1= =2• =3= =4= 
35. F:O:ELr:G HOPELESS ABOUT 
TEE ;:;.;':"'.:?.£ =0= =1= ..,2= "'3= =4= 
36. TROUBLE CO~!CE:iTRJI.TH:G =0= =1= =2= =3= =4= 
3 7. :;::E'LI.~G T(;E_;_l( IN FARTS 






FEF.LI~JG TE:~SE OR 
K::YED C? 
':"EOUGHTS OF I:·E.;':H C~E 
DYI~~G 
p._;"',t!~JG t:RG.ES TC BEAT I~lJ'~..~~RE CR HAR.'1 SC~~oNE 
H.:;VI}:G rF.GES 'ro EE~AK 
OR 5!-1h3H T:-i:~JGS 
FEELI::G ~RY SELF CON-
SCI·Jr.;s :·:I':H C:'HERS 
43. FEELI~;G T"'!~ASY IN 
:?Ci:DS 
44. ::E\~R ?:SELI~..:G CLOSE ::J 
=0= =1= =2= =3= =4= 
=0= =l= =2= =3= =4= 
=0= =l= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=J= =1= =2= =3= =4= 
=0= =1= =2= =3~ =4= 
=C= =1= =2= =3= =4= 
r.:;C':iOER ?E?.SCN =0= =l= =2= =3= =4= 
45. SFELLS OF TERROR OR 
f~.SIC 
46. GETTING INTO FREQGENT 
.".RGUXESTS 
47. FEELI~G ~IER'.'CUS \'.'HEN 
YOU APE LEFT ALONE 
48. C"f!"'RS '''"T GT'J"'IG Yr"'J 
FR:i?::R c?EDIT foR YouR 
=G= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
;; . :HIE'v-E:YENTS =0= =1= =2= =3= =4= 
49. F~rLI~~ co R~c~7 ES~ 
You .::O~L;:m'T~SIT STILi =O= =1= =2= =3= =4= 
50. FEELING CF i>CF.:'XL!:SS:;ESS=O= =l= =2= =3= =4= 
51. FEELING ~E,PLE I'IILL TAKE 
.;;r;v.~;:-.:c_-:;E CF YCU IF YOU 
LET ':'HE!1 =0= =1= =2= =3= =4= 
52. F:::EL!:;c;s C'F .:;t.'ILT =u'-" =1= oo2= =3= =4= 
53. 7.-iE r::::A TE.!:.'T SC,~·!E'T~ING 




Edo~• is a list of words that describe the way people sometimes feel. We would Zike you to 
t.3 :z !iS ::hether you hcro·e been having ar:y of these fee Zings during the past !!:!2_ ~· Please 
[;ccHcate the deg:rxe to z.1hich y01 .. have typicaZZy felt each emotion by fiZZing in one of the 
1::,~.:-en::d spa:Jes that best describes your experience. 
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=2= =3= =4= 
=2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
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=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
=0= =1= =2= =3= =4= 
SECTION VI I 
?dcr,y is a Zist of personality characteristics that are often used to describe people. ~ie 
:.·~·u!d :ike you to describe yow"Se lf in terrr.s of these characteristics. To do this, please 
-:> Hcate the degree to which each trait is typical of you--in other :.:ore!E, hOI.J r'!UOh of each 
:J':cZracter=:stic you have. Use the nurriJere'd scale given belcv, and place the a;::prcpricte 
'::-rier alo>1gsidB each trait. 
0 1 2 3 4 
NOT J..'I ALL A LITTLE BIT HODERATELY QUITE A BIT EliTPE~!ELY 
1. SYMPATHETIC [ 11. SENSITIVE [ 1 21. GRACEFUL [ 1 2. DECISIVE [ 12. INDEPENDENT [ 1 22. DOMINANT [ 1 3. FRIVOLOUS [ 13. DOHESTIC [ 1 23. SEDUCTIVE [ 1 
4. PRACTICAL [ 14. BOLD [ 1 24. AtJrHORITATIVE [ 1 5. SENTHIENTAL [ 15. rEP EN DENT [ 1 25. WHI!>'.SICAL [ 1 6. RATIONAL [ 16. ADVENTUroUS( 1 26. ATHLETIC [ 1 
7. SECRETIVE [ 17. FELINE [ 1 27. FASHIONABLE [ 1 8. CONFIDENT [ 18. STroNG [ ] 28. AGGRESSIVE [ 1 9. m:.w:;ssiONATE [ 19. FLIRl'ATIOUS [ 1 29. GENT I.E [ ] 




In th-!-s scCJticn :Je have Usted a Va:t'iety of ser..<aZ ideas, and fantasies that people sone-
t ~.,<Js ;u:;e. ;.;8 :..'c'A Zd Z ike you to indicate which of these fantasies you have experienced 
either in c!a~;:h•c:rs or> ire=s "-'hile asleep. For each fantasy th.at you have experienced 
pZ::z.:1e a e;:er;:;k ({I} ~n the S;'ace alongside tr.at item. 
1. { } HAVING ~lORE THAN ONE SEXUAL PARTNER AT THE SAME TII"E 
2. { } HAVING n;TERCOUR.SE IN UNUSUAL POSITIO:-JS 
3. { } p_wi:~G SEXUAL RELATIONS WITH ANIHALS 
4. { } i.'HI?PING OR BEATING YOUR SEXUAL PARTNER 
5. { } FGRCI:'G A PART.-IER TO SUBHIT TO SEXUAL ACTS 
6. { } DRESSING IN CLOTHES OF THE OPPOSITE SEX 
7. { } USirlG ARTIFICIAL DEVICES FOR SEXUAL STIHULATION 
8. { } BEI~IG A PROSTITUTE 
9. { } FORBIDDEN LOVER OR MISTRESS IN SEXUAL ADVENTURES 
10. { } HG:·lOSEXUAL FANTASIES 
11. { } ~.ATES\'IAPPING FANTASIES 
12. { } BEI:<G TIED UP OR BOUND DURING SEXUAL ACTIVITIES 
13. { } DEGR~DING A SEX PART.-IER 
14. { } BEING SEXUALLY DEGRADED 
15. { } ANAL INTeRCOURSE 
16. { } DRESSING IN EROTIC GAR'~NTS 
17. { } SEXUAL INTERCOURSE 
18. { } FANTASIZING THAT YOU ;RE OF THE OPPOSITE SEX 
19. { } O!V.L-GEmTAL SEX 
20. { } BEING FORCED TO SUE:1IT TO SEXUAL ACTS 
SECTION IX 
Belew are sol":e state~:ents ac-nceP1ing how you vie"w your body. Please indicate to wh.at de-
gree each of the fe!lZo:,;ing stc.terr:ents is tr-v~e of' 'JOU by aircZing the nur.:cer that best de-
cc:eices '.lOUr ex:::erience. .'lote that Part A is for both sexes, Pa:t't B is for nen ody, an:i 
?xrt C i~ for 1J~rr:en only. 
"" "v 
...,A. .Q"' ~ ~ ./3' 'b' ...,::.., 




. .., ' ~ ~
,? "" PART A (BOTH SEXES) ;;; ! 0:. ct 
"' "' "' "' "' 1. I AM LESS ATTRACTIVE TH.ll.N I WOULD LIKE TO BE 0 1 2 3 4 
2. I A.'1 TOO FAT 0 1 2 3 4 
3. I ENJOY BEING SEEN IN A BATHING SUIT 0 1 2 3 4 
4. I AM TOO THIN 0 1 2 3 4 
s. I \·lOULD BE EMBARAS SED TO BE SEEN NUDE BY A 
LOVER 0 1 2 3 4 
6. I AM TOO SHORT 0 1 2 3 4 
7. THERE ARE PARTS OF MY BODY I DON'T LIKE AT ALL 0 1 2 3 4 
8. I A . .'1 TOO TALL 0 1 2 3 4 
9. I HAVE TOO HUCH BODY HAIR 0 1 2 3 4 
10. MY FACE IS ATTRACTIVE 0 1 2 3 4 
PAGE 7 
PART B (MEN ONLY) 
11. I HAVE A ~~LL PROPORTIONED BODY 
12. I AM SATISFIED WITH THE SIZE OF 
MY PENIS 
13. WOMEN WOULD FIND MY BODY ATTRACTIVE 
14. I AM WELL-COORDINATED AND ATHLETIC 
15. I AM PLEASED WITH THE PHYSICAL CON-
DITION OF MY BODY 
PART C (WOMEN ONLY) 
16. I HAVE A SHAPELY AND WELL PROPORTIONED 
BODY 
17. I HAVE ATTRACTIVE BREASTS 
18. MEN WOULD FIND MY BODY ATTRACTIVE 
19. I HAVE ATTRACTIVE LEGS 




























Below are some statements about sexual satisfaction. Please indicate whether each state-
ment is true of you by checking either true or false for each item. 
1. USUALLY, I AM SATISFIED WITH MY SEXUAL PARTNER 
2. I FEEL I DO NOT HAVE SEX FREQUENTLY ENOUGH 
3. THERE IS NOT ENOUGH VARIETY IN MY SEX LIFE 
4. USUALLY AFTER SEX I FEEL RELAXED AND FULFILLED 
5. USUALLY, SEX DOES NOT LAST LONG ENOUGH 
6. I AM NOT VERY INTERESTED IN SEX 
7. USUALLY, I HAVE A SATISFYING ORGASM WITH SEX 
8. FOREPLAY BEFORE INTERCOURSE IS USUALLY VERY AROUSING 
FOR ME 
9. OFTEN, I WORRY ABOUT MY SEXUAL PERFORMANCE 
























GSSI - Below is a rating scale upon which we would like you to record your perso1wl 
evaluation of how satisfying your sexual relationship is. The rating is simple. 
Make your evaluation by pZacing a check in the appropriate box that best describe< 











B COULD NOT BE BETTER 
7 EXCELLENT 
6 GOOD 
5 ABOVE AVERAGE 
4 ADEQUATE 
3 SOMEWHAT INADEQUATE 
2 POOR 
1 HIGHLY INADEQUATE 
0 COULD NOT BE WORSE 
APPENDIX C 
~EMORIAL HOSPITAL 
12i5 YCRK AVENUE 
NEW YORK. N.Y. 10021 
PATIENT JN'JESTIGAiiVE CONSENT FO,RM 
C::NSE~;T rCP. ~EW PROCEDURE. STUuY OR DRUG UNOEii CLINICAL INVESTIGATION p 
PATIENT 
I have been asked to participate in a study of psychological adjustment 
to the successful treatment of Hodgkin's disease. The chief investigator of 
this project is Jirrmie.C.B. Holland, M.D.~ a ·Memorial Hospital attenaing 
physician. 
~articipation in tnis study will entail approximately two hours of rny 
time and will be scheduled at my convenience. I will be interviewed briefly. 
then asiu~d to ccmpiete five snort questionnaires, followed by an exercise in 
which I will tell imaginative stories to some pictures. A member of the 
study staff will be with me the entire time, and answer any questions I 
might have. This person, David Cella, can be reached for further questioning 
at (212) 794-8229. If I don't call him, he will phone me within the next 
month as a routine follow-up. 
I understand that participation in this study is voluntary, and that I 
will receive no direct benefit by participating. I know that I can withdraw 
from the study at any time, and that my medical treatment will in no way be 
influenced by such a decision. I also·know that, short of withdrawing from 
the project, I may decide not to answer any question or set of questions, 
and still continue with the intervie·.~. 
I have been informed that the study will involve questions about personal 
sexual matters, death-related concerns, self esteem, uncertainty, anxiety, and 
stress. All information I disclose to the stuay investigator will be kept in 
the strictest confidence and used only for research purposes. My name will 
not appear on any document or publication which might emerge from this project. 
While there are no physical risks involved in my taking part in this 
study, a few of the questions might revive emotional experiences which may 
at one time have been distressing. However, the interviewer will be available 
to discuss this with me should it occur. 
With the above in mind, I, , agree to participate 
in the study described above. It has been explained to my satisfaction, and I 
have been given the opportunity to discuss it further. 
SIGNED: _....;..... _______ _ DATE: ~--------
I have fully explained to the participant the nature and purpose of the 
study described above. 
Signature of research staffperson 
172 
MEMORlAl HOSPiiAL 
1275 YORK AVEt;UE 
NEW YCRK. N.Y. 10021 
~. w 
PATIENT INVESTIG.lTIVE CONSENT FORM 
CN;SENT FOR NEW PROCEDURE. STUDY OR DRUG ·u~IOEA CLINICAL INVEST!GA no~ 
CONTROL 
c 
I ~~ve been asked to participate, as a me~ber of a comp!rison grouo, in a 
>tudy of the successful treatment of Hodgkin's disease. The chief investigator 
of this prcject is Jirrmie C.B. Holland, t~.D., a Memorial Hospital attending 
physician. 
Participation in this study will entail approximately two hours of rr:y t~me, 
and will be sched~led at mv convenience. I wi11 be interviewed brieflv, then 
asi.ed -;;o COi.lp1ete five :>nort questionnaires, f;:;11~a•Cd :;.y .lr. exercise in .vr.icn ~ 
will tell imaginative stories to some pictures. A member of the study staff 
'.<iill be with me the entire time to answer any questions r might have. This 
person, David Ceila, can be reached for further questioning at {212) 794-8229. 
If I don't call him, he will phone me within the next month as a routine follow-up. 
I understand that participation in this study is voluntar~. and that I will 
receive no direct benefit by participating. I know that I can withdraw from the 
study at any time. I also know that, short of withdrawing from the project, I 
may decide not to answer any question or set of questions, and still continue 
with the interview. · 
I have been informed that the study will involve questions about personal 
sexual matters, death-related concerns, self esteem, uncertainty, anxiety, and 
stress. All information I disclose to the study investigator will be kept in 
the strictest confidence and used only for research purposes. My name will not 
appear on any document or publication which might emerge from this project. 
While there are no physical risks involved in my taking part in this 
study, a few of the questions might revive emotional experiences which may at 
one time have been distressing. However, the interviewer will be available 
to discuss this with me should it occur. 
With the above in mind, I, , agree to participate 
in the study described above. It has been explained to my satisfaction, and I 
have been given the opportunity to discuss it further. 
SIGNED: ----------- DATE: --------
I have fully explained to the participant the nature and pur?ose of the 
study described above. 
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